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Abstract 
Background: Freezing of gait (FOG) is considered to be a motor disorder symptom 
that affects some Parkinson Disease (PD) patients; however, it is hypothesized that 
sensory systems may also be involved in FOG.  
 
Purpose: The purpose of this thesis is to measure different 2-dimensional (2-D) and 
3-dimensional (3-D) clinical visual functions in FOG and non-FOG PD patients. The 
ability to maintain adequate alignment of the two eyes was assessed by measuring 
fixation disparity curve. The other objective of this thesis was to look at integrity of 
autonomic nervous system (ANS) and two non-motor functions mediated by the 
cholinergic system in FOG and non-FOG PD patients. FOG PD patients may have 
greater impairment of one, or more, of these functions.   
 
Methods:  The 2-D visual function measurements included high and low contrast 
visual acuities using Early Treatment Diabetic Retinopathy Study charts, low spatial 
frequency contrast sensitivity using Pelli-Robson chart, horizontal and vertical 
Vernier acuity using The Freiburg Visual Acuity Test. These tests were conducted 
under photopic, and then under mesopic conditions.  
 
The 3-D visual function measurements included local (contour) and global (random 
dot) stereopsis at near. Local stereoacuity was measured using Circles and MKH-
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Haase Line tests. Global stereoacuity was measured using the MKH-Haase Steps, 
TNO, Randot 3, and Butterfly tests. Fixation disparity curves were measured using 
the Saladin Near Point Card. 
 
Constriction and dilation pupil light reflexes (PLRs) were measured by using a 
handheld monocular pupillometer to evaluate the integrity of ANS. The inspection 
time (IT) was determined by a simple length discrimination task to evaluate the 
integrity of the cholinergic system.  
 
Twenty-two FOG PD patients, 25 non-FOG PD patients, and 25 aged matched 
healthy controls (HC) completed all of the measurements in this project. 
 
Results: FOG group had worse 2-D visual resolution results than other two groups 
especially under the mesopic condition. FOG group also had worse stereopsis than the 
other two groups. An impairment in global stereopsis was more common than local 
stereopsis in both PD patient groups. The reduction in stereopsis among PD patients 
was not associated with the fixation disparity.  
 
Both PD patient groups showed significant differences from healthy controls in most 
of PLR constriction parameters. FOG PD patients showed larger deficits than non-
FOG PD patients in some of the constriction parameters. Both groups of PD patients 
had longer dilation latencies than healthy controls.  
  vi 
FOG PD patients had slower IT scores than healthy controls. IT scores for the non-
FOG PD patients fell in between the FOG and HC results.  
Conclusions: FOG patients have a greater impairment in both 2-D and 3-D visual 
functions. Whether these impairments are contributing to the FOG or just associated 
with FOG is uncertain. FOG patients also had larger impairments in non-
dopaminergic mediated functions such as PLRs and IT, which suggests that FOG 
patients have greater impairment in two functions that involve cholinergic 
neurotransmitters.    
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Chapter 1 
GENERAL INTRODUCTION 
1.1 BACKGROUND  
Parkinson’s disease (PD) is a neurodegenerative disorder that affects the central and 
peripheral nervous systems and leads to disturbance of body motor functions such as 
bradykinesia (slow movement), muscle rigidity, resting tremor (shaking), and postural 
instability (Bernheimer et al., 1973). 
 Parkinson’s disease is the second most widespread neurodegenerative disorder after 
Alzheimer’s disease, and the most common neurodegenerative disease among older 
adults in developed countries. The estimated prevalence of PD in industrial countries 
is 0.3% and the incidence rate is about 8-18 per 100,000 person years (de Lau & 
Breteler, 2006). With increasing age, the prevalence increases to about 1% among 
those who are above 60 years old, and about 4% among those who are above 80 years 
old (de Rijk et al., 1995; Guttmacher et al., 2003). 
 
Reduction of the dopamine neurotransmitter through cell death is considered as the 
primary cause of motor disturbances in PD patients (Scatton, et al., 1983). The 
majority of cell death occurs within the basal ganglia complex, specifically in the 
frontal part of substantia nigra (or the black substance) which is called the pars 
compacta (Davie, 2008; Rabey & Hefti, 1990). 
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 Before any movement occurs, the basil ganglion complex inhibits various motor 
systems. Once a movement is coded, signals are sent to the basal ganglion to release 
inhibition (i.e. disinhibit) of the specific motor pathway. Dopamine release is one of 
the neurotransmitters responsible for the disinhibition. If the dopamine levels are low, 
such as in PD situation, then there is less disinhibition and patients will exhibit 
hypokinesia (i.e., slow body movement) or, akinesia (i.e., no body movement). PD is 
managed usually by prescribing Levodopa in order to compensate for the intrinsic 
reduction of dopamine. The additional dopamine may produce excessive dopamine 
levels, which results in hyperkinesia (i.e. increased body movement) (Obeso et al., 
2008).  
The basal ganglia is connected to many different  parts of brain such as superior 
colliculus, cerebral cortex, thalamus, and the brain stem through different channels 
i.e. motor, oculo-motor, associative, limbic and orbitofrontal circuits. These circuits 
are responsible for different functions including body movement, eye movement, 
perception, learning, attention, emotions, behaviors, cognitive abilities…, etc. For this 
reason, basal ganglia are not only involved in motor function, but they are also 
involved in sensory and cognitive functions. In addition, dopamine is found 
throughout different sites of the nervous system. These two findings have led 
investigators to look at other sensory and cognitive functions in PD. Non-motor 
disorders include anxiety, depression, cognitive dysfunction, sleeping disorders, pain, 
olfactory disturbances, visual hallucinations and impaired visual function have been 
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reported in PD patients (Chaudhuri, Healy, & Schapira, 2006; Chaudhuri & Schapira, 
2009; Hou & Lai, 2007; Park & Stacy, 2009; Poewe, 2008).  
PD patients are also characterized by non-motor symptoms and signs that are 
probably not solely due to a reduction in dopamine. These deficits are believed to be 
due to primarily the cholinergic system dysfunctions. Different cholinergic system 
dysfunctions in PD patients have been reported. Within the autonomic nervous 
system, these include cardiovascular functions, sexual and urinary problems, 
gastrointestinal problems, respiratory difficulties and thermoregulation problems. In 
the visual system, the pupil light reflex (PLR) is mediated by the autonomic nervous 
system. Different parameters of pupil light reflex are affected in PD patients 
(Chaudhuri et al., 2006; Chaudhuri & Schapira, 2009; Micieli, Tosi, Marcheselli, & 
Cavallini, 2003). 
Deficits in the cortical cholinergic systems are also linked to learning and executive 
function. Calabresi, et al (2006) hypothesize that some of the cognitive deficits in PD 
patients are due to a combination of dopamine and acetylcholine depletion because an 
increase in dopamine is not sufficient to affect certain cognitive performance and 
acetylcholinesterase inhibitors are useful in the treatment of dementia associated with 
PD. They further hypothesized that at the cellular level, dopamine and acetylcholine 
interact to produce the synaptic changes associated with learning and memory  
(Calabresi et al., 2006). This interaction is altered in PD and so these patients  
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experience problems with working memory and learning tasks. Given these findings, 
it is not surprising  that different sensory and cognitive functions are impaired along 
with motor functions in PD (Obeso, et al., 2008), despite James Parkinson’s statement 
in his opening chapter that “the senses and intellect being uninjured ” in his detailed 
description of the disease bearing his name ( Parkinson, 2014). 
 
Postural instability is one of the motor disturbances associated with PD disease. Two 
features of postural instability are falls and freezing of gait (FOG). Freezing of gait is 
defined as discontinuous or interrupted episodes, which lasts for few seconds, of 
inability to produce or maintain a forward movement or to make a turn (Gordin, 
Kaakkola, & Teräväinen, 2003). The underlying pathophysiological mechanisms for 
falls and FOG are not completely understood, but these mechanisms may be linked. 
First, these two symptoms are more common in the advance stages. Second, freezing 
of gait often leads to falls. Third, both of these two problems often have poor 
responses to dopaminergic treatment (Bloem et al., 2004; N. Giladi, Hausdorff, & 
Balash, 2013; Giladi et al., 1992; Nutt et al., 2011).    
 
Although FOG is considered classically as motor dysfunction in PD patients, it is now 
hypothesized that impairment of different non-motor systems may contribute to FOG 
(Giladi et al., 2007). Balance is a function that depends on intact processes from the 
visual, vestibular and somatosensory systems and from the motor outputs of muscles. 
The sensory and motor systems are integrated through different pathways in the brain 
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and work together to produce normal response of posture and locomotion (Gordin et 
al., 2003). Deficits in the sensory portion of balance may contribute to FOG. Almeida 
and Lebold (2010) hypothesized that the visual perception of the surrounding space is 
impaired in FOG patients more than non-FOG patients and that might contribute to 
their freezing symptoms. FOG patients have more visuospatial judgement and motion 
perception errors compared to non-freezers and normal individuals. The visuospatial 
deficits were correlated with their walking performances (Almeida & Lebold, 2010). 
FOG patients underestimated the actual distances to a target during both static and 
dynamic conditions more than non-freezers patients and normal individuals (Martens, 
Ellard, & Almeida, 2014). They also have more difficulty in moving through a 
narrow doorway compared with non-FOG ones (Silveira et al., 2015). This latter 
finding is consistent with their underestimation of distances. That is, objects appear 
closer to them compared to non-FOG. Nevertheless, removing visual cues will 
increase the number of FOG occurrences. The number of FOG occurrences/episodes 
increase when patients were asked to walk toward a door in a dark room compared to 
a well-lit room where they have full vision of their bodies and door. This finding 
suggests other sensory inputs involved in movement are impaired, there is problem 
with integration of the balance systems or both problems occur. The association of 
FOG with various visuospatial deficits and the non-responsiveness of FOG to 
dopamine also suggest that the FOG could be a result of an acetylcholine 
deficit/imbalance.  
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Impaired function of higher cortical centres is believed to be responsible for the 
visuospatial problems associated with FOG. The question we are addressing is 
whether basic clinical visual functions are affected differently in FOG patients. A 
number of basic visual problems have been reported in PD, but the studies did not 
separate the PD patients into freezers and non-freezers. Before reviewing these 
functions, however, I will review the pathophysiological changes in the visual system 
associated with PD.  
1.2 RETINA IN PARKINSON’S DISEASE 
Dopaminergic neurons are located in different layers of the retina with an A18 
subtype of amacrine cells of the inner plexiform layer being one of the more studied 
cells. The highest concentration is located in the perifoveal area of the primate retina 
(Archibald et al., 2009; Bodis-Wollner, 2013; Frederick et al., 1982; Nguyen-Legros, 
et al., 1993; Nowacka, et al., 2015). The inputs to these dopaminergic amacrine cells 
in the retina are not clearly defined, but A18 amacrine cells receive their input mainly 
from rod bipolar and, to lesser extent cone bipolar cells. The output of the amacrine 
cells is primarily to the retinal ganglion cells (Archibald, et al., 2009). Autopsy 
studies on PD patients showed severe loss in concentration of dopaminergic neurons 
in the perifoveal area of the retina (Tsironi, et al., 2012).  
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In general, dopaminergic neurons are involved in mediating the visual signals from 
cone and rod bipolar pathways to ganglion cells (Djamgoz & Wagner, 1992; Mangel 
& Dowling, 1985; Mangel & Dowling, 1987; Witkovsky, 2004). In many species, 
stimulating the retina with increasing light results in an increase of dopamine released 
especially from the amacrine cells (Da Prada, 1977; Godley, Flaherty, & Wurtman, 
1985; Iuvone et al., 1978; Kramer, 1971; Lamb & Pugh, 2004). The current theory is 
that dopamine plays a role in controlling the size of ganglion cell receptive fields 
(center-surround mechanism). An increase in dopamine reduces the size of the 
receptive field and may increase the strength of the antagonistic surround (Wink & 
Harris, 2000a). In contrast, a reduction in dopamine increases the size of the receptive 
field centre and reduces the strength of the antagonistic surround. The larger receptive 
field combined with the weaker surround would reduce the resolving power of the 
visual system (Bodis-Wollner, 2013; Brandies & Yehuda, 2008).  
Systemic injection of the protoxin MPTP (1-methyl, 4-phenyl, 1-2-5-6 
tetrahydropyridine) into primates destroys dopaminergic neurons. The effects of the 
protoxin MPTP on the retina were to reduce the amplitude and increase the latency of 
both pattern evoked electroretinogram (PERG) and pattern visual evoked potential 
(PVEP) signals. Both of these functions improved temporarily after administering 
levodopa (Ghilardi et al., 1988). The PERG studies indicate that the dopamine deficit 
was affecting the function of the inner retinal layers. Injection of neurotoxin 6-
hydroxydopamine into the retina produced similar results. Both the amplitude and  
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phase of pattern electroretinogram (PERG) and pattern visual evoked potential 
(PVEP) were abnormal especially for the higher spatial frequency stimuli (Ghilardi, et 
al., 1989).     
Electroretinogram (ERG) studies in PD patients have reported that PERG amplitudes 
were reduced, which is consistent with the animal models. The flash ERG was also 
affected. The ERG b-wave amplitude was reduced in PD patients, which suggests that 
the dopamine deficit primarily affects the inner retinal layers. Visual evoked potential 
(VEP) results in PD were also consistent with the animal models. The VEP 
amplitudes were lower and the latencies of P100 and N15 signals where longer in PD 
patients. Moreover, there was an inverse correlation between the latency of P100 
waves of VEP and the amplitude of PERG which suggests that the abnormalities of 
VEP signals in PD patients was mainly retinal in origin (Gottlob, et al., 1987; 
Nightingale, Mitchell, & Howe, 1986). Dopaminergic treatment can reduce the 
latencies of both the ERGs and VEPs (Bodis-Wollner, 2013; Bodis-Wollner et al., 
1987; Bodis‐Wollner et al., 1982; Ellis et al., 1987; Nowacka et al., 2015; Popova, 
2014).  
 
Optical coherence tomography (OCT) is a retinal imaging technique that can examine 
different retinal nerve fiber layers. OCT studies showed that the macular region is 
thinner in PD patients relative to healthy control subjects (Simao, 2013). More 
specifically, the inner nuclear, inner plexiform, and outer nuclear layers are all thinner 
in PD patients compared to healthy subjects. This thinning in the more proximal 
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layers of the retina is consistent with loss of dopaminergic amacrine cells in retina 
(Chorostecki et al., 2015). The anatomical and electrophysiological studies of 
primates and individuals with PD patients support the concept that some central 
visual functions, as previously reported, deterioration may due to dopaminergic 
deficiency in the retina. 
1.3 HIGHER VISUAL AREAS IN PARKINSON’S DISEASE 
Dopaminergic neurons were found in lateral geniculate nucleus (LGN) and occipital 
cortex in rats (Herrera, Machado, & Cano, 1993), in the occipital, parietal, frontal 
cortex in nonhuman primates (Berger, Gaspar, & Verney, 1991; Scatton et al., 1983), 
and in visual cortex of cats and humans (Parkinson, 1989; Phillipson, Kilpatrick, & 
Jones, 1987). There are two main dopaminergic pathways in the midbrain that may 
also influence visual processing. The first one originates in the substantia nigra and 
projects into the visual cortex. The second one starts from the tegmentum and projects 
into the frontal cortex (Nguyen-Legros et al., 1993).  
 
Visual processing begins at the retina and these signals are transmitted to the LGN by 
the optic nerve. The majority of fibers from the LGN project to the primary visual 
cortex, or “V1 area” in the occipital lobe. A smaller number of fibers project to the 
superior colliculus. From V1 area, the visual signal projects to the secondary visual 
cortex, or (V2) area. Two major pathways carry information from V2 to higher 
centers. The first pathway is called the ventral, or “What” visual pathway. This 
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pathway is also referred to as the parvo system because its inputs start from the parvo 
cells at retina and LGN. From V1 and V2, the ventral pathway projects to V4 area, 
lateral occipital cortex, and inferior temporal cortex (IT) areas. The input to the 
ventral pathway is mainly from the fovea and it is concerned with analysing central 
vision properties like fine details, contrast and colours under daylight conditions 
(photopic vision). The second pathway is called the dorsal, or “Where” visual 
pathway. This pathway is also referred to as the magno pathway because the ganglion 
cells feed into the magno cell layers at the LGN which then project to the visual 
cortex. The projections from V1 and V2 go to areas V3A, middle temporal cortex 
(MT/V5), middle superior temporal cortex (MST) and posterior parietal cortex. Input 
to the magno system is mainly from the perifoveal area and peripheral retina. The 
dorsal system involved primarily in analysing peripheral vision properties like 
perception under dim light conditions (mesopic and scotopic vision), localization of 
target, movement of objects, and depth perception (Daw, 2011).   
 
1.4 VISUAL FUNCTIONS IN PARKINSON’S DISEASE 
There have been many reports of visual deficits in moderate to severe PD patients. 
Harris (1998) and Armstrong (2011) have reviewed visual functions in PD patients. 
The list of deficits includes decreased high and low contrast visual acuity, reduced 
spatial and temporal contrast sensitivity, abnormal colour vision, peripheral visual 
field constrictions, abnormal ocular alignment, abnormal saccadic and smooth pursuit 
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eye movements, dry eye, reduced blink rate, abnormal pupil light reaction, visual 
hallucinations, abnormal dark adaptation, abnormal depth perception (Armstrong, 
2011; J. Harris, 1998).  
 In the next sections focus on the deterioration of several visual functions in PD 
patients in order to determine whether one of the main visual pathways (parvo or 
magno) is preferentially affected in the disease. I will also focus on other ocular 
functions that are controlled by prefrontal cortex pathway and the cholinergic system 
pathway as well. 
1.4.1 Visual Functions Mediated by Ventral Pathway in Parkinson’s disease   
 Spatial vision is defined as the ability of our visual system to detect or resolve 
spatially defined detail. The two common clinical spatial vision measurements are 
visual acuity and contrast sensitivity. Visual acuity is measured by varying the size of 
objects with a fixed contrast to determine the smallest detail that can be resolved. 
Contrast sensitivity is measured by maintaining the object at a fixed size but varying 
the contrast until the object can just be resolved (Schwartz & Meese, 2010). 
1.4.1.1 Visual Acuity   
Several studies have shown a reduction in visual acuity in PD patients. Nowacka et al. 
(2014) showed that visual acuity at distance using ETDRS log MAR charts was 
reduced by 0.08 log units in PD patients (VA = 0.15 ±0.23) relative to control 
subjects. This reduction is approximately equivalent to a reduction in acuity of one  
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line. Repka et al. (1996) showed that the mean visual acuity using Snellen acuity 
chart was poorer in the Parkinson's patients (20/39) compared with controls (20/28). 
This reduction was larger than reported by Nowacka, et al by 0.06 log units (15%).  
A reduction in high contrast acuity in PD does not always occur. Two studies 
reported that visual acuity for high contrast letters was unaffected by PD (Regan & 
Neima, 1984; Tzoukeva, et al. 2008). However, both studies reported that the PD 
patients’ low contrast acuities were significantly reduced. The reduction tended to be 
larger in more severe cases (Tzoukeva, et al. 2008). Treatment of PD may only 
produce a marginal, if any, improvement in visual acuity. Jones et al (1992) reported 
that the PD patient tended to have an improvement in acuity with treatment, although 
the improvement was not statistically significant, and Tzoukeva et al (2008) reported 
no improvement in acuity with treatment.  
The reduction in visual acuity is consistent with the hypothesis that the receptive 
fields of the ganglion cells are larger in PD. Nevertheless, it is still possible that the 
decrease in visual acuity is due to cortical dopaminergic reduction. The association of 
visual acuity reduction with the severity of the disease suggests that there could be 
both retinal and cortical involvement and  it is impossible to distinguish between 
them from measuring visual acuity alone (Jones et al., 1992; Repka, et al., 1996).  
Other confounding factors could be responsible for any reduction in acuity.  
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These factors include dry eye, poor blinking or abnormal fixational eye movements 
(Armstrong, 2011). Another confounding factor is that the prevalence of ocular 
diseases is higher in PD patients. Nowacka, et al. (2014) found that nuclear and 
posterior subscapular cataract, age-related macular degeneration (ARMD), blepharitis 
and glaucoma rates were higher in PD patients compared with age-matched healthy 
control subjects.  
Visuospatial perception is affected in patients with PD, particularly in PD with FOG 
(Johnson, et al., 2004a; Lord, et al., 2012; Martens et al., 2014; Silveira et al., 2015). 
It is possible that these visuospatial problems include a reduction in visual acuity, 
which suggests that FOG patients would have a larger reduction in visual acuity 
compared with non-FOG patients.   
1.4.1.2  Spatial and Temporal Contrast Sensitivity:  
Spatial contrast sensitivity is usually measured by varying the contrast of sinusoidal 
grating until the grating pattern is just visible. This is repeated for a wide range of 
spatial frequencies (i.e. different widths of the grating bars). The majority of these 
studies on PD patients agree that there is loss in contrast sensitivity at medium and 
high spatial frequencies (the narrower grating bars), especially for the cases with 
more advanced PD (Hutton et al., 1991). The loss in contrast sensitivity was marked 
mostly at 4.8 cycles per degree (cpd), which was the peak region of the contrast 
sensitivity function in controls.  
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The losses in contrast sensitivity of medium and high spatial frequencies were 
consistent with losses reported in the visual evoked potential (VEP) studies (Bodis-
Wollner et al., 1987; Harris, Calvert, & Phillipson, 1992).  
The loss of contrast sensitivity in PD is consistent with a decrease in retinal dopamine 
and corresponding increase in receptive field size. However, the loss in contrast 
sensitivity in some PD patients appears to be greater for horizontally oriented stimuli  
than vertically oriented stimuli. This finding suggests the cortical origin of contrast 
sensitivity loss rather than retinal origin (Bulens et al., 1986; Bulens, Meerwaldt, & 
Van der Wildt, 1988; Regan & Maxner, 1987). Interestingly, contrast sensitivity 
improves in PD patients after administrating L-DOPA (Bulens et al., 1986; Hutton, 
Morris, & Elias, 1993).  
Bulens and his coauthors described ‘notch losses’ in the contrast sensitivity function 
of PD patients. These losses occur only in the medium spatial and not anywhere else 
in the spatial frequency domain (Bulens et al., 1986; Bulens et al., 1988). Their 
interpretation is that this deficit represents selective loss visual neurons tuned to this 
range of frequencies. However, one should interpret their results with caution because 
uncorrected astigmatic refractive errors can create notch defects and differences in 
contrast sensitivity at different orientations (Apkarian et al., 1987; Regan & Maxner, 
1987). 
The severity of FOG correlated with losses of contrast sensitivity especially at lower 
spatial frequencies. Losses in low frequency contrast sensitivity was considered to be 
a stronger predictor for the freezing of gait severity more than motor impairments 
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(Davidsdottir et al., 2005; Lord et al., 2012). The loss of sensitivity at the lower 
spatial frequency is suggestive, but not definitive, of magno pathway loss rather than 
a parvo pathway loss. It is possible that freezer patients would have greater losses in 
magno pathway.  
Temporal contrast sensitivity measured using a 4 degree circle with range of 
flickering rates (1, 2, 4, 6, 8, and 16 Hz.) showed that PD patients had lower temporal 
contrast sensitivity especially at the higher flicker rates (8, and 16 Hz). These results 
suggest that there could be either a deficit in the magno pathway or a general 
reduction in the retinal gain such that the dopamine deficiency was equivalent to 
lowering the retinal illuminance (Bodis-Wollner et al., 1987). 
There is an interaction between the spatial and temporal contrast sensitivity functions 
in normals. If the flicker rate of the grating pattern increases from 1 Hz to 10Hz in 
normals, sensitivity at low spatial frequencies increases and sensitivity at the medium 
and high spatial frequencies decreases. The changes in sensitivities are thought to be 
due to a decrease in the strength of antagonistic surround of the receptive fields. In 
some PD subjects, increasing the flicker rate to 8 Hz decreased their sensitivity at all 
spatial frequencies without any sensitivity enhancement at the low spatial 
frequencies. This suggests that dopamine is involved in controlling the ganglion cell 
receptive field and if it is absent or in a low concentration, the receptive field 
surround is not very strong for the 1 Hz stimulus so that increasing the flicker rate 
decreases the contrast sensitivity at all spatial frequencies (Bodis-Wollner et al., 
1987). 
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1.4.2  Visual Functions Mediated by Dorsal Pathway in Parkinson’s disease 
1.4.2.1 Perception under Dim Light Condition (after Dark Adaptation): 
The human visual system is capable of operating under a wide range of lighting 
conditions. The two general processes involved in this large operating range are light 
and dark adaptation. Light adaptation is the ability of our visual system to adjust to 
increasing levels of light and maintain a high relative sensitivity to changes in the 
stimuli relative to the background. The initial phase of light adaptation occurs within 
a few seconds. On the other hand, dark adaptation occurs when we go from a bright 
environment to a dark environment. In this situation, the visual system is optimized 
for detecting a small amount of light on the absolute scale. As with light adaptation, 
the time course depends on the change in magnitude that occurs in the background 
environment. If the change in the background is about a factor of 100, then dark 
adaptation takes only a few seconds (Howard, Tregear, & Werner, 2000). However, if 
the change in light levels goes from operating based on cone input to operating based 
on the more sensitive rods, then the time course is 10 to 20 min. (Lamb & Pugh, 
2004).  
The light levels in an urban environment at night fall within the s mesopic range 
where both rods and cones are providing input. Since PD is characterised by a 
dopaminergic level reduction, it possible that their mesopic vision is compromised, 
particularly their spatial resolution in dim lighting (Beaumont et al. 1987). Two 
studies found that there were similarities in peripherally viewing contrast sensitivity 
functions between dark-adapted normal individuals (by wearing neutral density 
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filters) and light-adapted PD patients. This finding supports the view that 
dopaminergic neurons are involved in the light-dark adaptation processes and a 
decrease of dopamine release in the dark adapted retina weakens the strength of the 
antagonistic surround of the receptive fields (Harris et al., 1992; Wink & Harris, 
2000b). This would suggest that visual resolution of PD patients might decrease more 
as background light levels decreased. Whether dopamine depletion will affect the 
visual resolution of a totally dark adapted eye is uncertain. The possible role of visual 
impairment on the freezing of gait disorders in PD patients was discussed earlier in 
this literature review. If it is true that FOG is associated with visual dysfunction, then 
it is possible that freezers will suffer more than non-freezers at low light level vision 
such as walking or driving a car during night. A questionnaire study showed that PD 
patients had difficulties with driving cars especially during night. Half of PD patients 
of that study were freezers but the study did not compare between freezers and non-
freezers patients (Davidsdottir et al., 2005) How visual function at low light levels is 
affected by PD has not been fully described.  
1.4.2.2  Vernier Acuity: 
Another type of visual assessment is measuring the ability of subjects to tell when 
two targets are misaligned. This kind of acuity measurement is called hyperacuity.  
Traditional visual acuity is limited by the cone spacing in the fovea and the optical 
quality of the eye. The average spacing between the cones in the fovea is 0.6 minutes 
of arc (approximately 40 seconds of arc) and so this would be the minimum 
separation between two points or lines that could be resolved if the optics of the eye 
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were perfect. The term hyperacuity arises from the fact that one’s ability to judge 
whether two objects are in alignment l ranges from between 3 to 8 second of arc. 
These values are about 10 times better than the resolution threshold of human eyes; 
hence the term hyperacuity. In addition, optical image degradation has only a small or 
little effect on hyperacuity. This suggests that the hyperacuity task depends more on 
neural processing in higher visual centers beyond the retinal level to detect the small 
differences in the spatial locations of the two lines (Elliott, Whitaker, & Thompson, 
1989; Westheimer, 1979). 
 
Vernier acuity is a form of hyperacuity. It is the ability to detect the slight horizontal 
misalignment of two vertical lines (or bars). Vernier acuity can be as low as 3 second 
of arc (arc sec) in individuals who have had extensive practice and approximately 20 
arc sec for naïve subjects (Fahle & Edelman, 1993; Levi, Klein, & Aitsebaomo, 1985; 
Schwartz & Meese, 2010; Westheimer, 1979).  
 
Previous studies on the effect of age on Vernier acuity are mixed. Some showed there 
are no significant differences between age groups. Others showed there are no 
changes in Vernier acuity threshold until age of 60 years or above. However, these 
studies agree that Vernier acuity is minimally affected by the optical degradation due 
to normal aging changes. The studies that showed a decrease in in Vernier acuity in 
older people, assumed that the decrements were due to aging neural processes (Elliott 
et al., 1989; Enoch et al. 1999; Li, Edwards, & Brown, 2000; Odom et al., 1989). 
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Measuring Vernier acuity may be useful for evaluating the magno pathway neural 
functions of the PD visual system. The task has the advantage that optical problems 
such as mild cataracts have minimal affect. Vernier acuity as a function of light level 
may also allow one to tease out dopamine deficiencies at the higher centers versus at 
the retinal level. If the Vernier acuity decreases at a greater rate at lower luminance in 
PD subjects relative to normals, then the larger decrement increase could be due to 
less precise positional information leaving the retina because the ganglion cell 
receptive fields are larger.   
 
To my knowledge, Vernier acuity has not been investigated in patients with PD. One 
study that could be misinterpreted as a hyperacuity task was by Jones, et al (1992). 
They actually measured visual resolution in PD patients by asking subjects to 
discriminate when a circle was separated from the reference line. A Vernier task 
would be to ask when the line no longer bisected the circle. A task that could be 
related to Vernier acuity is orientation discrimination. Orientation discrimination 
could be a type of hyperacuity because one is measuring the relative angular position. 
Trick, et al. (1994) reported that PD patients had a loss in orientation discrimination 
for horizontal bars, but normal orientation discrimination for vertical bars in PD 
patients compared with healthy controls. This result suggests that vertical Vernier 
acuity should be worse (bars are horizontal) (Trick, et al., 1994).   
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It may be important to look at the Vernier acuity in PD patients for both horizontal 
oriented lines (i.e. detect a misalignment in the vertical direction) and vertical 
oriented lines (i.e. detect a misalignment in the horizontal direction). PD patients have 
difficulties with judgments of horizontal orientations relative to vertical judgments 
(Danta & Hilton, 1975; Fahle & Harris, 1998; Trick et al., 1994). 
1.4.2.3 Motion Perception: 
Flicker and temporal spatial contrast sensitivity are impaired for some PD patients; 
therefore, motion perception may also be affected since it involves processing 
changes in position over time. However, it is also possible that contrast sensitivity 
could be normal and motion perception could be impaired because of deficiencies in 
the higher motion processing centers of the magno pathway. 
Different studies showed motion detection deficits at high level among PD patients 
comparing to age-matched controls. One of the studies measured the motion 
perception by using the Useful Field of View test. This study showed that PD patients 
had more motion perception errors comparing to healthy controls; however, this study 
could not discriminate whether the motion detection deficit was originally retinal or 
cortical in PD patients (Uc et al., 2005).  
 
Coherent motion thresholds were measured for cognitively intact PD patients and for 
age-matched controls. This paradigm starts with over a hundred dots moving in 
random directions. The percentage of dots that are moving in the same direction 
increase until the subject can identify the direction of nonrandom motion. This is 
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considered a global motion task since the subject must integrate the information of a 
relatively large area of their visual field. PD patients required a significant higher 
percentage of dots moving in the same direction relative to age-matched controls 
(Trick et al., 1994). 
 
Castelo-Branco and his coworkers used a hierarchical approach to study temporal and 
motion perception in PD subjects (Castelo-Branco et al., 2009). They categorized the 
visual stimuli based on where in the visual system the processing likely occurred. 
Contrast sensitivity to a high temporal frequency target was their low level stimulus. 
Detection of this stimulus is believed to be mediated by the magno pathway. The 
intermediate-to- high level stimulus was global motion integration stimuli using 
random dot kinetogram (RDKs). This type of motion integration is believed to be 
mediated by the cortical dorsal pathway. They also looked at the relationship between 
the two stimuli. For all levels of stimuli, PD patients showed more deficits than 
healthy controls. However, the temporal contrast sensitivity impairment from the 
retinal level could not explain the motion integration deficits at the cortical level in 
PD patients, as there was no relationship between the two motion perception tests. 
From this study, it appears that motion perception in PD patients due to impairment in 
the cortical areas and not necessarily due to dopaminergic reduction in the retinal 
level.    
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Lee and Harris (1999) used a questionnaire to assess motion and space perception in 
everyday life of PD patients. The patients reported that they had difficulties when 
they tried to move through narrow spaces at their home, and they had difficulties 
determining the movement of pedestrians and vehicles in the street. They also 
reported difficulties in judging distances in space (i.e. distances between objects, or 
when they try to reach an object).   
1.4.2.4 Stereopsis (Depth Perception):  
The reports of difficulties in judging distances could result from an impairment in 
stereopsis (Lee & Harris, 1999). Stereopsis is a relative depth perception that arises 
from the integration of slightly different information from each eye in the visual 
cortex (I. P. Howard, 1995). Stereopsis is the highest level of binocular vision 
function possible to assess in the clinic (Rowe, 2012; Rutstein & Daum, 1998; 
Steinman & Steinman, 2000). Stereopsis is assessed with either simple shapes, such 
as circles (i.e. contour stereopsis), or random dot patterns (i.e. global stereopsis). The 
contour stereopsis perception arises from the integration of nearly identical images 
viewed by each eye. On the other hand, global stereopsis is the perception of form in 
depth that arises when viewing random pattern stereograms. That is, the form is 
perceived only when seen in depth. 
 
One of the main differences between the two types of stereopsis is integration of the 
information from each eye into a single percept. In contour stereopsis, the nearly 
identical contour information present in the images from each eye. Global stereopsis, 
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however, requires complex algorithms to extract the depth and form information. As a 
result, individuals often have more difficulty in perceiving depth information present 
in random pattern stereograms. 
 
Flowers & Robertson (1995) showed that global stereopsis for suprathreshold 
complex patterns in depth was impaired in the advanced stages of PD, but perception 
of simple global stereopsis suprathreshold patterns in depth was not impaired in mild 
and moderate PD subjects. Because interpretation of complex 2-D images was also 
impaired in the advanced stages, they believed that the inability to interpret complex 
3-D images reflected a general visual-spatial processing deficit in higher visual and 
cortical levels rather than a deficit just in depth perception. Thus, their results support 
the hypothesis that visual deficits in PD patients could either be of retinal origin or 
result from deficits in the higher visual centers. Kim et al (2011) reported that contour 
stereopsis was impaired in PD patients. This study also found that the contour 
stereopsis dysfunction was associated with other visual cognitive dysfunctions (e.g. 
visual memory and visual perception constructive function) which suggest that the 
deficit in contour stereopsis is associated with dopaminergic depletion in the cortical 
level. However, they did not investigate the possible role of retinal dopaminergic 
depletion as a potential factor of depth perception deficit. Sun et al (2004) found the 
number of individuals who had abnormal contour stereopsis was higher in PD 
patients than healthy controls and there was no improvement on stereopsis after 
taking medications for PD group. The impairment of stereopsis correlated with the 
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motor dysfunction, which suggests that the stereopsis deficits may be related to the 
severity of the disease. The interesting finding in this study is that they performed 
color perception tests and they found patients had more error scores than the controls. 
PD patients who had abnormal stereopsis had significantly worse color perception 
scores than PD patients with normal stereopsis. The latter finding suggests that the 
retinal dysfunctions in PD patients may contribute to higher visual deficits in PD 
patients such as contour stereopsis (Sun et al., 2014). 
Imaging studies of the human brain have shown activity related to binocular 
disparities or stereopsis in the occipital cortex, parietal cortex (V3A in particular), 
frontal cortex and cerebellum. Data from nonhuman primates’ cellular recording has 
identified cells that are stimulated by contour and random dot stereo stimuli in visual 
areas V1 and V2 and throughout the parietal lobe visual areas. Based on these and 
similar findings, stereopsis was thought to be mediated by the dorsal visual pathways 
(i.e., the “where visual system”). Supporting this hypothesis was the report that 
extensive lesions in the parietal lobe resulted in partially loss of any depth perception. 
Nevertheless, cells in the ventral visual areas (i.e. the “what visual system”) have also 
been to shown to respond to both contour and random dot stereo patterns in more 
recent experiments. Some of these cells in the inferotemporal cortex respond best to 
certain shapes whether the shape is formed by contours or seen in depth within a 
random dot pattern. These cells tend to be located in the posterior inferotemporal 
cortex (Daw, 2011).  
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Cowey & Porter (1979), have shown that lesions in a monkey’s inferotemporal 
cortical area will impair detection of forms in depth generated by random dot stereo 
patterns, whereas lesions earlier in cortical visual centers do not impair global 
stereopsis. Given that processing binocular disparities involves perception of objects 
in depth, form in random dot stereograms and control of vergence eye movements, it 
is not surprising that multiple areas of the brain are involved in processing this 
information. 
Given the multiple areas in the brain where stereopsis is processed, it is difficult to 
conclude that any impairment in stereopsis could be due to a dopamine deficiency in 
the parietal cortex. Nevertheless, the association of impaired stereopsis with other 
visual spatial problems in more severe cases may reflect changes in the inferior 
temporal cortex or ventral pathway.  
Stereopsis is only one factor that contributes to depth perception. There are several 
monocular clues that also contribute to depth, but stereopsis is one of the more salient 
clues. Some monocular clues are static such as perspective and others are dynamic 
such as optic flow (Daw, 2011). Impairment of any of the depth perception clues, as 
well as, impairment in the integration between the visual and motor systems in PD 
patients could lead to further movement disorders. Distance estimation of a 
remembered target is more inaccurate in PD patients than healthy controls during 
static (when they are not walking), active dynamic (when they walked toward it), or 
passive dynamic (moving on a wheel chair) conditions (Martens et al., 2013). Results 
from this study confirmed that there are more errors in distance estimation during 
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active movement condition than other two conditions. They attributed distance 
estimation deficit during active moving to two potential factors; a deficit in the 
proprioceptive perception, which is controlled by somatosensory system; or problems 
in the integration between proprioceptive and visual perception systems. In a 
subsequent study, they found that FOG-PD patients had more errors in distance 
estimation during both static and dynamic conditions than non-freezers DP patients 
and healthy controls (Martens et al., 2014). The results of this study suggest that the 
motor disturbances that cause freezing of gait disorders could be due to two different 
perceptual impairments:  the visuospatial (vision only) or visuomotor (vision and 
proprioception) deficits. 
 
The previous studies showed deficits in both contour and global stereopsis in PD, but 
no one has compared the stereo thresholds for both global and contour stereopsis for 
the same group of patients. Determining the threshold for global and contour 
stereopsis could be useful in monitoring the progression of the disease and may be a 
predictor of mobility in more complex environments. It is possible that global and 
contour stereopsis could be affected differentially in freezers and non-freezers PD 
because of how the two types of depth perception information are processed. It is also 
possible that the two types of stereopsis are equally affected which could be a result 
of either a sensory-integration deficit in visual areas or problems in controlling 
vergence eye movements.  
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1.5  EYE MOVEMENTS IN PARKINSON’S DISEASE 
Eye movements can be classified as either conjugate or disconjugate movements. 
Conjugate eye movements are defined as both eyes moving in the same direction such 
as saccade or smooth pursuit eye movement. These eye movements provide bifoveal 
fixation for a target moving across our visual field or bifoveal fixation as one scans 
objects in the visual field. Disconjugate eye movements are defined as the eyes 
moving in opposite directions. Disconjugate eye movements are synonymous with 
vergence eye movements. Vergence eye movement can be convergent, when the two 
eyes move toward each other, or divergent, when the two eyes move away from each 
other. Vergence eye movements provide bifoveal fixation for objects at different 
distance from one’s body. Vergence eye movements allow one to maintain single 
binocular vision over a wide range of retinal image disparities (Hung, et al., 1994; 
Leigh & Zee, 2015).  
The generation of eye movements is thought to begin in the visual motor areas (i.e. 
frontal eye field) in the frontal cortex. Signals are then sent to the superior colliculus 
and from there to extra ocular nuclei and then to the extraocular muscles. The basal 
ganglia and substantia nigra are located within the eye movement pathway between 
the frontal cortical areas and superior colliculus. Thus, it is possible that the 
dopaminergic pathway (basal ganglia and substantia nigra) mediate the neural 
activities of the eye movement pathway. Numerous studies have reported 
impairments in eye movements in PD patients (Fukushima et al., 2015; Hanuška et 
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al., 2015; Pinkhardt et al., 2012; Tereshchenko, et al., 2015). In the next subsections, I 
will review two types of eye movements in PD patients.    
1.5.1 Vergence Eye Movement  
 
Previous studies showed PD patients have difficulty with many near visual tasks and 
report reading difficulties and diplopia. The clinical findings are consistent with a 
diagnosis of convergence insufficiency. These findings include remote near point of 
convergence and reduction in fusional vergence amplitude at near compared to age 
matched normal individuals. Most of these functions improved after patients were 
treated with dopamine (Almer, et al., 2012; Biousse et al., 2004; Racette, et al., 1999). 
These findings suggest that the dopaminergic pathway regulates or influences 
convergence eye movements. 
A video oculography study of vergence eye movements in PD patients showed there 
was a significant delay of both convergence and divergence eye movements among 
PD patients compared to age matched normal individuals. These delays were not 
correlated with the severity, duration, or the treatments of the disease, which suggests 
that the dopaminergic system does not affect the vergence system in PD patients. 
(Hanuška et al., 2015). 
The conflicting conclusions could be a result of multiple areas involved in the control 
of the vergence eye movements. Alvarez et al. (2014) compared the neural activity 
and convergent peak velocity in non-PD convergence insufficiency patients and 
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control subjects using functional MRI (fMRI). The participants looked at 3 different 
targets representing 3 different vergence demands; far, middle, and near. The results 
showed that the convergence peak velocity in the patient group was lower than 
controls. Functional activities from frontal eye field, posterior parietal cortex and 
cerebellar vermis correlated with reduction of convergence peak velocity in the 
patient group (Alvarez et al., 2014). It is possible that latency deficits are due to 
defects in the non-dopaminergic pathways regulating vergence eye movements and 
other vergence problems are due to defects in the dopaminergic pathways. Neural 
activities of vergence system adaptation were studied on two monkeys while their 
vergence system adapted to both cross and uncrossed disparities. Extracellular 
recordings indicated that prism adaptation was not complete in the vergence-related 
neurons located dorsal lateral to the ocular motor nucleus (Morley, Judge, & Lindsey, 
1992). The authors concluded that other sites were responsible for prism adaptation 
and these sites were distal the ocular motor nucleus. However, Takagi, et al. (2003) 
showed that lesions to the cerebellum vermis impaired vergence adaptation in 
monkeys, suggesting that central sites also play a role in prism adaptation. Although 
neither of these studies rules out a possible role of the basal ganglion dopaminergic 
system in vergence adaptation, the electrophysiological studies suggest that vergence 
adaptation may be mediated by primarily a cholinergic system.   
Fixation disparity is the small ocular misalignment of one eye or both eyes when the 
two eyes are fixating on an object during normal binocular vision. The two images in 
the case of fixation disparity do not stimulate corresponding retinal points, but they 
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do fall within Panum’s fusional area and so a single image is perceived (Ogle, 
Mussey, & De, 1949; Ogle, 1951; Ogle & Prangen, 1951). If nonius lines are 
presented dichoptically (i.e. each line presented separately to each eye), while the 
person fixates on an object with both eyes, the nonius lines will be perceived in 
slightly different visual directions when a fixation disparity is present. The angular 
separation between the two lines (in minutes of arc) is the amount of fixation 
disparity. Schor (1980) described fixation disparity as a small error in the vergence 
system that is required to maintain fusion when the fast component of the vergence 
system changes. 
Fixation disparity can be measured as a function of  the vergence or accommodation 
demands; that is, by placing prisms or lenses of varying powers in front of the eyes 
while the observer looked at two nonius dichoptic lines. The fixation disparity plotted 
as a function of different powers of prisms, or lenses, is known as the forced vergence 
fixation disparity curve (FDC). There are 4 different parameters can be obtained from 
Fixation disparity curve which are: i) Y intercept (the fixation disparity value in 
minutes of arc), ii) X intercept (the associated phoria in prism diopter), iii) slope at 
the center of the curve, and iv) the curve type (Ogle et al., 1949; Ogle, 1951; Ogle & 
Prangen, 1951). Figure 1-1 shows an example of the FDC when prism is placed 
before each eye. 
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Figure 1-1: Forced Vergence Fixation Disparity Curve 
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There are four different types of fixation disparity curves (Figs. 1-2-1-5) (Ogle et al., 
1949).  These curves describe how the vergence system adapts to stress introduced by 
prims. Individuals who have good vergence system adaptation to both base-in and 
base-out prism are usually show a Type I curve, and these individuals are usually 
asymptomatic. However, other curve types may indicate binocular vision 
abnormalities. Individuals who adapted very well to base-out prism and poor 
adaptation to base-in prism are more likely to have eso (inward) deviation, and so 
they are more likely to have Type II curve. In the contrast, Type III curve individuals 
adapt to base-in prism better than base-out prism and they usually have an exo 
(outward) deviation. Type IV curve indicates unstable binocular vision and bad 
vergence adaptation to both base-in and base-out prisms (Schor, 1979a; Schor, 
1979b). Another important parameters of FDC is the slope. Flat slope usually 
indicates good vergence adaptation. On the other hand, a steep slope is an indicator 
for a bad vergence adaptation (Sheedy & Saladin, 1978).  
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                                           Figure 1-2: Forced Fixation Disparity Curve Type 1 
 
 
 
 
 
 
                                                                                      
                              
                                                                              
                                                                                                                                                           
                                                                                 
                       
                                                                                
                                                                                                                                     
 
                       
 
Figure 1-3: Forced Fixation Disparity Curve Type 2 
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Figure 1-4: Forced Fixation Disparity Curve Type 3 
 
 
 
 
 
 
                                                                                      
                              
                                                                              
                                                                                                                                                           
                                                                                 
                       
                                                                                
                                                                                                                                     
 
 
Figure 1-5: Forced Fixation Disparity Curve Type 4 
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Patients who have binocular vision disorders, such as convergence insufficiency, are 
characterized by abnormalities in their vergence system adaptation and do not have 
good vergence adaptation for near targets. Thus, it is expected these patients would 
not show Type I curve of FDC (Scheiman & Wick, 2008).  
Since the fixation disparity curve can be used to evaluate the vergence system, and 
the vergence system is impaired in some PD patients, it is worthwhile to investigate 
vergence adaptation by generating fixation disparity curves in PD patients. If PD 
patients have poor vergence system adaptation, then it is expected to have less PD 
patients with Type 1 curves, and more non-Type 1 curves compared to healthy 
controls. Moreover, it is important to look at the magnitude of the fixation disparity 
(without prisms or lenses in front of eyes) and how it could be related to stereopsis 
dysfunction in PD patients. To my knowledge, fixation disparity and fixation 
disparity curves have not been investigated in PD patients. 
 
1.5.2 Voluntary Saccadic Eye Movements  
Voluntary saccadic eye movements (predictive and anti-saccadic tasks) are affected in 
PD patients (Antoniades et al., 2015; Chan et al., 2005). In predictive, or anticipatory, 
saccadic eye movements, saccades are made toward a predictive location. Anti-
saccades are more complicated. In anti-saccadic tasks, the eye movement is in the 
opposite direction of a target, but with same amplitude (Hung et al., 1994; Leigh & 
Zee, 2015). There are two mechanisms involved in anti-saccadic eye movements. The 
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first one is to inhibit the saccadic eye movement toward a target. The second is to 
generate an eye movement toward the opposite direction, but with an amount equal to 
the presented target. Therefore, anti-saccadic tasks require more attentional and 
cognitive abilities than other saccadic eye movements (Wong, 2008).  
Mild to moderate PD patients did not show a significant difference in anti-saccadic 
tasks relative to  normal individuals; however, patients with severe PD, had more 
anti-saccadic errors and increased in latencies. PD patients who were treated with 
anticholinergic drugs had more anti-saccadic errors than those who did not receive 
these drugs (Kitagawa, Fukushima, & Tashiro, 1994). This suggests that 
acetylcholine depletion contributes to the anti-saccadic errors in PD patients. It is 
thought that the frontal cortex, especially the frontal eye field, controls the 
suppression of the movement toward a target in anti-saccadic task. Anti-saccadic 
errors correlated with poor performance on executive function tests in PD patients. 
Executive function is also mediated by areas in frontal cortex. This suggests that there 
is a general deficit in the frontal lobe functions in some PD patients. 
This study suggests that there is an evidence of early cognitive impairment in PD 
patients occurring at approximately the same time as when the motor symptoms start 
to develop. Moreover, the anti-saccadic errors are probably due to cognitive 
dysfunction regulated mainly by the prefrontal cortex pathway rather than 
dopaminergic pathway (Antoniades et al., 2015). Previous studies showed anti-
saccadic errors are associated with frontal cortex lesions. In animals, anti-saccadic 
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errors were associated with neural responses in the frontal eye field, supplementary 
eye field, and in the prefrontal cortex (Kitagawa et al., 1994).  
The severity of freezing of gait is associated with cognitive dysfunction mediated by 
the frontal lobe (Amboni et al., 2008). If frontal cortex is involved in gait freezing, 
then these subjects may show more deficits in pro and anti-saccadic tasks than non-
freezer patients. 
1.6 PUPIL LIGHT REFLEX IN PARKINSON’S DISEASE 
Pupil constriction begins with stimulation of the photoreceptors and intrinsically 
photoreceptive retinal ganglion cells. Ganglion cell axons enter the pretectal area of 
the midbrain through brachium of the superior colliculus and terminate in the 
pretectal olivary nucleus. Axons from these nuclei project bilaterally through the 
posterior commissure of Edinger-Westephal (EW) nuclei. Neurons from EW nucleus 
innervate the parasympathetic ciliary ganglion neurons, which send postsynaptic 
projections to the constrictor muscle in the iris.  
The sympathetic autonomic system controls pupil dilation (Micieli, Tosi, Marcheselli, 
& Cavallini, 2003). The first order efferent nerves originate in the posterior 
hypothalamus and terminate at the ciliospinal center of Budge and Waller in the 
spinal cord. From here, the second order leave through the ventral horn of the spinal 
cord and ascend to the superior cervical ganglion. The third order neurons leave the 
ganglion and innervate the dilator muscle.  
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Neural losses occur in several autonomic centers in PD patients including EW 
nucleus, ciliospinal center, locus coeruleus and other higher autonomic centers (Chan‐
Palay & Asan, 1989; Gelpi et al., 2014). ANS dysfunctions in PD patients are 
believed to be due to mainly acetylcholine (ACh) and norepinephrine (NE) 
neurotransmitters depletion rather than the dopaminergic reduction (Chaudhuri et al., 
2006; Chaudhuri & Schapira, 2009; Micieli et al., 2003).   
Previous studies showed that the latency of constriction onset, amplitude of 
constriction (pupil radius after 2 minutes of dark adaptation - minimum pupil radius 
after reaction to light), maximum constriction velocity and maximum constriction 
acceleration are affected in PD patients. These studies suggest that a dopamine 
deficiency in the retina or cortex is not responsible for the changes in the different 
pupillometric parameters because there was no correlation with any other motor 
symptoms of the disease (Giza, et al., 2011; Goetz, Lutge, & Tanner, 1986). In 
addition, there are more PLR parameters affected in cognitive impaired PD patients 
than those patients who have normal cognitive function (Stergiou et al., 2009). PLR 
parameters of cognitive impaired PD patients were similar to the pupil dysfunction 
reported in Alzheimer’s disease patients. This suggests that both groups of patients 
have the same central cholinergic (parasympathetic) deficit (Fotiou et al., 2009).  
Amboni et al. (2008) reported that freezing of gait and its severity are associated with 
frontal cognitive dysfunction and the severity of the frontal cognitive dysfunction 
respectively. Patients who experience gait freezing may show a greater impairment of 
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parasympathetic function (e.g. PLR) than those who do not experience gait freezing. 
This would support the hypothesis that cholinergic systems may be impaired in gait-
freezing individuals.  
1.7 VISUAL PROCESSING SPEED IN PARKINSON’S DISEASE 
Visual information processing speed is the ability to detect a characteristic of a 
stimulus that is presented for a specified time interval. The minimum presentation 
time required for an individual to visually identify the physical characteristics of a 
stimulus is called the inspection time (IT) (Deary & Stough, 1996; Johnson, Almeida, 
Stough, Thompson, Singarayer, & Jog, 2004b; Nettelbeck, 1982; Thompson, Stough, 
Ames, Ritchie, & Nathan, 2000; Vernon, 1986). An IT task can predict humans’ 
general intelligence, the performance abilities and the cognitive abilities (Petrill, Luo, 
Thompson, & Detterman, 2001).  
PD patients have significant deficits on reaction time (RT) tasks because RT tasks 
require motor responses (Gauntlett-Gilbert & Brown, 1998). However, from those 
studies someone cannot conclude whether such deficits are due to the motor system 
disorders of PD or it is more likely due to delay in the processing speed of the visible 
information. Because IT does not require motor responses from subjects, it can 
measure the perceptual processing speed. Thus, IT measurement, unlike RT 
measurement, can be used to dissociate between the deficits (slowness) in motor 
response and the delay in the information processing speed within impaired 
movement population such as PD (Johnson et al., 2004b).  
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Different studies have shown that PD patients have significantly slower visual 
processing speed compared to aged match controls. However, these studies used 
different visual stimuli than traditional IT task. For example, one PD patient needed 
significantly longer presentation times to recognize motion-defined letters than age-
matched controls and this delay in the perceptual speed did not improve after taking 
dopaminergic medication (Giaschi, Lang, & Regan, 1997). The limitation of this 
study is that the task required eye movements to track the letters so it is possible that 
the eye movement disorders in PD patients contributed to the delay in the processing 
speed. Even if eye movements are controlled, PD patients still showed significant 
slower processing speed than healthy controls using visual recognition tasks 
(Bachmann et al., 1998). Moreover, the performances of those patients did not 
improve after receiving medications, which is consistent with Giaschi et al. (1997) 
results. 
Other studies that examined IT in PD reported mixed results. In one study, subjects 
were required to recall the sequence of 4 random letters presented for varying 
durations. The results from this study showed that the medicated PD patients needed 
longer presentation times compared with the healthy controls (Shipley et al., 2002). In 
another study, two lights were presented to the subjects at slightly different times, and 
the subjects’ responses were to identify which light was presented first. The ITs for 
this task were not significantly different between PD who were on-medication and 
age-matched healthy controls (Phillips et al., 1999). Sawamoto et al. (2002) 
developed visual stimuli that required mental-operations tasks to evaluate visual 
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processing speed. The result from this study showed that PD patient group needed 
longer presentation times than healthy controls. However, this study also involved 
higher-order of intelligent processing so that it was not a simple IT task (Sawamoto et 
al., 2002). Johnson et al. (2004) examined the IT task by presenting a simple figure, 
which consists of two vertical lines. The lines differed in length and the subjects 
identified the longer line. Results showed that on-medicated patients required 
significantly longer presentation times in order to identify the longer line compared 
with healthy controls. Moreover, the IT score for the PD patients group was not 
significantly different between ‘ON’ and ‘OFF’ medication status (Johnson et al., 
2004b). 
Stough, et al., (2004) proposed that the dopaminergic pathway and dopamine levels in 
healthy subjects did not regulate visual information processing speed. Results from 
Johnson et al. (2004) supported this hypothesis as the IT deficits was not improved 
significantly when patients were on their ‘ON’ medication time vs. ‘OFF’ medication 
time. It is possible that IT deficits in PD patients are distinct from the motor 
impairments (Johnson et al., 2004b). 
 There is reasonable evidence that the cholinergic system mediates IT (Nathan & 
Stough, 2001). IT was significantly slower in patients with Alzheimer’s disease 
compared with healthy controls (Deary et al., 1991) and nicotine acetylcholine 
receptors (nAChRs) are involved in IT processing. Thus, manipulating nicotine 
acetylcholine pharmacologically may affect the IT score in healthy subjects 
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(Thompson et al., 2000). There is evidence that nicotine acetylcholine receptors 
(nAChRs) are reduced in PD patients especially in the nigrostriatal pathways (Court 
et al., 2000). It is possible that these receptors are also reduced in the areas, which are 
responsible for visual processing, which could explain the slower IT times for PD 
patients.  
FOG symptoms among some PD patients may be independent from the dopaminergic 
reduction and it is now hypothesized that the cholinergic system dysfunction may be 
involved. If this hypothesis were correct, then one would expect that FOG patients 
could have slower IT score compared with the non-FOG patients and the increase 
time to process visual information may contribute to the FOG symptoms. 
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Chapter 2 
RESEARCH OBJECTIVES 
2.1 PURPOSE:  
The purpose of this project is to conduct cross-sectional studies focusing on the 
characteristics of 2-dimensional and 3-dimensional clinical visual functions in PD 
patients. The study is essentially examining the visual resolution and localization 
capabilities of PD patients for 2-D stimuli and 3-D visual stimuli. The 2-D visual 
functions will be visual acuity for high and low contrast letters and contrast 
sensitivity for low spatial frequencies in both daylight (photopic) and dim light 
(mesopic) conditions. Individuals who experience gait freezing may have impaired 
acuity and/or contrast sensitivity, especially under low light levels. The 2-D 
localization capabilities will be assessed by Vernier acuity for both vertical and 
horizontal offsets in both daylight (photopic) and dim light (mesopic) conditions. This 
ability could be differentially affected in patients who experience gait freezing and 
contribute to their inability to judge their lateral position relative to any edges in the 
scene. Local (contour) and global (random dot) stereopsis will be the 3-D functions 
measured in the study. Impaired stereopsis could lead to reduced mobility because PD 
individuals have difficulty judging relative distances of objects. Furthermore, our 
pilot data suggests that global stereopsis, measured with random dot tests, may be 
affected sooner, or to a greater extent, than local stereopsis in PD patients. The ability 
to control eye alignment when viewing near objects (Fixation Disparity) will be 
measured. This is important to determine because reduced depth perception could be 
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due to an inability to maintain adequate alignment of the two eyes. PD patients’ 
ability to control their eyes may help determine whether any reduction in depth 
perception is a cognitive problem or related to problems with eye movement control. 
The fixation disparity curve may also provide further insight into any impairment of 
their vergence system.  
Measuring visual functions by using those clinical tests in this project will allow us to 
analyze visual performance within different visual channels or pathways. Also, 
measuring these visual functions in same group of patients can help us to determine 
whether the patterns of damage is due to dorsal pathway (magno) or ventral pathway 
(parvo) in PD patients, and whether these damages contribute to freezing of gait 
disorders. Deficits to both magno and parvo visual pathways have been reported in 
the same group of PD patients. However, there was no correlation between 
deterioration in visual functions that mediated by magno vs. parvo pathways (Silva et 
al., 2005). Another study showed that there was a preferential impairment in visual 
function mediated by the dorsal visual pathway in FOG-PD patients (Lord et al., 
2012). These two studies suggest that the dorsal (magno) and ventral (parvo) 
pathways are affected in PD patients by using non-clinical visual tests and the degree 
of loss in the dorsal pathway may be larger in FOG. A greater impairment of the 
“where” visual pathways could be contributing to the FOG symptoms. One of the 
problems in determining whether there is selective damage to one pathway is that any 
changes in the retina associated with PD may be nonselective. For example, the 
changes could be similar to decreasing the retinal illuminance. A decrease in retinal 
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illumination will affect parvo-mediated functions such as colour vision and visual 
acuity along with magno mediated functions such as sensitivity to flicker and 
stereoacuity. The other complicated factor is that the ventral and dorsal pathways 
interact with each other. There are extensive interconnections between the two 
streams (Felleman & Van Essen, 1991). 
Another purpose of this project is to look at other ocular and perceptual functions in 
PD patients that represent different pathways. We will measure the pupil light reflex 
(PLR) and the visual information processing speed, which represent primarily the 
cholinergic pathway among PD patients who experience FOG freezing of gait vs. 
those who are not to determine whether these measurements can discriminate 
between different PD groups. This would support the hypothesis that more than just 
the dopaminergic pathways are affected in PD.  
This work could also help in improving our understanding of the progression of PD, 
the contribution of basic visual function to gait freezing, and potentially provide 
simpler tests to evaluate the progression and severity of the disease. 
 
2.2 HYPOTHESES:  
The general hypothesis of this thesis project is that freezing of gait (FOG) PD patients 
have more visual perceptual difficulties than non-FOG PD patients and healthy 
controls, and this may contribute to their freezing symptoms. Specific hypotheses of 
this thesis project are: 
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1. Freezing of gait (FOG) PD patients have larger deficits in using 2D clinical 
visual stimuli especially under low light levels (Study 1). 
2. Freezing of gait (FOG) PD patients have larger deficits in using 3D clinical 
visual stimuli and ocular misalignments (Study 2). 
3. Freezing of gait (FOG) PD patients have larger impairments of pupil light 
reflex (PLRs). This could be due to a combination of sensory or motor deficits 
(Study 3). 
4. Freezing of gait (FOG) PD patients have slower visual information processing 
speed (IT) due to cholinergic system dysfunction (Study 4). 
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Chapter 3 
GENERAL METHODS 
3.1 PARTICIPANTS: 
The study took place at the Sun Life Financial Movement Disorders Research and 
Rehabilitation Center (MDRC), Wilfrid Laurier University, Waterloo, ON. Although 
many subjects have participated in other experiments at the Centre, none had 
participated in a vision experiment. Many were familiar with some of the tests 
through their interactions with their eye care practitioner. The subjects were classified 
into three groups as follows:     
1. Two on-medication Parkinson’s disease patient groups (Freezing and Non-
Freezing): all of patients met the criteria of Parkinson’s disease according to 
MDS-UPDRS scaling system (Giladi et al., 2000; Goetz et al., 2008). Patients 
with other neurological disorders, brain lesions or concussions were excluded. 
Freezing vs. non-freezing patients were determined based on the freezing of 
gait questionnaire for PD patients (Giladi et al., 2000; Goetz et al., 2008).  
2. Age matched healthy control group: subjects free from of any neurological 
disorders, brain damage history, positive history of Parkinson’s disease, or 
concussions.  
The exclusion criteria for all participants were a history of diabetes, nystagmus, 
strabismus, and/or corrected visual acuity worse than 20/30 at distance or near in 
either eye. All patients and healthy controls were recruited from the MDRC database.  
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The subjects gave informed written consent before participating. The study was 
approved by University of Waterloo's and Wilfrid Laurier University’s Offices of 
Research Ethics. 
3.2 Neurological & Cognitive Assessments: 
The first step was to determine the severity and cognitive ability of the PD patients or 
the cognitive abilities of the healthy controls. Dr. Quincy Almeida classified the 
severity of the disease and the freezing vs. non-freezing patients according to MDS-
UPDRS scaling system (Giladi et al., 2000; Goetz et al., 2008). The Montreal 
Cognitive Assessment Test (MoCA) was used to assess cognitive status (Nasreddine 
et al., 2005).  
3.3 Visual Screening (Eligibility):  
This assessment followed the neurological and cognitive assessments. Visual acuity 
and ocular alignment (i.e. cover test and near point of convergence) were measured to 
determine whether the participants met the eligibility criteria. If they did not meet the 
acuity requirement, then acuity was reassessed with a pinhole. If the acuity improved, 
then a refraction was performed. 
Twenty-two FOG PD patients, 25 non-FOG PD patients and 25 healthy controls 
participated in this thesis project. All of patients and healthy controls completed the 4 
studies in this thesis. Tables A1 and A2 (Appendix A) list the demographic 
characteristics for every FOG and non-FOG PD patients including age, sex, severity 
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(MDS-UPDRS score), duration of the disease, cognitive status (MoCA score), and list 
of medications that patients were taking during testing.   
 
Table 3-1 shows the mean values (mean ± SD) of different demographic 
characteristics of the participants and whether the differences were significant 
between groups. 
 
Table 3-1: Means and SDs of the demographic characteristics of the participants 
Groups FOG non-FOG Healthy 
Controls 
The 
differences 
(P value) 
Sample Size (N) 
(Male/Female) 
22         
(14/8) 
25         
(19/6) 
25           
(8/17) 
NA 
Age 72.31           
(6.9) 
67.52         
(9.4) 
70.43       
(7.67) 
0.059 
Cognitive (MoCA) Score 24.95      
(4.27) 
25.76         
(2.18) 
26.48         
(2.16) 
0.221 
Severity (UPDRS) Score 22.41       
(7.94) 
19.96        
(9.58) 
NA 0.349 
Duration of the Disease 10.52      
(6.6) 
8.08        
(6.35) 
NA 0.203 
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3.4 Study 1: Visual Resolution and Localization using 2D Visual Stimuli under 
Photopic and Mesopic Conditions  
In the next sections, I will describe the visual tests and procedures used in the first 
study.  
3.4.1 Distance Visual Acuity: 
High and low contrast visual acuities were measured binocularly at 4 meter distance 
using Early Treatment Diabetic Retinopathy Study (ETDRS) charts (Fig 3-1) (Ferris 
et al., 1982). Participants started reading from the largest letter size with their habitual 
distance glasses or with modified refractive power using trail lenses and frame. The 
participants continue to read the smaller letters row. Testing ended when participants 
read 2 out of 5 letters correctly. Visual acuity was recorded using the logMAR system 
in which each letter equals 0.02 logMAR (Hazel & Elliott, 2002). The chart was 
placed in a self-illuminated cabinet. The luminance of the high contrast charts was 
122 cd/m2 and 116.2 cd/m2 for the low contrast chart.   
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Figure 3-1: High and Low Contrast ETDRS Visual Acuity Charts at distance 
(Images courtesy of Precision Vision)   
 
 
3.4.2 Contrast Sensitivity: 
Contrast sensitivity at low spatial frequencies was measured with the Pelli Robson 
chart (Fig 3-2) (Elliott, Sanderson, & Conkey, 1990; Pelli & Robson, 1988). This 
chart consists of 8 lines of fixed size random letters that decrease in contrast from top 
to bottom. Each line consists of two groups of three letter of slightly different 
contrasts. Subjects viewed the chart from 1 m using habitual distance or intermediate 
glasses on, whichever made the chart clearer. Following the procedure of Elliott, et al, 
(1990), subjects started reading at the highest contrast letters (100%) and continued 
until they could read only one letter in a group of three letters. Contrast sensitivity 
was determined by subtracting 3 from the number of letters read correctly and then 
multiplying by 0.05 log unit. The chart luminance was 117.6 cd/m2.    
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Figure 3-2: Pelli-Robson Contrast Sensitivity Chart 
(Images courtesy of Precision Vision) 
 
 
3.4.3 Vernier Acuity: 
The Freiburg Visual Acuity Test (FrACT) (Bach, 1996) measured horizontal and 
vertical Vernier acuity. The Vernier acuity task consisted of two nonius lines display 
on a 27-inch wide computer screen at distance of 6 meter from participants. The 
luminance of the screen was 161.4 cd/m2. The computer program was calibrated so 
that each pixel of the computer screen subtends 0.19 min arc at distance of 6 meter 
away from the screen. This allows one to measure Vernier acuity up to 4.67 in 
decimal scale, which is equal to 12 sec arc. The participants performed the test with 
their habitual distance glasses or with the modified refractive correction. Figure 3-3 
shows an illustration for the horizontal and vertical Vernier acuity targets.  
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                           A                                                      B 
Figure 3-3: An illustration shows the Vernier Acuity Test 
A: Horizontal Verner Acuity Test, B: Vertical Vernier Acuity Test 
 
 
The FrACT uses a two alternative forced choice method to measure Vernier acuity. 
For the vertical orientation (measuring lateral separation), participants had to respond 
whether the top line was to the left or the right of the stationary bottom line to 
measure the horizontal Vernier acuity, and whether the right line was below or above 
the left line to measure vertical Vernier acuity. The Vernier acuity was calculated in a 
seconds of arc by the computer program using the best PEST psychometric method. 
This method considers 56.25% of the correct responses to calculate the threshold 
level (Lieberman & Pentland, 1982; Treutwein, 1995).     
The experiment began with a practice session. Horizontal Vernier acuity was 
measured before vertical. At each trail, participants needed to give a response 
verbally and the examiner entered their responses using a keyboard. There was audio 
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feedback after each response as to whether the response was ‘correct’ or ‘wrong’. The 
test consists of 42 trials. The presentation time for the stimulus was up to 1 second. 
The lines were then replaced by a random dot mask that remained on the screen for 
200 milliseconds. This pattern prevented the subjects from making judgments based 
on an afterimage. Participants were given 30 seconds to make a decision. If they 
could not make a decision within a 30 second period, then the response was counted 
as ‘wrong’.  
 
3.4.4 Visual resolution and localization under Mesopic Condition:  
High contrast visual acuity, low contrast visual acuity, contrast sensitivity and 
horizontal & vertical Vernier acuity were measured as described above but this time 
at a lower light level (mesopic condition). Visual acuity and contrast sensitivity were 
measured by using different version of letters to avoid the memorizing effect. 
Participants wore a welding helmet with a 1.0 ND plate filter in front of eyes for the 
low light conditions. A black cloth was attached from the back and on both sides of 
the helmet in order to block any possible source of light that might reach the 
participants’ eyes as shown in Fig 3-4. Participants wore the helmet with their 
habitual distance glasses or the modified refractive correction. The room lights were 
turned off. Participants adapted to the lower dim light for 5 min. The 5 min interval 
for dark adaptation was selected so that both cone and rod photoreceptors were 
providing inputs (mesopic condition) (Schwartz & Meese, 2010). Table 3-2 shows the 
luminance of different visual resolution tests under low light level.   
  55 
 
 
Figure 3-4: A participant wearing welding helmet with filter in front of eyes in order to reduce 
the light level. 
 
 
Table 3-2: The luminance of different visual resolution tests under low light level. 
Test Luminance 
Visual Acuity High Contrast 1.4 cd/m2 
Visual Acuity Low Contrast 1.11 cd/m2 
Pelli-Robson Contrast Sensitivity 0.23 cd/m2 
Vernier Acuity 1.8 cd/m2 
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3.5 Study 2: Binocular Vision Characteristics (Stereopsis and Fixation Disparity) 
In the next sections, I will describe the visual tests and procedures used in the second 
study. 
3.5.1 Stereopsis (3-D Visual Tests): 
Local (contour) and global (random dot) stereopsis were measured using six clinical 
stereo tests at 40 cm distance (Fig 3-5). Table 3-3 lists the stereoacuity tests and their 
clinical features. The design, methods and the clinical procedures of these tests 
described elsewhere (Eskridge & Eskridge, 1991; Rutstein & Daum, 1998; Scheiman 
& Wick, 2008; Scorth, 2012). Stereoacuity was measured for both crossed and 
uncrossed disparities.   
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Figure 3-5: The clinical stereoacuity tests 
A: MKH-Haase Test, B: TNO Test, C: Circles Test and Butterfly Tests, D: Random Dot 3 Test 
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Table 3-3: Features of Clinical Stereoacuity Tests 
Test Type Type of 
Disparity 
Disparity 
Rage 
(sec arc 
Type of 
Filters 
Light level Comments 
Circles Test 
(Stereo Optical 
Co., Inc. 
Chicago, IL, 
USA). 
Local Crossed 
and 
Uncrossed 
800 – 40  Polaroid 280 lx Measures 
stereopsis to near-
threshold values, 
Monocular Clues 
MKH-Haase 
Line Test 
 (Carl Zeiss 
Vision GmbH, 
Aalen 
Germany) 
Local Crossed 
and 
Uncrossed 
180 – 10  Polaroid 150 cd/m2 Measures 
stereopsis to near-
threshold values, 
Monocular Clues 
MKH-Haase 
Steps Test 
(Carl Zeiss 
Vision GmbH, 
Aalen 
Germany) 
Global Crossed 
and 
Uncrossed 
360 – 30  Polaroid 150 cd/m2 Measures 
stereopsis to near-
threshold values, 
Complex Shape  
Random Dot 3 
Test 
(Vison 
Assessment 
Corp. , IL, 
USA) 
Global Crossed 
and 
Uncrossed 
160 – 
12.5  
Polaroid 280 lx Measures 
stereopsis to near-
threshold values 
TNO Test 
(Alfred P. Poll 
Inc., NY, USA) 
Global Crossed 
and 
Uncrossed 
480 – 15   Red-
Green 
280 lx Measures 
stereopsis to near-
threshold values 
Butterfly Test 
(Stereo Optical 
Co., Inc. 
Chicago, IL, 
USA). 
Global Crossed 2000 – 
700  
Polaroid 280 lx Uses complex 
shape 
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A test started by explaining the procedure. Crossed disparities were always measured 
before uncrossed disparities for all tests. Crossed disparities were measured by 
holding the test booklet on the upright position with the Polaroid or red-green filters 
in front of participants’ eyes, whereas uncrossed disparities were tested by holding 
the test booklet upside down. Participants started by identifying the maximum 
disparity stimulus. If they were correct, then they proceeded through the rest of the 
test until they either identified all the disparities correctly or made an error. The 
lowest disparity level that was correctly perceived by participants was recorded. If a 
participant could not resolve the maximum disparity after 90 sec, then the testing was 
stopped. The 90-second was based on pilot work, which found that the majority of 
participants could identify the disparity within 90 sec. Time to complete each test was 
also recorded using manual stopwatch. Testing stereopsis was performed while 
participants were wearing their habitual reading glasses or the modified refractive 
correction using trial lenses and frame.   
 
3.5.2 Fixation Disparity:  
Horizontal fixation disparity and horizontal fixation disparity curves were measured 
at 40 cm. using Saladin Near Point Card (Michigan College of Optometry, Ferris 
State University) (Fig 3-6) (Corbett & Maples, 2004). The Saladin Near Point Card is 
a repeatable test to measure fixation disparity and fixation disparity curve (Corbett & 
Mapoples, 2004).                 
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Figure 3-6: Saladin Near Point Card 
 
 
Participants were seated behind the phoropter and using their habitual reading glasses 
or the modified refractive correction power was inserted into the phoropter along with 
the Polaroid lenses to dissociate the nonius lines. The Saladin Card was mounted on 
the phoropter using a rod. An incandescent lamp was placed just behind the Saladin 
Card to illuminate the nonius lines. The illuminance was 185 lx on the front of the 
card, and 360 lx on the back of the card. The test started by asking the participants to 
look at the horizontal row of circular openings at the top of the card. There were two 
nonius vertical lines inside each circular opening. The right eye saw the top lines and 
the left eye saw the bottom lines. Participants were also asked to look at the words 
and letters around those circles and to make them clear during the testing. In order to 
familiarize the participants with the test, they were asked to look with both eyes 
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opened at one circular opening that the fixation disparity is high (i.e. vertical lines are 
horizontally misaligned). The participants were directed to look at each individual 
opening until they found the one with the best horizontal alignment of the vertical 
lines. This value was the fixation disparity. 
To generate the horizontal fixation disparity curve, participants were asked to look at 
the circular opening again but this time with a range of prismatic power introduced in 
front of their eyes. Risley prisms were used to add 3Δ, 6Δ, 9Δ, and 12Δ prism demands 
in front of their eyes. Except for the 3 Δ trial, the prism power was divided equally 
between the eyes and the direction alternated between base in and base out. 
Participants were asked to pick the one circle with the best horizontal alignment of the 
vertical lines every time the prismatic power changed. The amount of fixation 
disparity was plotted against the prismatic power in order to generate the fixation 
disparity curve (Fig 1). Four different parameters can be obtained from the fixation 
disparity curve: i), the amount of fixation disparity (Y-intercept), ii) the amount of 
associated phoria (X-intercept), iii) the slope, which is the amount of fixation 
disparity at 3Δ BI minus the amount of fixation disparity at 3Δ BO divided by 6 (Slope 
= Y1 - Y2 / X1 - X2) and iv) the curve type.  
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3.6 Study 3: Pupil Light Reflex 
The pupil light reflex (PLRs) parameters were measured using a NeurOpticsTM 
PLRTM -3000 Pupillometer (NeurOptics, Inc. Irvine, CA, USA). PLR-300 is a 
handheld monocular pupillometer that can measure both pupil constriction and pupil 
dilation parameters (Fig 3-7). PLR-3000 records the pupil size using an infrared 
camera (32 frames/sec) and can measure the pupil size to within +/- 0.03 mm. 
 
 
 
Figure 3-7: PLR-3000 Pupillometer  
(Images courtesy of NeurOptics) 
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PLR-3000 pupillometer measures both pupil constriction and pupil dilation 
parameters. To measure the pupil constriction parameters, bright stimuli flash against 
dark background. To measure pupil dilation parameters, the subjects adapt to a steady 
light and then it is extinguished for a brief period. Table 3-4 list all of the stimuli 
characteristics used in this study for both constriction and dilation conditions. 
 
 Table 3-4: Stimuli characteristics used to measure PLRs 
Protocol Constriction Condition Dilation Condition 
Definition Stimuli brighter than 
Background 
Stimuli Dimmer than the 
Background 
Stimulus Intensity  50 uW 0 uW 
Background Intensity  0 uW 50 uW 
Measurement Duration 5 seconds 5 seconds  
Stimulus Duration 0.07 second 1.07 second 
 uW: micro Watts 
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The procedure was explained and demonstrated. Next, participants adapted to a 
darkened room for 5 min. This time allows pupils to expand to the maximum amount. 
The illuminance on the participants’ chair during the dark condition was less than 0.1 
lx. Pupil constriction was measured next for the right eye followed by the left eye. 
Measurements were repeated three times with 30 sec intervals between trials on each 
eye alternatively.  
After that, the light of the room was turned on in order to measure the pupil dilation 
parameters. The procedures were similar to the constriction condition measurements 
except that the measurements were collected in a bright room. If a participant blinked 
during the measurement, then the data was deleted and another measurement was 
made. The pupillometer software calculates the various parameters automatically. The 
raw data and calculated parameters were downloaded to a computer for analysis.  
Tables 3-5 and 3-6 list all of PLR parameters that were calculated by the PLR-3000 
for constriction and dilation conditions respectively. 
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Table 3-5: PLR parameters for the constriction condition 
Function Definition Unit 
Initial Diameter (Init) Initial dark adapted  pupil size before 
constriction 
mm 
End Diameter (End) Pupil diameter at maximum of constriction mm 
Constriction Percentage 
(Con %) 
(Init – End ) / Init % 
Latency of Constriction 
(LAT-C) 
Time to onset of constriction Millisecond 
(msec) 
Average Constriction 
Velocity (ACV) 
The average speed of the pupil constriction  mm/sec 
Maximum Constriction 
Velocity (MCV) 
The maximum speed of the pupil constriction mm/sec 
Re-Dilation Velocity  (re-
ADV) 
The average speed of the  pupillary re-dilation 
after the pupil has reached the peak of 
constriction 
mm/sec 
75 % Recovery Time 
(T75%) 
The time to reach 75 % of the original baseline 
pupil diameter after the peak of the 
constriction 
sec 
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Table 3-6: PLR parameters for the dilation condition 
Function Definition Unit 
Initial Diameter (Init) Initial light adapted pupil size before dilation mm 
End of Diameter (End) Pupil diameter at peak of dilation mm 
Dilation Percentage (Dia 
%) 
(Init – End ) / Init % 
Latency of Dilation 
(LAT-D) 
Time to onset of dilation Millisecond 
(msec) 
Average Dilation 
Velocity (ADV) 
The average speed of the  pupil  dilation mm/sec 
       
3.7 Study 4: Visual Information Processing Speed (Inspection Time) 
The fourth study was an inspection time (IT) task developed by using 
Psychocinematics. The stimulus was calibrated for a 13-inch screen wide Mac Book 
computer placed 50 cm away from participants. The luminance of the screen was 360 
cd/m2.  
The IT stimulus consisted of two vertical lines connected from the top by a horizontal 
line. The vertical lines differed in length and the participant’s task was to identify 
which line was longer. The length of the long line was 29 mm, and the length of the 
short line was 21 mm. The visual angle of the long line was 199.32 min of arc and the 
visual angle of the short line was 144.36 min of arc. The difference in the angular 
length of the two lines was 55 min arc, which was much larger than the subjects’ 
minimum angle of resolution for high contrast targets. A trial started with fixation 
cross appearing in the middle of the screen for 500 msec. Next, the IT stimulus 
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appeared and remained visible for a variable amount of time. A mask that consisted of 
random length vertical lines was presented next and remained on the screen for 360 
msec. The duration of the stimulus was varied using a staircase procedure. The IT 
threshold was the duration at which 50% of the responses were correct (Stough et al., 
2001; Stough et al., 2001). Figure 3-8 depicts the IT procedure.  
 
 
 
 
   
                      Then                               OR                               Then 
 
 
Fixation Cross                                    Stimulus                                            Mask 
   (500 msec)                            (Variable Presentation Times)                (360 msec) 
 
Figure 3-8: Inspection Time (IT) Procedure 
 
 
 
 
 
 
  
 
    X 
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Participants practiced until they could complete one full run of the test. They viewed 
the display with their habitual reading glasses. Participants responded verbally and 
examiner entered the responses into the computer program so that no motor action 
was required. Participants were instructed to give their responses after the stimulus 
(the two vertical lines) disappeared. They were encouraged to be as accurate as they 
could regardless how much time they spent before they made a response.  
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Chapter 4 
VISUAL RESOLUTION AND LOCALIZATION USING 2-D VISUAL 
STIMULI UNDER PHOTOPIC AND MESOPIC CONDITIONS IN 
FREEZING AND NON-FREEZING PARKINSON’S DISEASE 
PATIENTS 
 
4.1 SUMMARY 
This study focused on different 2-D visual resolution tasks under photopic and 
mesopic conditions in FOG PD, non-FOG PD patients, and age matched healthy 
controls. Results from this study showed that FOG PD patients have a greater 
impairment for most of 2-D visual resolution tasks. The reduction was larger under 
the mesopic condition. 
4.2 INTRODUCTION 
Freezing of gait (FOG) is a main movement disorder symptom that presents in certain 
PD patients especially those in the advance stages. It may lead to further 
complications such as falls, reduction in quality of life, and lack of independence 
(Bloem, et al, 2001; Bloem et al., 2004; Moore, Peretz, & Giladi, 2007). FOG-PD 
patients experience intermittent episodes; that could last for a few seconds; of 
inability to produce or maintain a forward movement or to make a turn. FOG is more 
likely to occur when the person is walking in narrow spaces such as passing through 
corridors or doorways (Cowie et al., 2010; Giladi, Hausdorff, & Balash, 2013). The 
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pathophysiological mechanism of the FOG symptom is unclear. Even though freezing 
of gait is classically considered as one of the motor disturbances, recent evidence 
suggests that the pathophysiological underlying FOG involves both motor and non-
motor systems (Almeida & Lebold, 2010; Giladi, et al., 2007; Grabli et al., 2012).  
The concept that the FOG disorder has a distinct pathophysiological mechanism from 
other motor disorders in PD arises from the fact that FOG does not respond positively 
to dopaminergic treatment, whereas other motor disorder symptoms do respond 
(Giladi et al., 2007). In addition, FOG is strongly associated with non-motor 
symptoms such as depression, stress, anxiety, and cognitive dysfunctions (Bodis-
Wollner, 2003; Giladi & Hausdorff, 2006; Lieberman, 2006). 
The underlying pathophysiology of FOG has not been established. Among the recent 
theories is the cross-talk model suggested by Lewis and Barker (2009). In normal 
individuals, the basal ganglion is involved in the coordination of a number of neural 
activities. These neural activities include motor, cognitive and limbic processes and 
these processes both complement and compete with other in terms of the basal 
ganglion resources. In PD-FOG patients, the loss of dopamine alters the balance from 
competing inputs so that there is now cross talk between these inputs. In certain 
situations, this cross-talk put an excessive load on the processing capacity of the 
striatum, and combined with reduced responses from the output nuclei, this results in 
increased inhibition of the thalamus (i.e. a failure of disinhibition) which in turn 
inhibits movement (Lewis & Barker, 2009).   
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Based on the cross-talk model, a PD patient walking in a crowded environment or 
narrow corridors has an increase in the amount of sensorimotor input. This increase in 
input overloads the system and produces the FOG. Simply overloading the system 
with sensory input may not be the only mechanism responsible for FOG. PD patients 
have more visuospatial perception errors than healthy controls (Johnson et al., 2004), 
and FOG patients have more visuospatial judgement and motion perceptual errors 
compared to non-freezers and healthy controls. Furthermore, the performance on 
these tasks correlated with the severity of the gait disorder (Almeida & Lebold, 2010; 
Cowie et al., 2010; Martens et al., 2014; Silveira et al., 2015). Thus, the degraded 
quality of visuospatial information could be contributing to FOG symptoms. PD 
patients have a higher dependence on visual cues to help them to control their posture 
(Suarez et al., 2011) and so it is possible that FOG is due to degraded visual 
information involved in balance and posture. Because of the degraded visual 
information, the FOG patients are less sure of their balance in making the next 
movement and so they stop.  
The reduction in visual acuity and contrast sensitivity reported for PD could be 
partially responsible for the visuospatial perception deficits (Jones & Donaldson, 
1995, Archibald et al., 2011; Jones, Donaldson, & Timmings, 1992; Nowacka, et al., 
2014). However, the visual acuity differences between groups were small and so it is 
unlikely that the visual acuity reduction was solely responsible for the visual 
perception errors. However, the impairment in visual acuity is larger when using low 
contrast letters (Tzoukeva, et al, 2008, Regan & Neima, 1984). Contrast sensitivity at 
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medium and high spatial frequencies was affected as well in PD patients (Bodis-
Wollner et al., 1987). The losses were more severe in advanced stages of PD patients 
(Hutton et al., 1991). Importantly, the loss in contrast sensitivity is correlated with the 
severity of FOG disorders (Davidsdottir, Cronin-Golomb, & Lee, 2005; Uc et al., 
2005).  
PD is characterised by a reduction in retinal dopamine. Dopamine is an important 
retinal neurotransmitter that may mediate visual resolution by increasing the strength 
of the antagonistic surround in the retinal receptive fields. Lower dopamine levels 
would result in a decrease in visual acuity and contrast sensitivity at medium to high 
spatial frequencies. As the light levels decrease, the dopamine levels decrease, the 
strength of the antagonistic surround weakens and so spatial resolution decreases. 
Because the PD patients already have a lower level of dopamine, the antagonistic 
surround is weakened to a greater extent and so they would be expected to have 
greater reduction in visual resolution in dim lighting conditions (Beaumont et al., 
1987). Supporting this hypothesis is data showing that peripheral contrast sensitivity 
functions were similar between dark-adapted healthy individuals and light-adapted 
PD patients (Harris et al., 1992; Wink & Harris, 2000b).   
In questionnaires, PD patients report more difficulties driving especially during night. 
Half the PD patients in that study were freezers but the study did not compare 
between freezers and non-freezers patients (Davidsdottir et al. 2005). If FOG is 
associated with visual dysfunction, then it is possible that freezer patients would have 
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a larger visual acuity and contrast sensitivity impairment than non-freezer patients 
especially under dim lighting conditions. However, any deficit in visual resolution 
would suggest that it was caused by a decrease in dopamine at the retinal level.        
 
4.3 AIM OF THE STUDY 
The purpose of this study is to run cross-sectional studies focusing on the 
characteristics of 2-dimensional clinical visual functions in FOG and non-FOG PD 
patients. The study is examining the visual resolution and localization capabilities of 
PD patients for 2-D visual stimuli. The 2-D visual functions will be visual acuity for 
high and low contrast letters and contrast sensitivity for low spatial frequencies in 
both daylight (photopic) and dim light (mesopic) conditions. The 2-D localization 
capabilities will be assessed by Vernier acuity for both vertical and horizontal offsets 
in daylight (photopic) and dim light (mesopic) conditions. This ability could be 
differentially affected in patients who experience gait freezing and contribute to their 
inability to judge their lateral position relative to any edges in the scene. 
Measuring these visual functions in the same group of patients may help us to 
determine whether the patterns of damage are due to dorsal pathway (i.e. visual acuity 
and contrast sensitivity under photopic condition) or ventral pathway (i.e. Vernier 
acuity and visual resolution under mesopic vision) in PD patients, and whether these 
deficits could contribute to freezing of gait disorders.  
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4.4 METHODS 
4.4.1 Procedures: 
The testing procedures and protocols of the study were fully explained in details in 
Chapter 3. Briefly, high contrast visual acuity, low contrast visual acuity, contrast 
sensitivity and horizontal & vertical Vernier acuities were measured in random order. 
These visual tests were measured twice, first under a photopic condition and then 
under a mesopic condition (after 5 min of dark adaptation). All of these 
measurements were measured binocularly while participants wearing their habitual 
glasses or the modified optical refractive correction for the appropriate testing 
distance. Twenty-two FOG PD patients, 25 non-FOG PD patients and 25 healthy 
controls participated on this study. Table 3-1 (Chapter 3) list the subject 
demographics.  
 
4.4.2 Data Analysis: 
Comparison of different visual function tests under different lighting conditions were 
analyzed between groups using repeated measures analysis of variance (RMANOVA) 
model with the various tests and lighting conditions as the within subject factors and 
the three groups as the between-subjects factor. All pairwise between-group 
comparisons were evaluated with the Tukey’s post hoc test. The second analysis was 
examining the relationships between different visual functions and the severity, 
duration, and MoCA scores in PD patients by calculating the Pearson correlation 
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coefficients. IBM SPSS ver. 24 was used for this data analyses. The criterion of p< 
0.05 was used to determine a significant effect.  
 
4.5 RESULTS 
4.5.1 High and low contrasts visual acuities under photopic and mesopic conditions:  
 
Table B1 (Appendix B) lists the means and standard error of the means (SEMs) for 
all groups. Figure 4-1 shows the means for the high and low contrast visual acuity for 
the two light levels. As expected, visual acuities were lower for low contrast letters 
(F= 1061.66, DF =1, p<0.0001), and lower light levels (F= 881.226, DF=1, 
p<0.0001). There was also a significant interaction in contrast by light levels (F= 
59.650, DF =1, p<0.001) confirming that the low contrast acuity was affected more 
than high contrast acuity by the decrease in the light level.   
 
The differences between groups was significant (F= 15.632, DF =2, 69, p<0.001). 
Pairwise multiple comparisons showed that the differences between healthy controls 
and both FOG and non-FOG PD groups reached to statistically significant levels (p < 
05). However, the differences between FOG and non-FOG groups approached, but 
did not reach the significant level (p=0.091). Two interactions that included groups 
were significant. First, there was significant interaction between groups and contrast 
levels (F=4.034, DF =2, 69, p=0.022), and significant interaction between groups and 
light levels (F=8.334, DF =2, 69, p=0.001); however, the interaction between 
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different contrasts, light levels, and groups was not significant (F=1.219, DF = 2, 69, 
p = 0.302). Taken together, the data showed that both non-FOG and FOG had lower 
high and low contrast visual acuity than HC. Lowering the light level reduces low 
contrast visual acuity in FOG PD group more than other two groups, and non-FOG 
PD was lower than HC. However, reduction in high contrast visual acuity after 
lowering light level was almost equal across groups.  
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Figure 4-1: Means plot of visual acuity for each group 
Error bars represent the standard error of the means 
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4.5.2 Pelli-Robson contrast sensitivity under photopic and mesopic conditions:  
 
Table B2 (Appendix B) lists the means and standard error of the means (SEMs) for 
all groups. Figure 4-2 shows the Pelli-Robson contrast sensitivity results. As 
expected, the contrast sensitivity was significantly lower under low light levels (F= 
552.521, DF =1, p<0.0001). The interaction between groups and light levels was 
significant (F=10.533, DF =2, 69, p<0.0001). Differences between groups were 
significant as well (F= 34.982, DF =2, 69, p<0.001). Pairwise multiple comparisons 
showed that differences was significant between healthy controls and both FOG 
(p<0.001) and non-FOG PD (p=0.007) groups respectively. The differences between 
FOG and non-FOG groups is significant as well (p<0.001). These results suggest that 
contrast sensitivity affected to greater extent in FOG PD patients than the other two 
groups, and non-FOG PD patients were affected more than HC after reducing the 
light level.  
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Figure 4-2: Means plot of Pelli-Robson contrast sensitivity for each group 
Error bars represent the standard error of the means 
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4.5.3 Horizontal and vertical Vernier acuity under photopic and mesopic conditions:  
Table B3 (Appendix B) lists the means and standard error of the means (SEMs) for 
all groups. Figure 4-3 shows the results for the horizontal and vertical Vernier acuity 
under different light levels for all groups. Although the difference was small, the 
vertical Vernier acuity was significantly larger (worse) than horizontal Vernier acuity 
(F= 5.094, DF =1, p= 0.027). In addition, Vernier acuities were larger (worse) in low 
light levels (F= 257.172, DF=1, p<0.0001). The interaction between different light 
levels and orientations within subjects was not significant (F= 3.039, DF =1, p = 
0.086). This indicates that both horizontal and vertical Vernier acuities were affected 
similarly by low light levels.  
 
The differences between groups were significant (F= 20.472, DF =2, 69, p<0.001). 
Pairwise multiple comparisons showed that differences were significant between 
healthy controls and both FOG (p<0.001) and non-FOG PD (p=0.002) groups 
respectively. The difference between FOG and non-FOG groups was significant as 
well (p=0.013). 
 
The analysis revealed a significant interaction between groups and different light 
levels (F=14.328, DF =2, 69, p<0.0001), but not between groups and orientation 
(F=1.34, DF =2, 69, p=0.268) and the 3-way interaction between light level, 
orientation, and group (F=2.961, DF = 2, 69, p = 0.061), although the latter result was 
approaching significance. Taken together, the data showed that the non-FOG and 
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FOG had lower Vernier acuity with FOG having the lowest. Lowering the light level 
reduces Vernier acuity, especially for the PD groups, and there was the suggestion 
that HC and non-FOG had better horizontal Vernier acuity, especially at the lower 
light level, whereas the FOG subjects did not show this difference.  
 
 
 
 
Figure 4-3: Means plot of horizontal and vertical Vernier acuity for each group 
Error bars represent the standard error of the means 
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4.5.4 Relationships between different visual functions and severity, duration, and 
cognitive abilities of PD Patients:  
Relationships between different visual function tests under different conditions with 
severity (UPDRS score) of the disease, duration of the disease and the cognitive 
status (MoCA) score were tested by performing Pearson correlation coefficients for 
FOG and non-FOG PD patient groups separately. None of the visual function tests 
correlated significantly with severity, duration, or the cognitive status of the FOG PD 
group. The results for the non-FOG PD patient group were similar for most of the 
tests. There were two exceptions to this general trend. First, there was a weak 
positive, but significant correlation (ρ = 0.397, p=0.049) between MoCA score and 
contrast sensitivity score under dim lighting condition. Second, there was a negative 
correlation between MoCA score and horizontal Vernier acuity under bright light 
condition (ρ = - 0.444, p=0.028).   
These results suggest that the deficits in different visual function tests under different 
conditions are independent of the severity, duration, and the cognitive status of the 
disease if they have FOG symptoms. This trend generally held for the non-FOG 
although contrast sensitivity in low light levels and Vernier acuity for horizontal 
displacement decreased as their cognitive scores decreased. 
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4.6 DISCUSSION 
To my knowledge, this is the first study to examine different visual functions on the 
same individuals of PD patients using 2-D clinical tests under different light levels 
with respect to freezing of gait symptom. Both PD groups showed a greater reduction 
in all visual functions relative the health controls with the FOG usually having the 
larger reduction.  
Multinomial logistic regression was conducted using all of visual resolution tests and 
light levels in order to determine the best discriminant parameters between groups. 
The results showed that the final logits regression model adequately fits our data 
(Chi-square test = 78.584, DF=20, p<0.0001). Table 4-1 shows the rank order of the 
different visual resolution tests that could best discriminate different subject groups. 
Contrast sensitivity under low light level was the best discriminant among other 
parameters between groups and the top five predictors were either a low contrast 
visual resolution task or a relative spatial judgment. Although the photopic high 
contrast acuities were reduced in the PD patients, the test was poor in discriminating 
between the two PD groups.  
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Table 4-1: The rank order of different visual resolution tests that can discriminate 
groups 
Test Chi-Square DF P value 
Intercept 7.448 2 0.024* 
Contrast Sensitivity Mesopic 16.704 2 0.000* 
Vertical Vernier Acuity Mesopic 8.424 2 0.015* 
Low Contrast VA Photopic 6.975 2 0.031* 
Horizontal Vernier Acuity Mesopic 6.638 2 0.036* 
Horizontal Vernier Acuity Photopic 5.790 2 0.055 
Vertical Vernier Acuity Photopic 4.519 2 0.104 
High Contrast VA Mesopic 2.115 2 0.347 
Contrast Sensitivity Photopic 1.535 2 0.464 
High Contrast VA Photopic 0.475 2 0.788 
Low Contrast VA Mesopic 0.170 2 0.918 
        * The parameter shows significant effect between groups 
  
 
Table 4-2 shows the parameter estimates for the two PD patient groups when they are 
compared separately with the healthy controls using the different parameters on Table 
4-1. We can clearly predict that healthy controls can significantly perform better than 
FOG PD patient group on Pelli-Robson contrast sensitivity test under mesopic 
condition and this parameter was the best discriminant between these two groups. 
However, this parameter is not as good discriminator between non-FOG PD group 
and HC. This clearly suggests that contrast sensitivity under low light level affected 
to greater extend among FOG PD patients.   
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Table 4-2: The visual resolution parameter estimates of two PD patient groups to 
healthy controls 
Group Test B DF P value 
 
 
 
 
 
FOG 
Intercept 32.694 1 0.041* 
Contrast Sensitivity Mesopic -15.591 1 0.016* 
Vertical Vernier Acuity Mesopic -0.146 1 0.037* 
Low Contrast VA Photopic -19.879 1 0.198 
Horizontal Vernier Acuity Mesopic 0.162 1 0.035* 
Horizontal Vernier Acuity Photopic -0.245 1 0.032* 
Vertical Vernier Acuity Photopic 0.19 1 0.091 
High Contrast VA Mesopic 11.73 1 0.252 
Contrast Sensitivity Photopic -8.854 1 0.288 
High Contrast VA Photopic 6.3 1 0.59 
Low Contrast VA Mesopic 1.399 1 0.883 
 
 
 
 
Non-
FOG 
Intercept 4.112 1 0.589 
Contrast Sensitivity Mesopic -0.943 1 0.745 
Vertical Vernier Acuity Mesopic 0.009 1 0.735 
Low Contrast VA Photopic 6.8 1 0.318 
Horizontal Vernier Acuity Mesopic 0.026 1 0.305 
Horizontal Vernier Acuity Photopic -0.112 1 0.125 
Vertical Vernier Acuity Photopic 0.007 1 0.89 
High Contrast VA Mesopic -0.92 1 0.882 
Contrast Sensitivity Photopic -3.133 1 0.425 
High Contrast VA Photopic -0.446 1 0.955 
Low Contrast VA Mesopic 2.346 1 0.685 
        * The parameter shows significant effect between groups 
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Another way to examine the ability of the tests to discriminate between the 3 groups 
is to examine the association between high contrasts VA under photopic condition 
with other visual resolution tests. Table 4-3 shows the Pearson correlation values for 
all groups. The majority of the correlations were significant except the shaded cells on 
table 4-3. The relatively good correlations between clinical visual acuity and most of 
the other tests indicates that high contrast acuity may be the only test necessary to 
predict resolution capabilities for a variety of different stimuli. The exceptions are the 
mesopic contrast sensitivity and mesopic Vernier (horizontal) acuity. The lack of a 
significant correlation between these results and clinical visual acuity combined with 
the multinomial logistic regression suggests that PD should have their contrast 
sensitivity and/or Vernier acuity assessed under mesopic conditions in order to get a 
more complete picture of their basic visual function. 
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Table 4-3: Correlation between high contrast VA under photopic condition with other 
visual resolution tests. 
 
Test 
High Contrast VA under Photopic 
Condition 
FOG Non-FOG HC 
Low Contrast VA Photopic 0.801** 0.657** 0.799** 
High Contrast VA Mesopic 0.643** 0.529** 0.842** 
Low Contrast VA Mesopic 0.703** 0.558** 0.606** 
Contrast Sensitivity Photopic -0.298 -0.594** -0.408* 
Contrast Sensitivity Mesopic -0.578** -0.273 -0.365 
Horizontal Vernier Acuity Photopic 0.550** 0.596** 0.616** 
Vertical Vernier Acuity Photopic 0.493* 0.641** 0.442* 
Horizontal Vernier Acuity Mesopic 0.545** 0.370 0.481* 
Vertical Vernier Acuity Mesopic 0.496* 0.446* 0.507** 
* Correlation is significant at 0.05 level 
** Correlation is significant at 0.01 level 
 
 
This study found that best corrected high contrast visual acuity in PD patient was 
relatively worse than healthy controls, which was consistent with some studies 
(Nowacka et al. 2014, Repka et al. 1996, Jones et al. 1992), but not others who did 
not find a difference (Regan and Neima, 1984; Tzoukeva, et al. 2008). Although our 
results were significantly different, the difference in the mean high contrast acuities 
between the healthy controls and non-FOG subjects was only 0.062 LogMAR, which 
was only 3 letters different. One of the reasons for the small difference was that the 
inclusion criterion restricted individuals to an acuity of 0.2 LogMAR (6/9) or better 
and so are range of acuities within sample was small.   
The reduction in contrast sensitivity shown in our PD subjects agreed with all of the 
previous studies regardless that different studies used different contrast sensitivity 
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tests (Hutton et al., 1991, Bodis-Wollner et al., 1987; Harris, Calvert, & Phillipson, 
1992; Tzoukeva et al, 2008). This decrease was even larger in low light levels and in 
FOG group. Although none the previous studies compared contrast sensitivity in FOG 
with non-FOG or health controls. Davidsdottir et al, (2005) found that the severity of 
FOG correlated with losses in contrast sensitivity especially at lower spatial 
frequencies. Interestingly, they reported that the loss in contrast sensitivity was a 
better predictor of the freezing of gait severity than motor impairments (Davidsdottir, 
Cronin-Golomb, & Lee, 2005). We did not find a relationship between the severity of 
FOG symptoms and visual function because our sample had generally mild-to-
moderate FOG. Nevertheless, the result that contrast sensitivity was the best 
discriminator between the groups was consistent with their findings that contrast 
sensitivity could be a very good predictor of FOG symptoms. 
 
Previous studies showed that reductions in visual acuity and contrast sensitivity were 
associated with the severity PD, but only in the moderate-to-severe cases (Jones et al., 
1992; Repka, Claro, Loupe, & Reich, 1996; Hutton et al., 1991; Bodis-Wollner et al., 
1987; Harris, Calvert, & Phillipson, 1992). Although we found reductions in visual 
resolution tasks in the PD groups, there was no correlation between the reduction and 
severity of the disease. The lack of association in our study could be due to that all of 
our PD patients were either mild or moderate cases, and there were no severe cases. 
Vernier acuity is believed to be mediated by the magno pathway (Kéri et al., 2004; 
Kéri & Benedek, 2009; Livingstone & Hubel, 1994), although there is not general 
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agreement (Skottun & Skoyles, 2010). Our results for the healthy controls showing a 
significant decrease in acuity under low light level was consistent with a previous 
study (Livingstone & Hubel, 1994). Vernier acuity in PD has not been reported 
before. Orientation discrimination in PD patients showed a loss in both horizontal and 
vertical oriented bars compared to healthy controls, but the difference was bigger and 
significant for horizontal bars only (Trick et al., 1994). This suggests that vertical 
Vernier acuity should be worse. Our results showed PD patients showed significant 
loss in both horizontal and vertical oriented Vernier acuity compared to healthy 
controls, but there was not a clear difference between the horizontal and vertical 
acuities. The vertical Vernier acuity tended to be worse than the horizontal acuity for 
healthy controls and non-FOG at the low light level, but the relative difference was 
similar for both groups, and the difference only approached statistical significance. 
Trick et al. did not specify the luminance of their monitor and so it is difficult to 
determine whether the lack of difference in our study was due to a lack of statistical 
power or whether any orientation specific loss of Vernier acuity in non-FOG PD 
subjects is luminance dependent. If it is the latter case, then the selective positional 
discrimination losses suggested for non-FOG subjects may occur at a higher light 
level than healthy controls.   
The reduction in resolution is consistent with the hypothesis that the receptive fields 
of the ganglion cells are larger in PD due to retinal dopaminergic reduction (Bodis-
Wollner, 2013; Brandies & Yehuda, 2008). Retinal imaging technique showed that 
different retinal layers are thinner in PD patients relative to control subjects (Simao, 
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2013). The thinning was more in the proximal layers of the retina, which is consistent 
with loss of dopaminergic amacrine cells in retina (Chorostecki et al., 2015). Polo et 
al (2016) reported that the reductions in visual acuity and contrast sensitivity 
correlated with the structural changes of the retinal layer in PD patients, especially the 
retinal ganglion cells layer. Contrast sensitivity was the most affected visual function 
that was correlated with the structural changes in the retina of PD patients (Polo et al., 
2016).   
Assuming that the ganglion receptive field follows the difference of Gaussian model, 
reducing the strength of the antagonistic surround would reduce visual resolution, but 
it would also increase the sensitivity of the center of the receptive field and result in 
an increase in contrast sensitivity at lower spatial frequencies, or certainly no change 
in contrast sensitivity. Our results suggest that there is an overall reduction in the 
receptive field sensitivity in addition to a potentially greater loss of the antagonistic 
surround. 
Our results, combined with the evidence of retinal thinning suggest that PD results in 
a general reduction in contrast sensitivity that is equivalent to placing a neutral 
density filter in front of the eye. Our photopic data suggest that the density of the 
filter is no greater than 1.0 for the FOG-PD because their mean photopic resolution 
acuity and contrast sensitivity were reduced relative to HC, but not as much as was 
found for HC when they viewed through the 1.0 ND filter. However, the reduction in 
FOG Vernier acuity is approximately equal to the corresponding value for the HC 
when viewing through a 1.0 ND filter. The non-FOG PD did not show as large of a 
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loss so that their equivalent filter would be less dense. Reducing the light levels to the 
mesopic region would then have a larger effect on the PD subjects because their 
sensitivity is already lower. The reduction in Vernier acuity could be due to less 
precise positional information leaving the retina because the ganglion cell receptive 
fields are larger.  
 
It is well established that PD is characterized by oculomotor dysfunction which could 
affect their ability to fixate on a target of regard (Antoniades et al., 2015; Chan et al., 
2005). Another theory for reduction in visual acuity in PD patients is that the 
decreased acuity is due to abnormal fixational eye movements (Armstrong, 2011). We 
cannot rule this possibility out, but our results suggest that if there are abnormal 
fixational eye movements, the problem worsens in low light. 
PD patients are usually treated with dopaminergic medications such as dopamine 
agonists to enhance the release of dopamine in basal ganglia, or by the anticholinergic 
medications to reduce the acetylcholine levels, or by combination of both kinds of 
treatment (Naylor, 2005). There are several ocular and visual adverse reactions to 
these treatments that has been already reported in PD patients. The most common 
adverse reactions are loss of visual acuity, blurry vision, dry eye, photophobia, visual 
hallucinations, reduced accommodation, nystagmus, and reduced saccadic eye 
movements (Friedman & Neumann, 1972; Michell et al., 2006; Pearlman, Kadish, & 
Ramseyer, 1977; Peters et al., 2000; Spiers, Calne, & Fayers, 1970). Thus, it is 
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possible that the reduction in different visual resolution tasks among our PD patients 
is secondary to their treatment effects on the visual system. 
 
Measuring different visual resolution tests under two different light levels in the same 
group of patients can help us to determine whether the pattern of damage is due to 
dorsal pathway (magno) or ventral pathway (parvo) in PD patients, and whether this 
damage contribute to freezing of gait disorders. The general losses found in our study 
suggest that both the magno and parvo pathways are affected. However, the result that 
the Pelli Robson contrast sensitivity at low light levels and the Vernier acuity were 
the best at distinguishing between the 3 groups suggests that the FOG subjects had a 
larger deficit in the magno pathway. This conclusion is consistent with a previous 
study (Lord et al., 2012).  
 
Regardless of our interpretation of the results, the result that FOG had larger 
reduction in visual function at low light levels suggests that they should have an 
increase in their FOG episodes under dim lighting conditions (i.e. street light level).    
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Chapter 5 
BINOCULAR VISION CHARACTERISTICS (STEREOPSIS AND 
FIXATION DISPARITY) IN FREEZING AND NON-FREEZING 
PARKINSON’S DISEASE PATIENTS 
 
5.1 SUMMARY 
This study is measuring some of the binocular vision characteristics in FOG PD, non-
FOG PD patients, and age matched healthy controls. Binocular vision measurements 
include local and global stereopsis using different clinical stereo tests, along with 
fixation disparity and fixation disparity curves. The fixation disparity measures are 
primarily an assessment of the vergence motor system and the clinical stereo tests 
assess the combined effects of motor and sensory aspects of binocular vision. Results 
from this study showed that FOG group had worse stereopsis than non-FOG group, 
and non-FOG group had worse stereopsis than healthy controls. The impairment of 
global stereopsis was more common than local stereopsis in PD patient groups. The 
reduction in stereopsis among PD patients was not associated with fixation disparity. 
The results suggest that measuring stereopsis could be used to monitor progression of 
non-motor symptoms in PD patients. 
5.2 INTRODUCTION 
Normal binocular single vision is defined by the Dictionary of Visual Science, as “the 
use of both eyes simultaneously in such a manner that each retinal image contributes 
to the final precept” (Hofstetter, 2000). Binocular vision was classified by Worth into 
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three degrees or levels, which is referred to as Worth’s classification of binocular 
vision. The first degree is Simultaneous Perception, which is the perception of the 
two images of an object of regard from both eyes at the same time. The second degree 
is Fusion, which is the formation of a single image by combining the two images. 
Fusion is sub-categorized into sensory fusion and motor fusion. Sensory fusion is the 
ability of blending the two images into one. Motor fusion is the ability to align the 
eyes so that the image in each eye falls within a specified area of each retina. The 
third degree is Stereoscopic Vision, which is the ability to perceive fine relative depth 
from the two retinal images (cited by Rutstein, 1998; Steinman, 2000; and Rowe, 
2012).   
Stereopsis arises from the integration of slightly different information from each eye 
in the visual cortex (Howard, 1995). Stereopsis is considered the highest level of 
binocular visual function that can be assessed clinically (Rutstein, 1998; Steinman, 
2000; and Rowe, 2012). Stereopsis can be measured using simple shapes, which is 
called local or “contour” stereopsis, or using random dot or “global” stereopsis. 
Chapter 1 describes these two types of stereoscopic vision in more detail.  
 
Suprathreshold global stereopsis using complex patterns is impaired in advance stages 
of PD patients (Flowers & Robertson, 1995). This study suggests that the deficit in 
global stereopsis is not due to the dopaminergic retinal reductions in PD patients; 
instead, it is mainly due to cortical dysfunction (Flowers & Robertson, 1995). 
Contour stereopsis is impaired as well in PD patients and the deficit in stereopsis is 
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associated with visual cognitive abilities and motor disturbances of patients, which 
suggests there is relationship between the dopaminergic reduction and stereopsis 
dysfunction in PD patients (Kim et al., 2011). The reduction in contour stereopsis is 
also associated with  failure on color vision tests which suggests that the deficit in 
stereopsis may due to degradation of the one, or both, monocular images at the  
retinal level in PD patients (Sun et al., 2014). 
Although the previous studies showed that both contour and global stereopsis could 
be affected in PD, no one has compared both global and contour stereopsis for the 
same group of patients. It is possible that global and contour stereopsis could be 
differentially affected in freezer and non-freezer PD patients because of how the two 
types of depth perception information are processed. If they are equally affected, then 
there may be either a sensory-integration deficit in visual areas or problems in 
controlling vergence eye movements. Regardless, of the underlying cause, 
determining the threshold for global and contour stereopsis may be useful in 
monitoring the progression of the disease and may be a predictor of mobility in more 
complex environments.   
Impairment of any of the depth perception cues, as well as, impairment in the 
integration between the visual and motor systems in PD patients could lead to further 
movement disorders. It was found that FOG-PD patients had more errors in distance 
estimation of a remembered target during both static and dynamic conditions than 
non-FOG PD patients and healthy controls (Martens et al., 2014). These results 
suggested that the motor disturbances that cause freezing of gait disorders could be 
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due to two different perceptual impairments; the visuospatial (vision only) and 
visuomotor (vision and proprioception) deficits.     
Vergence eye movements are affected in PD patients (Hanuška et al., 2015). One way 
to evaluate the vergence system is to measure the fixation disparity curve. The 
fixation disparity curve measures vergence adaptation. Moreover, it is important to 
look at how the fixation disparity data relates to stereopsis dysfunction in PD patients 
because a vergence eye movement deficit could contribute to reduced stereopsis. To 
my knowledge, fixation disparity and fixation disparity curves have not been 
investigated in PD patients. 
 
5.3 AIM OF THE STUDY 
The purpose of this study is to assess the 3-dimensional clinical visual functions in 
FOG and non-FOG PD patients by measuring local (contour) and global (random dot) 
stereopsis. Impaired stereopsis could lead to reduced mobility because PD 
individuals, especially FOG patients, have difficulty judging relative distances of 
objects; therefore, it is possible that FOG patients have larger depth perception 
deficits than non-FOG patients and healthy controls. 
Fixation disparity assesses the ability to control eye alignment when viewing an 
object with both eyes. Reduced depth perception could be due to an inability to 
maintain adequate alignment of the two eyes rather than a sensory or cognitive 
problem. Thus, fixation disparity is important to determine in PD patients. Moreover, 
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the fixation disparity curve may also provide further insight into any impairment of 
their vergence system in PD patients.  
 
5.4 METHODS 
5.4.1 Procedures:  
Local and global stereopsis were measured with different clinical tests in random 
order. The stereo tests were, Circles Test, Random dot Butterfly Test, MKH-Haase 
Line Test, MKH-Haase Steps Test, TNO Test and Random dot Randot 3 Test. For 
each test, stereoacuity for crossed disparities was measured before uncrossed 
disparities. Chapter 3 describes the tests in more detail. After completing the 
stereopsis tests, the horizontal fixation disparities and fixation disparity curves were 
measured using the using the Saladin Near Point Card. Participants viewed all tests 
binocularly while wearing their habitual glasses or the modified optical refractive 
correction for the given test. Chapter 3 describes the testing procedures. Participants 
of this study were the same of those who participated on the previous study.   
5.4.2 Data analysis:  
There were a number of participants who could not resolve the maximum stereo 
disparity on a given global stereo test. For these participants, a value twice the 
maximum disparity for that given test was assigned. All participants could perceive at 
least the maximum disparity on the local tests.  
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Because the range of disparities on the various stereoacuity tests was limited, the 
stereoacuity values were not normally distributed. As a result, statistical significance 
between groups was determined using non-parametric statistical tests.  
 
Results of stereoacuity tests between groups were analyzed according to the following 
methods. First, comparisons between groups for each stereo test were analyzed by 
using non-parametric ANOVA on the Ranks test. All pairwise, comparisons were 
measured by Dunn’s method. Second, because the minimum disparity and step size 
varies across tests, the number of participants who attained the minimum stereo 
threshold, the number of participants who attained 60 sec arc or better, and number of 
participants who failed to resolve the maximum stereo threshold of a given test were 
determined. Statistical analysis across groups was carried out by using the Chi-square 
test based on the number of subjects who attained 60 sec arc, or better, for all local 
and global stereo tests. The 60 sec arc criterion was used because it is usually 
considered to define the upper limit of normal stereopsis in clinical settings (Kim et 
al., 2014). 
 
The time to complete each test was also recorded. A value of 90 seconds was assigned 
to all subjects who could not see the maximum disparity on a given test. These data 
were analyzed using a One Way ANOVA test. Tukey’s post-hoc test was used to 
perform the pairwise multiple comparisons. The relationships between different 
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stereoacuity tests and the severity, duration and MoCA scores in PD patients were 
examined by running Pearson correlation coefficients.  
 
For each stereoacuity test, except the Random dot Butterfly Test, both crossed and 
uncrossed stereopsis were measured. Direct comparisons between the two disparities, 
after pooling all of the three subjects groups together, were performed by running the 
Signed Ranks test for each test separately. Results showed that the crossed disparity 
results were significantly lower than the uncrossed disparities on the Circles Test, 
Line Test and Steps Test. Although the median values for the crossed disparities were 
smaller on Random dot Randot 3 Test, and TNO Test, they did not reach statistical 
significance. Because there were statistical differences between crossed and 
uncrossed disparities for some tests and a similar trend was present on other tests, the 
crossed and uncrossed stereoacuity for each test were analyzed separately.   
 
The parameters of the fixation disparity curve that were analyzed included the amount 
horizontal fixation disparity (Y-intercept), the amount of horizontal associated phoria 
(X-intercept), and the slope of the curve. Because these parameters were not normally 
distributed, ANOVA on Ranks test was performed to compare the differences 
between groups. The curve type was also considered between groups by counting the 
number of participants who have different types of curves. Differences between 
groups in terms of curve types’ frequencies were tested by applying Chi-square test. 
Finally, correlation between the amount of fixation disparity and different 
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stereoacuity scores were performed using non-parametric Spearman correlation 
coefficients. The criterion of p< 0.05 was used to determine a significant effect. IBM 
SPSS ver. 24 was used for this data analyses.      
 
5.5 RESULTS 
5.5.1 Comparison of local stereoacuity tests between groups:  
Table C1 (Appendix C) lists the median, the minimum, the maximum, and the range 
of the two local stereoacuity tests for all groups. Non-parametric ANOVA on Ranks 
test showed the differences between groups were statistically significant for both 
Circles and Line tests. Table 5-1 shows the Ranks test results and all of the pairwise 
comparisons. Figures 5-1 and 5-2 show the box-plot graphs of Circles test-crossed 
and uncrossed disparities respectively where the all of the pairwise comparisons 
between groups were significantly different. Figure 5-3 shows the box-plot graph of 
Line test -crossed disparity where only significant pairwise comparisons were 
between the health controls and the two PD groups.    
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Table 5-1: ANOVA on Ranks tests of local stereoacuity tests between groups 
 
Test 
 
ANOVA 
 
DF 
P 
 value 
Pairwise Multiple Comparisons 
Groups Non-FOG HC 
Circles 
Crossed 
 
32.35 
 
2 
 
<0.001 
FOG Yes Yes 
Non-FOG  Yes 
Circles 
Uncrossed 
 
29.96 
 
2 
  
<0.001 
FOG Yes Yes 
Non-FOG  Yes 
Line 
Crossed 
 
28.2 
 
2 
 
<0.001 
FOG No Yes 
Non-FOG  Yes 
Line 
Uncrossed 
 
27.84 
 
2 
 
<0.001 
FOG No Yes 
Non-FOG  Yes 
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Figure 5-1: Box plot of the Circles Crossed Disparity test.The vertical bars represent 10% to 
90% percentile, the box represents 25 % to 75% quartiles, the solid horizontal lines represent 
the medians, and the ● are the outliers, the blue dashed line represent the minimum 
stereoacuity level 
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Figure 5-2: Box plot of the Circles Uncrossed Disparity test. The vertical bars represent 10% to 
90% percentile, the box represents 25 % to 75% quartiles, the solid horizontal lines represent 
the medians, and the ● are the outliers, the blue dashed line represent the minimum 
stereoacuity level 
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Figure 5-3: Box plot of the Line Crossed Disparity test. The vertical bars represent 10% to 90% 
percentile, the box represents 25 % to 75% quartiles, the solid horizontal lines represent the 
medians, and the ● are the outliers, the blue dashed line represent the minimum stereoacuity 
level 
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Table C2 (Appendix C) summarizes the results of number of participants who 
attained different stereoacuity levels on local stereo tests. Figure 5-4 shows the 
percentages of participants from each group who obtained 60 sec arc, or better, on 
both Circles and Line tests-crossed disparity respectively. The results of uncrossed 
disparity tests showed the same trends, that most of the subjects in each group could 
obtain at least 60 sec arc on the line test, whereas the percentage of PD subjects, 
especially the FOG, who could obtain that level on the Circles test was lower. Chi-
square test showed that frequencies in each group were significantly different for the 
Circles test-crossed disparity (X2 =17.96, DF= 2, and p=<0.001). However, Chi-
square test did not show significant differences between the groups frequencies for 
the Line test-crossed disparity (X2 =3.49, DF= 2, and p=0.174).  
 
 
 
 
 
 
 
 
 
 
 
  106 
 
 
 
 
 
Figure 5-4: Vertical bars showed the percentages of subjects who resolved 60 sec arc or better 
on two contour stereoacuity tests for all groups 
1: FOG PD, 2: non-FOG PD, 3: HC  
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Table C3 (Appendix C) shows the mean and standard error of the mean of the time 
that the participants needed to complete each local stereoacuity test. Figure 5-5 shows 
the mean times needed to complete each of crossed-disparity local stereoacuity tests 
for all groups. The one-way ANOVA test showed that the differences between groups 
were significant for both Circles and Line test for both crossed and uncrossed 
disparities. Pairwise multiple comparisons showed the healthy controls had 
significantly lower (i.e. faster) completion times than both FOG and non-FOG PD 
patient groups. Even though, the non-FOG PD patient group were, on average, faster 
than the FOG PD patient group with local stereo tests, the differences between the 
two PD patient groups were not statistically significant (Table 5-2).     
 
Table 5-2: One-way ANOVA tests of times needed to perceive local stereoacuity tests 
between groups 
 
Test 
 
ANOVA 
 
DF 
P 
 value 
Pairwise Multiple Comparisons 
Groups Non-FOG HC 
Circles 
Crossed 
 
4.67 
 
2,69 
 
0.013 
FOG No Yes 
Non-FOG  Yes 
Circles 
Uncrossed 
 
7.17 
 
2,69 
  
0.001 
FOG No Yes 
Non-FOG  Yes 
Line 
Crossed 
 
15.84 
 
2,69 
 
0.001 
FOG No Yes 
Non-FOG  Yes 
Line 
Uncrossed 
 
16.37 
  
2,69 
 
0.001 
FOG No Yes 
Non-FOG  Yes 
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Figure 5-5: Means plot of completion time of crossed-disparity local stereoacuity tests 
for each group 
Error bars represent the standard error of the means 
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5.5.1 Comparison of global stereoacuity tests between groups:  
Because the random dot Butterfly test used very large stereo disparities, most of the 
participants from all groups could see the minimum disparity on that test. Only 4 
FOG participants and 1 non-FOG participant could not see the minimum disparity 
(i.e. 700 sec arc) on Butterfly test. All participants from all groups could see the 
maximum disparity. Because all of the HC saw the minimum disparity, only the FOG 
and non-FOG were included in the Chi-square analysis. The frequencies of two 
patient groups who could see the minimum disparity were not significantly different 
(X2= 2.4757; p=0 .115). Table C4 (Appendix C) lists the median, the minimum, the 
maximum, and the range of the global stereoacuity tests for all groups. Non-
parametric ANOVA on Ranks test showed the differences between groups were 
statistically significant for Steps, Randot 3 and TNO global tests. Table 5-3 lists the 
differences between groups based on the median values and all of the pairwise 
comparisons. Figure 5-6 shows the box-plot graph of TNO test-crossed disparity 
where the all of the pairwise comparisons between groups were significantly 
different. Figures 5-7, and 5-8 show the box-plot graph of Steps test-crossed disparity 
and Randot 3 test-crossed disparity respectively where the pairwise comparisons 
showed significant differences only between the control group and the two PD 
groups. In addition to having lower stereoacuity, the figures show that very few of the 
FOG subjects could perceive the maximum disparity on any of the tests. 
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Table 5-3: ANOVA on Ranks tests of global stereoacuity tests between groups 
 
Test 
 
ANOVA 
 
DF 
P 
 value 
Pairwise Multiple Comparisons 
Groups Non-FOG HC 
Steps 
Crossed 
 
35.72 
 
2 
 
<0.001 
FOG No Yes 
Non-FOG  Yes 
Steps 
Uncrossed 
 
34.98 
 
2 
 
<0.001 
FOG No Yes 
Non-FOG  Yes 
Randot 3 
Crossed 
   30.56  
2 
 
<0.001 
FOG No Yes 
Non-FOG  Yes 
Randot 3 
Uncrossed 
   29.32  
2 
 
<0.001 
FOG No Yes 
Non-FOG  Yes 
TNO 
Crossed 
 
29.24 
 
2 
 
<0.001 
FOG Yes Yes 
Non-FOG  Yes 
TNO 
Uncrossed 
 
27.26 
 
2 
 
<0.001 
FOG Yes Yes 
Non-FOG  Yes 
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Figure 5-6: Box plot of the TNO Crossed Disparity test. The vertical bars represent 10% to 
90% percentile, the box represents 25 % to 75% quartiles, the solid horizontal lines represent 
the medians, and the ● are the outliers, the blue dashed lines represent the minimum and 
maximum stereoacuity levels 
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Figure 5-7: Box plot of the Steps Crossed Disparity test. The vertical bars represent 10% to 
90% percentile, the box represents 25 % to 75% quartiles, the solid horizontal lines represent 
the medians, and the ● outliers, the blue dashed lines represent the minimum and maximum 
stereoacuity levels 
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Figure 5-8: Box plot of the Randot 3 Crossed Disparity test. The vertical bars represent 10% to 
90% percentile, the box represents 25 % to 75% quartiles, the solid horizontal lines represent 
the medians, and the ● are the outliers, the blue dashed lines represent the minimum and 
maximum stereoacuity levels 
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Table C5 (Appendix C) summarizes the results of the percentage of subjects who 
attained different stereoacuity levels on global tests for each group. Figure 5-9 shows 
the percentages of participants from each group who attained 60 sec arc or better on 
different random dot stereoacuity tests. The results of uncrossed disparity tests 
showed the same trends that only a minority of the PD could obtain at least 60 sec arc 
on the global tests and this was particularly challenging for the FOG on the TNO and 
Steps test. Chi-square test showed that the frequencies between groups were 
significantly different for all three tests for both disparities; Step test-crossed disparity 
(X2 =35.317, DF= 2, and p=<0.001); Randot 3 test test-crossed disparity (X2 =21.230, 
DF= 2, and p=<0.001); and TNO test-crossed disparity (X2 =18.375, DF= 2, and 
p=<0.001).  
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Figure 5-9: Vertical bars showed the percentages of subjects who resolved 60 sec arc or better 
on three random dot stereoacuity tests for all groups 
1: FOG PD, 2: non-FOG PD, 3: HC  
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Table C6 (Appendix C) shows the mean and standard error of the mean of the time 
that the participants needed to complete each global stereoacuity test. Figure 5-10 
shows the mean plots of the time needed to complete each of crossed-disparity global 
stereoacuity tests for all groups. The ANOVA analyses showed that, with the 
exception of the TNO, there was significant group effect for the global tests 
(ANOVA). Most pairwise comparisons showed that both PD groups were 
significantly slower in completing the test than the HC, but not significantly different 
from each other even though the non-FOG PD patient group were, on average, faster 
than the FOG PD. This result was for both crossed and uncrossed disparities. 
Although the results from the TNO did not reach statistical significance (but 
approached significance for the crossed disparity), the trend between groups was 
similar to other tests. That is HC were faster than both FOG PD and non-FOG PD 
groups, and the non-FOG PD group was faster than FOG PD ones. The one test 
where the two PD group did differ significantly was the random dot Butterfly test, 
where the non-FOG PD group was significantly faster than the FOG PD group, but 
slower than the HC (Table 5-4). The latter finding is probably due to the complexity 
of the pattern of Butterfly test in depth that required more time for the FOG group to 
resolve. 
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Table 5-4: One-way ANOVA tests of times needed to perceive global stereoacuity tests 
between groups 
 
Test 
 
ANOVA 
 
DF 
P 
 value 
Pairwise Multiple Comparisons 
Groups Non-FOG HC 
 
Steps 
Crossed 
 
13.23 
 
2,69 
 
<0.001 
FOG No Yes 
Non-FOG  Yes 
 
Steps 
Uncrossed 
 
12.65 
 
2,69 
 
<0.001 
FOG No Yes 
Non-FOG  Yes 
 
Randot 3 
Crossed 
 
10.29 
 
2,69 
 
<0.001 
FOG No Yes 
Non-FOG  Yes 
 
Randot 3 
Uncrossed 
   
 10.53 
  
2,69 
 
<0.001 
FOG No Yes 
Non-FOG  Yes 
 
TNO 
Crossed 
 
3.02 
 
2,69 
 
0.055 
FOG No No 
Non-FOG  No 
 
TNO 
Uncrossed 
 
1.36 
 
2,69 
 
0.263 
FOG No No 
Non-FOG  No 
 
Butterfly 
 
25.328 
 
2,69 
 
<0.001 
FOG Yes Yes 
Non-FOG  Yes 
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Figure 5-10: Means plot of completion time of crossed-disparity global stereoacuity tests 
for each group 
Error bars represent the standard error of the means 
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5.5.3 Relationships between different stereoacuity tests and severity, duration, and 
cognitive abilities of PD Patients:  
None of stereoacuity tests had a significant correlation with severity, duration, or the 
cognitive status in the FOG PD patient group. In contrast to the FOG PD results, 
several tests were correlated with the severity and duration of the non-FOG PD or 
cognitive status. First, there was a significant correlation between the severity of the 
disease and Circles test-uncrossed disparity (ρ = 0.48, p=0.014). Second, there was a 
significant correlation between the duration of the disease and Steps test for both 
crossed (ρ = 0.417, p<0.001) and uncrossed (ρ = 0.421, p=0.036) disparities. Finally, 
there was a negative correlation between the cognitive status and the Circles test-
uncrossed disparity (ρ = - 0.497, p=0.012), and TNO test-uncrossed disparity (ρ = - 
0.405, p=0.044). The correlations between the cognitive status and all stereoacuity 
tests were not significant for the healthy controls.    
 
5.5.4 Comparison of fixation disparity and fixation disparity curve parameter between 
groups:  
Table C7 (Appendix C) shows the means, standard deviations, medians, and standard 
error of the means for the  horizontal fixation disparity, horizontal associated phoria, 
and slopes for all groups. Positive values indicate an eso-deviation, and negative 
values indicate exo-deviation. Comparisons between groups for different fixation 
disparity parameters were performed based on the median values by applying non-
parametric ANOVA on Ranks test because the results were not normally distributed. 
None of the comparisons between groups showed any significant differences for any 
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of the fixation disparity parameters (p>0.61 for all parameters). Table C8 (Appendix 
C) lists the percentages of participants in each group who had the different fixation 
disparity curve types. Figure 5-11 shows the frequencies of the various curve types 
for each group. From the graph, the FOG PD patient group had more type 4 curve 
than the other two groups, whereas healthy controls had more type 1 curves more than 
the two patient groups. Nevertheless, the differences in frequencies were not 
significant based on Chi-square test (X2 = 7.091, DF=6, p=0.312). These results 
suggests that, even though the amount of fixation disparity, associated phoria, slopes, 
and curve type were not significantly different across groups, it is still possible that 
some PD patients have less stable vergence system compared with  healthy controls.  
There was no significant correlation between the different fixation disparity 
parameters and the severity of the disease, duration, or the cognitive status of patients.  
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Figure 5-11: Percentages of subjects who had the various types of fixation disparity curve for 
all groups. 
1: FOG PD, 2: non-FOG PD, 3: HC  
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5.5.5 Relationships between stereoacuity and fixation disparity: 
Relationships between the amount of fixation disparity and the stereoacuity tests 
were tested for each group by using the non-parametric Spearman regression test. 
Results showed that none of the local or global stereoacuity tests were significantly 
correlated with the amount of fixation disparity for FOG and non-FOG PD patient 
groups. Relationships between different stereoacuity tests and fixation disparity for 
healthy controls were not significant in most cases. There were 3 cases where the 
correlations were significant. First, there was a positive correlation between the 
fixation disparity and Circles test- uncrossed disparity (ρ = 0.58, p=0.0025). Second, 
there was also a positive correlation between fixation disparity and Line test- 
uncrossed disparity (ρ = 0.46, p=0.019). Third, the correlation between fixation 
disparity and TNO test- uncrossed disparity (ρ= 0.42, p=0.0382). These results 
suggest that the larger stereoacuity deficits in the two PD groups were not influenced 
by their vergence system instability as measured by the fixation disparity parameters. 
Rather, it probably reflects more sensory-cognitive dysfunctions.  
     
5.6 DISCUSSION 
The main objectives of this study project were to evaluate the binocular depth 
perception of PD subjects by measuring local (contour) and global (random dot) 
stereoacuity using different clinical stereo tests. This was the first study to evaluate 
stereoacuity in FOG PD patients. The findings from this study clearly show that both 
global and local stereopsis were significantly worse in both FOG and non-FOG PD 
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patients compared with healthy controls. PD subjects, especially the FOG showed 
reductions in global stereopsis tests more frequently than local stereopsis tests. 
Although the difference did not always reach statistical significance, the FOG group 
had worse stereoacuity based on the median values, or the frequencies of subjects 
who could not obtain at least 60 sec arc or better relative to the non-FOG. The tests 
where the two PD showed similar losses were the Line test, Steps test, and Randot 3 
test. The reasons for the variability across tests were probably due to differences in 
the disparity range and step size along with the spatial characteristics of the tests.      
In terms of which test is best at separating the groups, multinomial logistic regression 
was conducted with all of local and global stereoacuity tests. The results showed that 
the final logits regression model adequately fits our data (Chi-square test = 87.428, 
DF=22, p<0.0001). Table 5-5 shows the rank order of different stereoacuity tests that 
could best discriminate between the different subject groups. The Randot3 and TNO   
global stereo tests were the best discriminators between groups. The standard cross 
disparity presentation appeared to be sufficient. In contrast, groups were not 
discriminated by any of local stereo tests.  
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Table 5-5: The rank order of different stereoacuity tests that can discriminate groups 
Test Chi-Square DF P value 
Intercept 1.110 2 0.574 
 Global Randot3 Crossed Disparity 11.433 2 0.003* 
 Global TNO Uncrossed Disparity 7.582 2 0.023* 
 Global TNO Crossed Disparity 6.082 2 0.048* 
 Global Randot3 Uncrossed Disparity 5.386 2 0.068 
Local Circles Crossed Disparity 3.048 2 0.218 
Local Line Crossed Disparity 2.180 2 0.336 
Global Steps Crossed Disparity 2.130 2 0.345 
 Global Steps Uncrossed Disparity 1.930 2 0.381 
Local Circles Uncrossed Disparity 0.771 2 0.680 
 Global Butterfly Crossed Disparity 0.201 2 0.905 
Local Line Uncrossed Disparity 0.020 2 0.990 
        * The parameter shows significant effect between groups 
   
 
Table 5-6 shows parameter estimates for the two PD patient groups when they are 
compared separately with the healthy controls using the different parameters on table 
5-5. Again, Randot 3 and TNO global stereo tests were the best discriminant between 
either of the two patient groups comparing to HC and the local tests were not 
sufficient to discriminate each group from the HC.   
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Table 5-6: The stereoacuity parameter estimates of two PD patient groups to healthy 
controls 
Group Test B DF P value 
 
 
 
 
 
 
 
 
FOG 
Intercept -25.177 1 0.000* 
Global Randot3 Crossed Disparity 0.102 1 0.020* 
Global TNO Uncrossed Disparity -0.013 1 0.113 
Global TNO Crossed Disparity 0.015 1 0.059 
Global Randot3 Uncrossed Disparity -0.071 1 0.038* 
Local Circles Crossed Disparity -0.100 1 0.229 
Local Line Crossed Disparity 0.088 1 0.291 
Global Steps Crossed Disparity -0.026 1 0.170 
Global Steps Uncrossed Disparity 0.025 1 0.190 
Local Circles Uncrossed Disparity -0.011 1 0.889 
Global Butterfly Crossed Disparity 0.031 1 0.256 
Local Line Uncrossed Disparity 0.081 1 0.425 
 
 
 
 
 
 
 
 
Non-FOG 
Intercept -23.054 1 0.000* 
Global Randot3 Crossed Disparity 0.089 1 0.037* 
Global TNO Uncrossed Disparity 0.016 1 0.040* 
Global TNO Crossed Disparity -0.018 1 0.031* 
Global Randot3 Uncrossed Disparity -0.055 1 0.090 
Local Circles Crossed Disparity -0.127 1 0.121 
Local Line Crossed Disparity 0.110 1 0.183 
Global Steps Crossed Disparity -0.019 1 0.256 
Global Steps Uncrossed Disparity 0.019 1 0.284 
Local Circles Uncrossed Disparity 0.079 1 0.436 
Global Butterfly Crossed Disparity 0.031 1 0.465 
Local Line Uncrossed Disparity -0.010 1 0.898 
        * The parameter shows significant effect between groups 
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Although PD subjects had lower global stereoacuity on all tests, the TNO and Randot 
3 emerged as the best tests for discriminating between the 3 groups. It is not clear as 
to why these two tests were the best discriminators. Both presented disparities that 
were less than 20 sec arc, but the maximum disparity of the Randot 3 was only 180 
sec arc and the TNO was 480 sec arc. The result that the TNO was a good 
discriminator between groups could be that fact that TNO used red-green filters to 
isolate the image for each eye and these filters reduce the retinal illuminance more 
than the Polaroid filters. Based on the mesopic visual resolution results, one might 
expect that the performance of the PD groups, especially the FOG subjects would be 
worse.   
The reason why the Randot 3 was a good discriminator may be related to the pattern 
formed by the disparities. The stimulus for each disparity is a diamond-shaped 
background of random dots. The objects that are seen in depth are circles located near 
the vertices. In the normal test presentation, one of the circles has a crossed disparity 
and other three have an uncrossed disparity so that the patient should see 3 circles 
behind the background and one in front. Near, the stereoacuity limit, the individual 
circles may not be apparent, but diamond background could appear slanted in depth 
with the closest part corresponding to the crossed disparity circle. Although the 
circle-form is not obvious, its location can be identified using this information. It is 
possible that PD patients, especially the FOG, could not interpret this artifact 
correctly or they had difficult processing a global stereopsis stimulus that had both 
crossed and uncrossed disparities present.  
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Our results showing that  that PD patients had more difficulties of resolving simple 
global stereopsis patterns appears to contradict the Flowers and Robertson (1995) 
study that found no difference between HC and PD for simple random dot patterns. 
However, their simple patterns were likely well above threshold for the PD group. 
The result that all the subjects could perceive the Butterfly correctly, which was 
composed of large disparities was consistent with their findings; however, our PD 
subjects did require more time to perceive the pattern.        
Flowers and Robertson (1995) attributed the PD group’s inability to perceive 
complex global stereopsis patterns to general visuospatial processing deficits. The 
correlations between the TNO and Circle stereo acuities and cognitive status in the 
non-FOG were consistent with their conclusion. The result that both the TNO (i.e. 
global stereopsis) and the Circles (contour stereopsis) deficits were correlated with 
cognitive function suggests that the general visuospatial deficits could include 
difficulty matching corresponding features from each eye to give rise to a single 
percept, especially for the non-FOG subjects. This could be why the Line test results 
in terms of perceiving at least 60 sec arc were better than the Circles contour test. 
Matching points along thin line contours was likely easier and more precise than 
matching points on thick annuli images (Howard, 1995). The other factor that may 
have made Line test easier was the luminance of the self-illuminated background of 
the Line test was brighter than the Circle test.   
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Associations between different stereoacuity tests and photopic high contrast visual 
acuity, photopic horizontal and photopic vertical Vernier acuity were tested by 
running Spearman correlation coefficient (Table 5-7). Only three significant 
correlations were found and two of these were only within the healthy controls. These 
results suggest that the impairments seen in the PD were not related to decrements 
found in their 2-D visual resolution. This lack of association suggests that the 
stereopsis deficits seen in the PD groups were due to impairments in higher visual 
centers rather than degraded input from each eye. Stereopsis is a complex process that 
is mainly controlled by the extra striatal cortex (Cao & Grossberg, 2012; Westheimer, 
2009). Interestingly, contour stereopsis was associated with horizontal Vernier acuity 
in healthy controls, which suggests that both functions are mediated by higher visual 
centers (Stevenson, Cormack, & Schor, 1989).   
 
 
 
 
 
 
 
 
 
 
  129 
Table 5-7: Correlations between different visual resolution tests and stereoacuity tests 
Groups 2-D 
Resolution 
Tests 
Circles 
(Local) 
Lines 
(Local) 
Steps 
(Global) 
Randot 3 
(Global) 
TNO 
(Global) 
 
FOG 
VA 0.11 0.399 0.388 0.141 0.378 
H. Vernier -0.310 -0.254 -0.083 0.021 -0.039 
V. Vernier -0.318 -0.245 -0.181 -0.028 -0.179 
 
Non-
FOG 
VA 0.127 0.074 0.403* 0.22 0.10 
H. Vernier 0.132 -0.105 0.119 0.097 0.038 
V. Vernier 0.206 0.065 0.121 0.011 -0.008 
 
HC 
VA 0.347 0.337 -0.107 0.306 0.021 
H. Vernier 0.583* 0.558* -0.074 0.201 -0.075 
V. Vernier 0.219 0.260 -0.095 0.225 -0.033 
* Correlation is significant at 0.05 level 
 
 
Our results showing deficits in contour stereopsis agreed with the previous studies 
(Sun et al., 2004; Kim et al., 2011). One of the conclusions from our study is that an 
abnormal finding on a contour test will be dependent on the test and the definition of 
abnormal stereopsis. If abnormal stereopsis is defined as less than 60 sec arc and a 
contour test similar to the Line test is used then about 10% of each PD group would 
have abnormal stereoacuity. However, for the Circle test, nearly 60% of the FOG PD 
subjects have abnormal stereopsis.   
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The previous studies reported that reduced contour stereopsis was more likely in PD 
patients with more severe motor dysfunction (Kim et al., 2011, Sun et al., 2014). Our 
results were mixed in that the only significant correlation between stereoacuity and 
disease severity was with uncrossed disparity Circles test. The lack of association 
between different stereo tests and the severity of the disease in this study could be 
because all of PD patients on this study were either in their mild or moderate severity 
level.  
Fixation disparity and associated phoria provide an assessment of the vergence eye 
movement since the two eyes are not totally dissociated during the testing. Although 
different studies reported that PD patients had different oculomotor deficits including 
vergence eye movements (Hanuška et al., 2015, Almer et al., 2012; Biousse et al., 
2004; Racette et al., 1999), none of these studies looked at the fixation disparity or the 
associated phoria. These two parameters are often used to assess the slow component 
of the vergence system. Our results did not reveal any significant differences between 
groups nor correlations with stereoacuity. Generating fixation disparity curves can 
give us information about the integrity of the slow component of vergence system. 
The FOG PD group had more type 4 curve than other two groups; however, the 
frequency of subjects who had type 4 curve were not significantly different than other 
two groups. Assuming that a type 4 curve is more common in PD patients, the finding 
suggests that PD patients, especially the FOG group, could have less vergence system 
adaptation when adding prismatic stress. This would be consistent with PD subjects 
reporting more frequent eyestrain and tiredness when reading. It is possible that the 
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instability of their vergence system is due to cortical mechanisms, rather than a 
dopaminergic reduction. Hanuška et al (2015) reported that activity in frontal cortical 
areas, such as frontal eye filed (FEF), influence the latency of vergence eye 
movements in PD patients; however, we are not certain whether the FEF also affect 
the vergence system adaptation.  
Nevertheless, the fixation disparity and associated phoria may not be the best test to 
measure vergence system abnormalities in PD. The fixation disparity, associated 
phoria and slope are not necessarily optimum clinical parameters to identify non-PD 
subjects with oculomotor problems (Sheedy & Saladin, 1977).       
Stereopsis impairments were not associated with the fixation disparity in both PD 
patient groups although some of the parameters were associated with the stereoacuity 
in the HC. Interestingly, these associations were found for uncrossed disparities, 
which normally are not measured clinically. One possible reason for the lack of 
association in the PD group was that PD variability was large. The higher variability 
was reflected in the higher frequency of the Type 4 curves in the PD groups.  
Regardless of the underlying cause, our results indicate that FOG PD group has a 
greater loss in stereopsis than the non-FOG group as the complexity level of the target 
increases. This finding suggests that FOG PD patients need more time to analyze a 
crowded environment during walking, and this may lead to or increase the FOG 
episodes during their movements. 
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Chapter 6                                                                                                                              
PUPIL LIGHT REFLEX IN FREEZING AND NON-FREEZING 
PARKINSON’S DISEASE PATIENTS 
 
6.1 SUMMARY 
Non-motor autonomic nervous system (ANS) dysfunctions have been reported in PD 
patients. The pupil light reflex (PLR) is a reliable measure of the sympathetic and 
parasympathetic ANS. Different dilation and constriction PLR parameters may be 
used to investigate whether FOG PD patients have more impairment than non-FOG 
PD patients or healthy controls of the sympathetic or parasympathetic ANS system. 
Results of this study showed that most of constriction parameters and dilation latency 
of both patient groups differed significantly from healthy controls. FOG PD patients 
showed larger pupil size under light condition and larger deficits in constriction 
latency than non-FOG PD patients. These results suggest that the cholinergic ANS 
systems is affected in PD more than the adrenergic system. 
6.2 INTRODUCTION 
Different autonomic nervous system (ANS) dysfunctions including abnormal pupil 
light reflexes (PLR) have been reported in PD (Giza et al., 2011; Goetz, Lutge, & 
Tanner, 1986). Moreover, cognitively impaired PD patients had more PLR parameters 
abnormalities than those patients who had normal cognitive function which supports 
the thinking that PD is not just a dopaminergic function problem function since 
cognitive abilities are controlled by the frontal lobe where the pathways are mediated 
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by acetylcholine (ACh) and other non-dopaminergic neurotransmitters (Stergiou et 
al., 2009). 
Freezing of gait (FOG) PD patients are characterized by having different 
pathophysiological mechanism than non-freezers. Frontal cognitive dysfunctions 
were found to be associated with FOG PD patients (Amboni et al., 2008); however, to 
my knowledge, there are no comparisons between FOG-PD and non-FOG PD 
patients using PLR parameters. It is possible that FOG-PD patients could have a 
larger impairment of this ANS function than non-FOG patients. This would support 
the hypothesis that cholinergic (parasympathetic), or perhaps adrenergic 
(sympathetic), ANS system may be impaired in FOG individuals.  
6.3 AIM OF THE STUDY 
The purpose of this study is to compare different pupil constriction and dilation 
parameters in FOG-PD and non-FOG PD with each other and age-matched health 
controls. Measuring both the constriction and dilation parameters will allow us to 
assess both the cholinergic and adrenergic pathways of the pupil reflexes.  
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6.4 METHODS 
6.4.1 Procedures: 
The pupil light reflex (PLRs) parameters were measured using a NeurOpticsTM 
PLRTM -3000 Pupillometer (NeurOptics, Inc. Irvine, CA, USA).The testing 
procedures and protocols of this study were fully explained in details in Chapter 3. 
Participants of this study were the same of those who participated in the previous 
studies.   
 
6.4.2 Data Analysis: 
Constriction and dilation PLRs parameters were measured three times on each eye. 
The average from the three measurements was calculated for each eye separately. The 
right and left eye parameters were compared by a paired t-test for each group 
separately. Results showed that none of the PLRs comparisons were statistically 
significant between eyes for any group. For this reason, the average values of the two 
eyes were used for further comparisons.   
Differences between groups were examined using one-way ANOVA with Tukey’s 
post hoc tests to examine all pairwise comparisons between groups. The second 
analysis examined the associations between different PLRs and the severity, duration, 
and MoCA scores in PD patients by calculating the Pearson correlation coefficients. 
IBM SPSS ver. 24 was used for this data analyses. The criterion of p< 0.05 was used 
to determine statistical significance.  
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6.5 RESULTS 
6.5.1 Constriction pupil light reflex:  
Figure 6-1 shows representative data of the pupil diameter as a function of time after 
the eye was stimulated with the white light pulse. Table 6-1 shows means and 
standard error of the means of different constriction parameters. Table 6-2 shows the 
ANOVA results and the pairwise multiple comparisons between groups for those 
parameters that showed a significant group effect. There was a significant group 
effect for all the constriction parameters, except the minimum diameter (End) 
(F=2.193, DF= 2, 69, p=0.119), and the re-dilation velocity (re-ADV) (F=2.112, DF = 
2, 69, p=0.129). Pairwise comparisons showed, however, that the group effect was 
primarily due to the differences between the one, or both, of the PD groups and the 
HC for most parameters. The only significant difference between the FOG and non-
FOG PD was the constriction latency (LAT-C), and T 75%.   
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Figure 6-1: Pupil size response to light stimulus as a function of time in 3 representative 
participants from each group. The two yellow vertical lines shows where the stimulus started 
and ended, the black vertical line shows the constriction latency, the blue vertical line shows 
T75% 
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Table 6-1: Means and SEMs for different constriction PLRs for all groups 
 
Group 
Initial 
(mm) 
End 
(mm) 
Amount 
–Con 
(mm) 
Con  
(%) 
LAT-C 
(msec) 
ACV 
(mm/sec) 
MCV 
(mm/sec) 
re-
ADV 
(mm/sec) 
T75
% 
(sec)  
 
FOG 
(N=22) 
Mean 5.22 3.80 1.42 27.81 0.26 2.92 4.15 1.05 1.25 
Std. Error 
of Mean 
0.15 0.14 0.07 1.18 0.005 0.10 0.12 0.037 0.09 
non-
FOG 
(N=25) 
Mean 4.64 3.29 1.32 29.15 0.24 2.95 4.06 1.03 1.50 
Std. Error 
of Mean 
0.22 0.18 0.072 1.14 0.01 0.13 0.17 0.07 0.08 
 
HC 
(N=25) 
Mean 5.28 3.59 1.69 32.43 0.21 3.41 4.63 0.90 1.76 
Std. Error 
of Mean 
0.20 0.17 0.06 0.96 0.01 0.11 0.14 0.04 0.03 
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Table 6-2: One way ANOVA tests of constriction PLRs between groups 
 
Test 
 
ANOVA 
 
DF 
P 
 value 
Pairwise Multiple Comparisons        
(P values) 
Groups Non-FOG HC 
 
Initial 
 
3.299 
 
2,69 
 
0.034 
FOG 0.1 0.974 
Non-FOG  0.056 
 
Amount -
Con 
 
7.8 
 
2,69 
 
0.001 
FOG 0.63 0.021* 
Non-FOG  0.001* 
 
Con% 
4.68  
2,69 
0.012 FOG 0.672 0.012* 
Non-FOG  0.086 
 
LAT-C 
   27.128   
2,69 
 
<0.001 
FOG 0.006* <0.001* 
Non-FOG  <0.001* 
 
ACV 
 
5.45 
 
2,69 
 
0.006 
FOG 0.977 0.014* 
Non-FOG  0.019* 
 
MCV 
 
4.09 
 
2,69 
 
0.021 
FOG 0.904 0.084 
Non-FOG  0.024* 
 
 T75% 
 
13.652 
 
2,69 
 
<0.001 
FOG 0.041* <0.001* 
   
Non-FOG  0.022* 
(*): Differences between groups is significant at 0.05 significant level 
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6.5.2 Dilation pupil light reflex:  
Figure 6-2 shows representative data of the pupil diameter as a function of time after 
the light was extinguished for 1.03 second. Table 6-3 lists the means and standard 
error of the means different pupil dilation parameters for all groups. One way 
ANOVA showed the differences between groups were statistically significant for all 
of the dilation PLR parameters except the dilation percentage of change (Dia %) 
(F=1.757, DF= 2, 69, p=0.180) and the dilation velocity (ADV) (F=1.82, DF = 2, 69, 
p=0.169). Table 6-4 shows the results and the pairwise multiple comparisons between 
groups for those parameters who showed significant differences between groups.  
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Figure 6-2: Pupil size response to light stimulus as a function of time in 3 different participants 
representing the 3 subject groups. The two orange lines shows where the stimulus started and 
ended, the black vertical line shows the dilation latency 
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Table 6-3: Means, SDs, and SEMs for different dilation PLRs for all groups 
 
Group 
Initial 
(mm) 
End 
(mm) 
Amount-
Dia 
(mm) 
Dia 
(%) 
LAT-D 
(msec) 
ADV 
(mm/sec) 
 
FOG 
(N=22) 
Mean 2.90 3.43 0.53 19.25 0.40 0.87 
Std. Error 
of Mean 
0.09 0.11 0.028 0.92 0.016 0.036 
 
non-
FOG 
(N=25) 
Mean 2.54 2.96 0.41 16.81 0.39 0.74 
Std. Error 
of Mean 
0.093 0.10 0.03 1.15 0.010 0.054 
 
HC 
(N=25) 
Mean 2.53 3.02 0.48 19.43 0.34 0.80 
Std. Error 
of Mean 
0.06 0.09 0.03 1.20 0.013 0.05 
 
 
Table 6-4: One way ANOVA tests of dilation PLRs between groups 
 
Test 
 
ANOVA 
 
DF 
P 
 value 
Pairwise Multiple Comparisons         
(P values) 
Groups Non-FOG HC 
 
Initial 
 
5.517 
 
2,69 
 
0.006 
FOG 0.014* 0.013* 
Non-FOG  0.99 
 
End 
 
6.049 
 
2,69 
 
0.004 
FOG 0.05* 0.018* 
Non-FOG  0.89 
Amount -
Dia 
3.83  
2,69 
0.027 FOG 0.021* 0.56 
Non-FOG  0.233 
LAT-D    5.24   
2,69 
 
0.008 
FOG 0.75 0.009* 
Non-FOG  0.048* 
(*): Differences between groups is significant at 0.05 significant level 
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6.5.3 Relationships between different PLR parameters and severity, duration, and 
cognitive abilities of PD Patients: 
Relationships between different PLR parameters with severity (UPDRS score) of the 
disease, duration of the disease and the cognitive status (MoCA score) were examined 
by calculating the Pearson correlation coefficients for FOG and non-FOG PD patient 
groups separately. Results showed that none of the constriction or dilation PLR 
parameters correlated significantly with severity, duration or the cognitive status of 
the FOG PD patient group. The results for the non-FOG PD patient group were 
similar for most of the PLR parameters; however, there were two exceptions to this 
general trend. First, there was a negative and significant correlation (ρ = -0.428, 
p=0.033) between UPDRS score and constriction percent change. That is, the more 
severe the disease, the smaller the relative change in pupil size for the non-FOG 
subjects. Second, there was a negative correlation between MoCA score and T 75% 
recovery (ρ = - 0.539, p=0.012). That is, the more cognitive impairment, the longer it 
takes to re-dilate after the light was extinguished.   
 
6.6 DISCUSSION 
Non-motor symptoms due to ANS dysfunctions have been reported in PD patients 
(Stern, Lang, & Poewe, 2012, Parkinson, 2014). Both sympathetic and 
parasympathetic branches of ANS are known to be affected (Ziemssen & Reichmann, 
2010). Measuring the pupil size under light and dark conditions and measuring 
different pupil light reflex (PLR) parameters is a relatively easy and non-invasive 
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technique to evaluate the integrity of the ANS sympathetic and parasympathetic 
pathways (Wilhelm & Wilhelm, 2003).  
The main objectives of this study were to examine both constriction and dilation 
parameters of the pupil light reflex (PLR) to determine whether the cholinergic 
mediated (parasympathetic) and adrenergic mediated (sympathetic) ANS were 
differentially affected in FOG PD and non-FOG patients. In addition, the previous 
clinical results might help disentangle the afferent (sensory) PLR vs. efferent (motor) 
PLR pathways. This information would help us to determine whether the problem 
originates in the retina or in the central nervous system. 
Most of constriction parameters and dilation latency among dilation parameters were 
significantly different for one or both of PD patient groups compared with healthy 
controls. Our results were in agreement with previous findings for those common 
constriction parameters (Giza et al., 2011; Goetz, et al., 1986). Similar to previous 
studies (Giza et al., 2011; Goetz, et al., 1986), our results suggest that pupil changes 
could be independent from the dopaminergic deficiency because there was no 
correlation with any other motor symptoms of the disease except for one case, which 
could be a spurious correlation. In addition, others have reported that dopaminergic 
treatment has no effect on different PLR parameters (Harris, 1991; Hori et al., 2008).  
Multinomial logistic regressions were conducted for all of constriction and dilation 
PLR parameters separately in order to determine the best discriminant parameters 
between groups. The results showed that the final logits regression models adequately 
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fit our data for the constriction parameters (Chi-square test = 96.961, DF=18, 
p<0.0001), and for the dilation parameters (Chi-square test = 27.684, DF=12, 
p=0.006). Table 6-5 shows the rank order of different PLR parameters that can best 
discriminate different subject groups. Except the constriction percentages, the average 
constriction velocity and maximum constriction velocity, the other constriction 
parameters were good discriminators between groups. Dilation latency was the only 
parameter that could discriminate between groups among dilation parameters. These 
findings suggest that both parasympathetic and sympathetic ANS pathways were 
affected in PD patients compared with healthy controls, and the parasympathetic ANS 
pathway is more affected than sympathetic ANS pathway in PD patients. 
 
Table 6-6 shows parameter estimates of the two PD patient groups separately to the 
healthy controls using the different constriction and dilation PLR parameters in Table 
6-5. If we look at the constriction latency (LAT-C) B coefficient for the FOG, it is 
175.773. This indicates that LAT-C is very good at discriminating between HC and 
FOG. The value for the non-FOG is 125.8, which was still high, but it was not 
significant. Thus, the constriction latency (LAT-C) is a good discriminator between 
HC and FOG PD patient group, but not as good between HC and non-FOG PD 
patient group. Even though re-dilation velocity (re-ADV) did not show significant 
differences on average between groups, the logistic regression model suggests that 
this parameter is a good discriminator for both of PD patient groups compared with 
healthy individuals.     
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Table 6-5: The rank order of different PLR parameters that can discriminate groups 
 
 
Test Chi-Square DF P value 
 
 
 
 
 
Constriction 
Parameters 
Intercept 0.276 2 0.871 
re-ADV 20.332 2 0.000* 
LAT-C 15.413 2 0.000* 
Amount of Constriction 13.754 2 0.001* 
End 12.088 2 0.002* 
Init 11.732 2 0.003* 
T 75% Recovery 10.349 2 0.006* 
Con % 3.912 2 0.141 
MCV 3.658 2 0.161 
ACV 2.182 2 0.336 
 
 
Dilation 
Parameters 
Intercept 5.289 2 0.071 
LAT-D 7.648 2 0.022* 
Amount of Dilation 3.803 2 0.149 
Init 3.225 2 0.199 
End 3.181 2 0.204 
ADV 0.904 2 0.636 
Dia % 0.040 2 0.980 
           * The parameter shows significant effect between groups 
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Table 6-6: The parameter estimates of PLR of two PD patient groups to healthy controls 
 Group Test B DF P value 
 
 
 
 
 
 
 
 
 
 
 
 
Constriction 
Parameters 
 
 
 
 
 
 
 
 
FOG 
Intercept -0.076 1 0.998 
re-ADV 26.551 1 0.020* 
LAT-C 175.773 1 0.022* 
Amount of Constriction -427.556 1 0.652 
End -458.675 1 0.629 
Init 450.402 1 0.635 
T 75% Recovery -10.677 1 0.051 
Con % -1.506 1 0.065 
MCV -6.446 1 0.112 
ACV 5.111 1 0.106 
 
 
 
 
Non-
FOG 
Intercept -6.369 1 0.819 
re-ADV 29.195 1 0.012* 
LAT-C 125.774 1 0.079 
Amount of Constriction -456.701 1 0.630 
End 462.050 1 0.626 
Init -469.458 1 0.621 
T 75% Recovery -2.093 1 0.667 
Con % -0.967 1 0.140 
MCV -3.545 1 0.341 
ACV 4.301 1 0.140 
 
 
 
 
 
 
Dilation 
Parameters 
 
 
 
FOG 
Intercept -9.961 1 0.036* 
LAT-D 11.390 1 0.030* 
Amount of Dilation -13.882 1 0.869 
Init -9.037 1 0.913 
End 11.173 1 0.893 
ADV 0.483 1 0.856 
 
 
Non-
FOG 
Intercept -3.880 1 0.404 
LAT-D 11.308 1 0.023* 
Amount of Dilation -84.252 1 0.243 
Init -74.388 1 0.288 
End 75.091 1 0.285 
ADV 2.439 1 0.368 
     * The parameter shows significant effect between groups. 
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Previous studies showed that maximum constriction velocity and maximum 
constriction acceleration were the best discriminants among PLR constriction 
parameters between PD patients and healthy controls (Yamaji, Hirata, & Usui, 2000, 
Giza et al., 2011; Stergiou et al., 2009; Fotiou et al., 2009). Several reasons could 
explain different findings of our study compared with the previous studies. First, the 
temporal resolution of the pupillometric systems were different. The pupillometer in 
this study had a frame rate of 32 frames per second, whereas the other the 
pupillometric systems were much faster with a frame rate of 263 frames per second.  
 
Second, different studies used different experimental conditions and different 
stimulus light intensities. We used 50 mW as the stimulus intensity in this study. It 
could be that this light level was not sufficient to show PLR dysfunctions among 
some PD patients. Different stimulus intensities can change different PLR responses 
(Bremner, 2012a; Ellis, 1981; Sharma et al., 2016). In addition, the previous studies 
included PD patients with more severe cases, which could contribute to the difference 
in results. Another factor is that the previous studies based their conclusions on 
comparing the ROC curves of the individual parameters. This approach may produce 
different results from the multinomial logistic regression. 
 
PLR parameters are not solely controlled by the motor responses of ANS. Deficits in 
the retina or optic nerve could affect PLR as well. Reduction in retinal illuminance 
levels can reduce light adapted baseline pupil sizes and produce similar decrements in 
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PLR parameters as found in our study (Bremner, 2012a; Ellis, 1981; Sharma et al., 
2016; Bergamin, Zimmerman, & Kardon, 2003; Ellis, 1981). This means that some of 
pupil deficits seen in our results could be a result of retinal dysfunction, given the 
visual acuity and contrast sensitivity losses found in PD subjects.  
 
One PRL parameter deficit that could be either a sensory deficit or parasympathetic 
motor deficit is the minimum pupil size after constriction (i.e. End) (Thiagarajan & 
Ciuffreda, 2015). A deficit in either branch of the pathway could produce a larger 
minimum pupil diameter. Our minimum pupil diameter results do not allow for any 
further analysis on this parameter because there was no significant difference+ 
between groups. This result suggests that the minimum pupil diameter is not a very 
sensitive parameter for measuring pupil deficits in PD patients.  
 
 Another difference that could be due to sensory deficit is a larger initial pupil size 
under light adaptation (Initial). The larger mean FOG PD initial pupil size under light 
conditions suggests that FOG PD group had a larger sensory deficit due to lower 
retinal inputs. This pupil deficit would be consistent with the greater losses found in 
the visual resolution results for FOG subjects. Although a larger pupil size under light  
suggests sensory deficits, it is has been suggested that larger pupil size under light 
conditions reflects dysfunctions in parasympathetic (cholinergic) nervous system due 
to an acetylcholinergic (ACh) reduction (Bremner, 2009; Loewenfeld & Lowenstein, 
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1993). However, this parameter is not considered as a strong indicator of the 
cholinergic system dysfunction (Yamaji, Hirata, & Usui, 2000).  
A third parameter that is known to reflect the retinal contribution to PLR is the 
amount of constriction (Bergamin & Kardon, 2003; Fotiou et al., 2007; Lowenstein, 
Kawabata, & Loewenfeld, 1964). Both PD patient groups had lower amount of 
constriction compared with healthy controls, which suggests that either their retinal 
function or optic nerve function was impaired. Constriction latency (LAT-C) is fourth 
indicator of the sensory inputs to the pupil responses (Bitsios, et al., 1996; Bos, et al., 
1990; Capó-Aponte, et al., 2013). This parameter was shown to be one of the 
strongest discriminator between groups among the r constriction parameters. The 
longer latency for FOG-PD subjects due to a retinal deficit was consistent with our 
finding that FOG PD group had larger deficits in visual acuity and contrast sensitivity 
especially under low light levels (Chapter 4).  
Additional supporting evidence that the PLR deficits were sensory based comes from 
a study by Salter et al (2009). They measured constriction PLR parameters using the 
same device in multiple sclerosis (MS) patients with optical neuritis. Their MS 
patients had reduced high contrast visual acuity, low contrast visual acuity and 
contrast sensitivity. In addition, all of constriction parameters were found to be 
significantly affected in MS patients compared with the healthy controls. Moreover, 
the reduction in constriction percentage, average constriction velocity and maximum 
constriction velocity along with the increase in constriction latency found in the MS  
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group were comparable to the changes found in our PD patients results. They also 
reported that thinning in different retinal layers including total macular volume due to 
optic neuritis could predict the deficits in different constriction PLR parameters. 
Lagreze and Kardon (1998) also found a correlation between the estimated ganglion 
cell loss and the relative afferent pupillary defect (RAPD) in optic neuritis. In his 
review, Simao (2013) summarized a number of studies reporting a thinning of the 
retinal nerve fiber in similar regions of the eye in PD patients. It is possible that this 
retinal deficit underlies the deficits in pupil function. Nevertheless, he pointed out that 
the amount of thinning was not correlated with visual function or duration of the 
disease and so more study about the proposed linkage is required. 
 
Retinal inputs to PLR response is a combination the signals originating at the rods 
and cones and the intrinsic response of the Intrinsically-photosensitive Retinal 
Ganglion Cells (ipRGCs), which project to the pretectum. Although the role of the 
ipRGCs in the PLR response is still being studied, it appears that these cells play a 
major role in maintaining the steady-state size of the pupil (McDougal & Gamlin, 
2010). There is evidence that ipRGCs may be damaged in open angle glaucoma 
(ONG). The differences between red and blue post-illumination pupil responses were 
reduced in patients with ONG relative to controls. A smaller difference between the 
post-illumination responses is believed to indicate damage to ipRGCs (Kankipati, 
Girkin, & Gamlin, 2011). The input into the ipRGCs includes dopaminergic amacrine 
cells and so it is possible that the larger mean pupil size under light adaptation found 
  151 
in the FOG-PD arises from reduced dopaminergic inputs into these cells in addition to 
reduced input from the photoreceptor pathways.  
 
Because it is possible that many of the PLR deficits could be due to a sensory deficit, 
the associations between different PLRs and different 2D visual resolution tests were 
tested by calculating the Pearson correlation coefficients. We used those 2D visual 
resolution tests that showed good discrimination between groups based on the logistic 
regression model. These included contrast sensitivity under low light levels, low 
contrast visual acuity under high light levels and horizontal & vertical Vernier 
acuities under low light levels (Table 4-1). The high contrast visual acuity under high 
light levels was included as well because it would be included any assessment of 
visual function in PD. Table 6-7 shows correlations between PLR parameters and 
high contrast visual acuity under high light levels, and contrast sensitivity under low 
light levels. The correlations with the other 2-D resolution tests are shown on Table 
D1 (Appendix D). None of the correlations in the appendix were significant. The 
majority of correlations in Table 6-7 were also not significant within each group. 
However, there were few exceptions, which are shown on the highlighted cells. The 
lack of consistent correlations across the various visual parameters with PLR 
parameters do not exclude the possibility that some PRL deficits found in this study 
are mainly sensory related, especially if there are separate pathways mediating the 
pupil reflexes and the visual resolution tasks. 
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   Table 6-7: Associations between different PLR and visual resolution tests. 
PLR 
Parameters 
FOG non-FOG HC 
High 
Contrast 
VA 
Photopic 
Contrast 
Sensitivity 
Mesopic 
High 
Contrast 
VA 
Photopic 
Contrast 
Sensitivity 
Mesopic 
High 
Contrast 
VA 
Photopic 
Contrast 
Sensitivity 
Mesopic 
 Init-Con -0.438* -0.025 
0.287 0.0079 0.053 0.10 
 End-Con -0.450* 0.109 
0.136 -0.02 0.11 0.08 
Amount of 
Constriction 
0.003 -0.277 
0.525** 0.109 -0.14 0.12 
 Con % 0.258 -0.220 
0.26 0.047 -0.29 0.03 
LAT-C 0.030 0.055 
-0.37 -0.01 0.24 -0.399* 
 ACV 0.072 -0.404 
0.661** -0.02 -0.22 0.06 
 MCV 0.081 -0.419 
0.642** -0.069 -0.16 0.11 
 re-ADV 0.004 -0.403 
0.26 -0.03 -0.17 0.22 
T75 %  0.086 -0.021 
0.106 0.067 -0.076 0.11 
Init-Dia -0.278 -0.109 
0.25 0.20 0.23 0.038 
 End-Dia -0.234 -0.117 
0.32 0.140 0.13 0.047 
Amount of 
Dilation 
0.010 -0.099 
0.30 -0.113 -0.10 0.058 
Dia % 0.210 -0.168 
0.146 -0.25 -0.30 0.194 
LAT-D 0.215 -0.149 
-0.07 0.23 0.09 -0.048 
ADV 0.015 -0.314 
0.408* -0.078 -0.11 0.065 
(**): Correlation is significant at the 0.01 level  
(*): Correlation is significant at the 0.05 level  
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Nevertheless, we cannot completely rule out a motor pathway dysfunction. First, our 
result that very few of the visual resolution losses correlated with PLR deficits 
suggests that deficits may not be just sensory. A lack of correlation between the PRL 
and VEP latencies was also reported in MS patients when the disease was inactive 
(Jakobsen, 1990; Pozzessere et al., 1997). A study was done on rats found that the 
number of retinal photoreceptors do not predict the PLRs, which suggests the PLR is 
not a good indicator of the integrity of retinal photoreceptor cells (Kovalevsky et al., 
1995). Although none of these findings excludes the possibility that the ganglion cells 
to the pretectum are affected differentially relative to the cells projecting to the LGN, 
it does raise the question as to whether there is also a motor dysfunction.   
 
Second, the result that the initial pupil size under dark adaptation was smaller in the 
non-FOG PD group suggests a motor deficit in this group of PD patients. A smaller 
pupil size in darkness is a sign of either increase in parasympathetic influence or 
reduction in sympathetic input (Bremner, 2009; Loewenfeld & Lowenstein, 1993, 
Pettigrew, Sanderson, & Levick, 1986). Nevertheless, this imbalance was not evident 
in the minimum pupil size during constriction or the during the light adapted state 
before the dilation was measured, which suggests that the result could be due to other 
factors such as attention or general arousal level (Bradley et al.,  2008; Stanners et al., 
1979). As to why these levels would be different in the non-FOG subjects is 
uncertain. 
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Third, the maximum constriction velocity was slower in the two PD groups, which 
suggests a parasympathetic deficit (Bitsios et al., 1996; Bos et al., 1990; Capó-Aponte 
et al., 2013). However, previous studies have shown that there is a positive and 
significant relationship between pupil response velocities with the amplitude size 
change. This means that, if constriction amplitude is lower for a certain disease 
patient, then it is expected that their constriction velocity is slower and there is no 
new information gained by looking at each parameter (Bitsios et al., 1996; Kaufman 
et al., 2011; F. D. Bremner, 2012b; Ciuffreda, Joshi, & Truong, 2017). There was a 
positive and significant relationship between pupil constriction velocities and the 
amplitude size change and both PD groups also had significantly smaller constriction 
amplitudes. Linear regression results of maximum constriction velocity (MCV) vs. 
amplitude of constriction were significant (r ≥ 0.818, p>0.001) for all subject groups.  
Scatterplots of these relationships are shown on Figure 6-3 for all subject groups. All 
of groups showed the expected strong and significant relationships between MCV and 
constriction amplitude. The FOG group has a flatter slope for pupil constriction than 
the other two groups. The results should be interpreted cautiously because these data 
are across subjects and not within, but it suggests that the subjects in the FOG group 
who had a relatively large amplitude of constriction had the slower pupil velocity 
response. This could indicate a deficit in the parasympathetic motor pathway. The 
difference in slopes between the groups suggests that measuring the PRL reflexes as a 
function of light level may help determine separate the sensory deficit from any 
motor deficit.   
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Figure 6-3: Scatter plots of pupil maximum constriction velocity (MCV) as a function 
amplitude of pupil constriction for the subject groups 
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Fourth, it may not possible to exclude the motor contribution to the results of 
constriction latency (LAT-C). Comparisons between FOG and non-FOG PD patient 
groups regarding this parameter showed FOG group had significant longer 
constriction latency compared to non-FOG group. The longer constriction latency 
could suggest deficits in either afferent (sensory) or efferent (motor) parasympathetic 
pathway of ANS. However, constriction latency is not considered as a good as 
maximum constriction velocity to represent the cholinergic (motor) mediated 
pathway of ANS (Capó-Aponte et al., 2013, Yamaji, Hirata, & Usui, 2000).  
 
Delay in T75% recovery time and slower re-dilation velocity were considered to be 
strong indicators of motor impairment in the sympathetic pathway of ANS due to 
adrenergic reduction (Capó-Aponte et al., 2013, Bremner, 2009). Unexpectedly, both 
PD patient groups showed faster recovery time (T75%) and faster re-dilation velocity 
after pupil constriction (re-ADV) compared to healthy controls with FOG being faster 
than non-FOG group on these two parameters. Faster T75% and re-ADV that were 
shown in PD patients could be secondary to less constriction percentages (Con %) 
that were shown among PD patients compared to healthy controls. That means 
because both PD patient groups constricted less than healthy controls, then it 
expected that their re-dilation recovery time and velocity would be faster. This 
finding suggests two things. First, both PD patient groups have no obvious motor 
impairment in the sympathetic pathway of ANS compared to healthy controls. 
Second, faster T75% and re-ADV in PD patient groups is a secondary effect to motor 
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impairment in the parasympathetic pathway of ANS. However, the results of dilation 
latency (LAT-D) showed both PD patient groups had significant delay compared to 
healthy controls. Also, the amount of dilation of non-FOG PD patient were less than 
the other two groups which still it may not possible to exclude the potential 
impairment of sympathetic pathway of ANS among PD patients. Similar to our 
results, it has been found PD patients had faster but not significant 50% re-dilation 
recovery time than healthy controls (Micieli et al., 1991).   
 
Cognitively impaired PD patients have been shown to have more constriction PLR 
deficits than those patients who have normal cognitive function (Stergiou et al., 
2009). The deficits in the cognitive impaired PD patients were similar to the pupil 
dysfunction reported in Alzheimer’s disease patients. This suggests that both groups 
of patients have the same central cholinergic deficit (Fotiou et al., 2009). It has been 
shown that freezing of gait and freezing of gait severity are associated with frontal 
cognitive dysfunction and frontal cognitive dysfunction severity respectively 
(Amboni et al., 2008). Cognitive impairment could be due to degeneration of 
subcortical regions such as locus coeruleus (LC) in brain stem. This area is known to 
be affected in PD and Alzheimer disease patients (Zarow et al., 2003).  
It is possible that the PLR deficits are due to alterations in the brain stem rather than 
more centrally or in the peripheral pathways. The locus coeruleus (LC) in the brain 
stem is one possible site. Pupil size is a good indicator of activity in the LC (Joshi et 
al., 2016; McDougal & Gamlin, 2015). Rapid changes in the release of acetylcholine 
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(ACh) and adrenaline (NE) occur due to variation activity in LC. The LC activity 
changes the pupil responses (Reimer et al., 2016). Because FOG PD patients showed 
larger impairments on some of sympathetic and parasympathetic PLR parameters, it 
is possible that adrenergic and cholinergic systems are impaired in FOG PD patients 
to a greater extent than non-FOG PD patients due to abnormal activities in LC or 
other autonomic cortical centers.    
Although the results confirmed that the PLR were affected in PD, we could not rule 
out that many of these deficits were due to degraded sensory input from the retina. 
The general trend in the results was that the deficits reflect a deficit in the 
parasympathetic pathway, but there is also data suggesting a sympathetic deficit. It is 
possible that measuring the PRL for different light levels may provide a better 
understanding of the pupil deficits in PD. 
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Chapter 7 
VISUAL PROCESSING SPEED IN FREEZING AND NON-FREEZING 
PARKINSON’S DISEASE PATIENTS  
 
7.1 SUMMARY 
Visual information processing speed, or the inspection time (IT), which is 
independent from the motor response, is a reliable measure of the cholinergic system 
integrity. Thus, IT can be used to investigate whether FOG PD patients have a larger 
impairment in cholinergic mediated functions than non-FOG PD patients and healthy 
controls. Results of this study showed that FOG PD patients had slower IT score than 
healthy controls. IT scores for the non-FOG PD patients fell in between the two other 
groups. These results support the hypothesis that the cholinergic system is integrity is 
affected more in FOG PD patients.   
 
7.2 INTRODUCTION 
Inspection time (IT); unlike reaction time (RT); is a reliable measure of visual 
processing speed that does not require any motor responses (Deary & Stough, 1996; 
Johnson et al, 2004b; Nettelbeck, 1982; Thompson, et al, 2000; Vernon, 1986). IT 
can be used to investigate the integrity of the cholinergic mediated functions and can 
predict the intelligence and the cognitive abilities of individuals (Petrill et al., 2001; 
Nathan & Stough, 2001). PD patients have slower ITs relative to healthy controls 
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(Johnson et al. 2004). IT is unaffected by dopaminergic treatment and is independent 
of motor impairments (Giaschi, Lang, & Regan, 1997; Bachmann et al., 1998, 
Shipley et al., 2002, Sawamoto et al. 2002, Johnson et al. 2004). 
As it is already mentioned in previous chapters that freezing of gait (FOG) symptom 
among some PD patients may be independent of the dopaminergic reduction and it is 
now hypothesized that cholinergic system dysfunction may be involved; therefore, 
FOG patients may have slower IT scores compared to non-FOG patients. If this true, 
then slower visual information processing may contribute to the FOG symptoms.   
 
7.3 AIM OF THE STUDY 
The purpose of this study is compare visual information processing speed; or 
inspection time (IT), of PD patients who experience FOG vs. non-FOG to determine 
whether these measurements can discriminate between different PD groups.     
 
7.4 METHODS 
7.4.1 Procedures: 
The inspection time (IT) stimulus was developed using Psychocinematics. The testing 
procedures and protocols of this study were fully explained in Chapter 3. Participants 
of this study were the same of those who participated in the previous studies. 
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7.4.2 Data Analysis:  
Comparisons of IT scores were performed by ANOVA on Ranks test based on the 
median values due to the non-normal distribution of the data. Associations between 
the severity of the disease, duration, and the cognitive status of patients with IT scores 
were evaluated by Pearson correlation coefficient for FOG and non-FOG PD patient 
groups separately. IBM SPSS ver. 24 was used for this data analyses. The criterion of 
p< 0.05 was used to determine a significant effect. 
 
7.5 RESULTS 
Figure 7-1 shows the box plot of IT scores for all groups. Table 7-1 lists the mean, 
standard deviation (SDs), and the median of IT scores in milliseconds for all groups. 
The FOG PD group has the highest (more time needed to process the target) and most 
variable IT scores. ANOVA on Ranks test showed that the differences between 
groups were significant. (ANOVA on Ranks =14.512, DF=2, p<0.001). Pairwise 
multiple comparisons between groups revealed that the difference was only 
significant between healthy control and FOG PD patients. The differences between 
non-FOG PD patient group and other two groups were not significant.  
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           Table 7-1: Means, SDs, and Medians of IT in milliseconds for all groups 
Group 
 
Mean Std. 
Deviation 
Median 
FOG 
(N=22) 
76.8 58.2 58 
non-FOG 
(N=25) 
49.36 21.8 54 
HC 
(N=25) 
36.44 16.48 33 
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Figure 7-1: Box plot shows the differences between groups based on the IT score.                    
The vertical bars represents 10% to 90% percentile, the box represents 25 % to 75% quartiles, 
the solid horizontal line represents median differences, and ● outliers 
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Correlations between the UPDRS score and the IT score for the non-FOG-PD group 
was significant (ρ = 0.446, p=0.025), and the correlation approached significance in 
the FOG-PD subjects (ρ = 0.417, p=0.054) indicating that longer IT were associated 
with more severe PD, especially in the non-FOG. There was no significant correlation 
between the duration of the disease with the IT score in FOG PD group (ρ = -0.34, 
p=0.121), and the non-FOG PD group (ρ = -0.021, p=0.922).  
There was significant negative correlation between the MoCA score and IT score for 
the FOG PD (ρ = -0.432, p= 0.045), non-FOG PD (ρ = -0.476, p=0.016), and HC (ρ = 
-0.411, p=0.0415), confirming that longer IT is associated with lower cognitive 
ability. Figure 7-2 shows the scatterplots of IT and MoCA scores for all subject 
groups. Scatterplots showed that FOG PD patient groups has higher regression y-
intercept and steeper slope than other two groups which means that FOG PD patients 
who had slow IT score are likely to have more cognitive impairments.  
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Figure 7-2: Scatter plots of IT score as a function MoCA score for the subject groups 
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7.6 DISCUSSION 
IT can be used to evaluate the cholinergic system integrity (Nathan & Stough, 2001). 
The longer IT values for the FOG group were consistent with the hypothesis that they 
have a general cholinergic system dysfunction. However, the differences were only 
significant between FOG PD group and healthy controls. Non-FOG PD group fell in 
between with slower and more variable IT score on average than healthy controls; but 
faster than the FOG group. These results suggest that both PD groups had a 
cholinergic deficit, with FOG PD having a more severe impairment. Although not 
unique to the FOG PD patients, the longer processing time could contribute to the 
FOG symptoms. Nevertheless, it is unlikely that the slower visual processing speeds 
are solely responsible for the symptoms given that several FOG subjects had IT 
within the normal range. 
Visual processing speed could be related to one’s ability to resolve the difference in 
the line length. However, the difference in the line length was 55 min arc, which was 
36 times longer than the high contrast acuity limit for inclusion in the study. 
Additional evidence that the difference in lines was easily resolved are the 
correlations between the IT scores and high contrast VA, horizontal Vernier, vertical 
Vernier acuities, and stereo tests. Table 7-2 lists the Pearson correlation coefficients. 
Except for the correlation between IT and vertical Vernier acuity in HC, none of the 
correlations were statistically significant for both patient groups. These findings 
further indicate that the delay in IT in PD patients was not due to the reduction in 
their visual resolution capabilities.   
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         Table 7-2: Correlation coefficients (R) between IT and visual resolution tests for all groups 
Visual Resolution Tests IT 
FOG Non-FOG HC 
High Contrast VA Photopic 0.031 0.223 0.297 
Horizontal Vernier Acuity Photopic -0.065 -0.220 0.251 
Vertical Vernier Acuity Photopic -0.006 -0.025 0.50* 
Local Circles Stereo Test -0.014 0.089 -0.092 
Local Line Stereo Test 0.168 0.162 -0.087 
Global Steps Stereo Test -0.306 0.211 0.414 
Global  Randot3 Stereo Test -0.121 0.103 0.029 
Global TNO Stereo Test 0.050 -0.010 0.423 
 (*): Correlation is significant at the 0.05 level  
 
 
Previous studies that examined IT in PD reported mixed results. Phillips et al., (1999) 
reported that the ITs were not significantly different between PD patients and age-
matched healthy controls, whereas other showed significant differences between the 
two groups (Shipley et al., 2002; Sawamoto et al., 2002). One reason for the mixed 
results was that some of these studies used higher-order of intelligent processing so 
that it was not a simple IT task. However, Johnson et al. (2004) used a similar target 
to the one used in this study. Their results showed that on-medication patients 
required significantly longer IT compared with healthy controls (Johnson, et al, 
2004b). 
Our results may provide additional reasons for the conflicting results between studies. 
First, if FOG subjects are included in the PD group, then the ITs are more likely to be 
longer than controls. None of the previous studies reported whether there were FOG 
PD patients among their study sample. Second, the correlations of IT with the MoCA 
and UPDRS showed if the cognitive ability was impaired or PD was more severe, 
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then the IT of the PD group was more likely to be longer than controls. Our finding 
that IT was longer with lower MoCA scores support the concept that the IT test is a 
reliable measure of the intelligence and the cognitive functions (Petrill et al.,  2001).  
As to why some FOG participants’ ITs increased either before or to a greater extent 
compared to non-FOG participants is not clear. It is believed that the dopaminergic 
reduction in PD does not affect the visual information processing speed (Stough et al 
2001). Moreover, the IT score on the PD patients group was not significantly 
different between ‘ON’ and ‘OFF’ medication status (Johnson et al, 2004b). IT 
processing was found to be influenced by nicotine acetylcholine receptors (nAChRs). 
Pharmacologically blocking the nicotine acetylcholine receptors increased the IT 
score in healthy subjects (Thompson et al., 2000). There is evidence that nicotine 
acetylcholine receptors (nAChRs) are reduced in different locations of the striatum 
that includes the basal ganglia and nigrostriatal pathways. These receptors are 
involved in stimulating the release of dopamine and so the reduction of these 
receptors can cause an attenuation in dopamine release such as the case in PD patients 
(Court et al., 2000). A reduction in nicotine acetylcholine receptors (nAChRs) is also 
associated with reduced cognitive ability (Court et al., 2000). It is possible that the 
FOG patients have the initial loss of the nAChRs in the striatum region and visual 
processing areas that affects both motor and processing speed, whereas non-FOG 
have the initial loss in the cognitive areas that eventually includes visual processing 
speed.     
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The slower IT among FOG PD patients was consistent with the results of Study 2 
(Chapter 4) that FOG PD patients needed more time to perceive the depth in different 
stereoacuity tests. Association between IT and the time to complete the Butterfly 
stereoacuity test was examined by applying Pearson correlation coefficient for the 3 
subject groups separately. The result showed that the two variables are moderately 
and significant correlated to each other for the FOG PD group only (ρ= 0.444, 
p=0.0386). The two variables were not significantly correlated for both non-FOG PD 
(ρ= 0.103, p=0.625) and HC (ρ= 0.114, p=0.588). Figure 7-3 shows the linear 
regression between IT and the time to complete Butterfly stereoacuity test for the 
FOG PD patient group. This result suggest that FOG PD patients needed more time to 
analyze the visual space around them and that may contribute to the occurrence or to 
increase the freezing episodes (Martens, Ellard, & Almeida, 2014). 
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Figure 7-3: Linear regression plot between IT score and the time to complete Butterfly 
stereoacuity test for the FOG PD group. 
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Chapter 8 
GENERAL DISCUSSION AND CONCLUSIONS 
The main objective of this thesis was to evaluate different visual functions using 2-D 
and 3-D clinical tests in persons with PD with a special interest in determining 
whether the functions were affected differentially in persons who experiencing FOG 
symptoms. Measuring the different visual functions could help in determining 
whether any sensory deficits could be contributing to the FOG symptoms.  
Results from Study 1 (Chapter 4) showed that both PD groups had a greater 
impairment in most of 2-D visual resolution tests compared with healthy controls. 
The FOG PD tended to have the larger deficits. The reduction was larger under 
mesopic conditions especially with FOG group. This last finding suggests that the 
deficit was due to decreased dopamine level at the retina affecting the dark adaption 
processes. The results do not show a selective loss of functions mediated by either the 
magno or parvo pathways; however, magno pathway mediated visual functions (i.e. 
the Pelli Robson contrast sensitivity at low light levels, and the Vernier acuity) were 
the best tests at distinguishing between the 3 groups. This suggests that the FOG 
subjects had a larger deficit in the magno (dorsal) pathway.  
 
Results from Study 2 (Chapter 5) showed that both PD groups had lower stereopsis 
than the HC with the FOG having the worse stereopsis. Impairment of global 
stereopsis was shown to be more frequent than the local stereopsis loss in PD groups. 
The reduction in stereopsis among PD participants was not associated with fixation 
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disparity or other 2-D visual resolution tests. These results suggest that stereopsis 
deficits in PD were due to impairments in higher visual centers rather than degraded 
input from each eye or inadequate vergence eye movements. Similar to the finding of 
Study 1, this study suggests that FOG PD participants had greater impairment in 
visual functions that were mediated by the magno (dorsal) pathway (i.e. global 
stereopsis) than non-FOG patients or healthy controls.  
 
Our findings confirm other studies showing that both magno and parvo visual 
pathways deficits may be present in the same group of PD patients. Silva et al. (2005) 
found the deficits in visual functions that were mediated by magno vs. parvo 
pathways were not correlated which is consistent to the results of this study. FOG-PD 
patients did have a preferential impairment in visual function mediated by the dorsal 
(magno) visual pathway, which is consistent with other findings (Lord et al., 2012). 
Our findings in FOG group could reflect a more general impairment of visual 
processing that is mediated by dorsal visual pathway (Davidsdottir et al., 2008). It is 
believed that the visuospatial information that is processed by the dorsal stream is 
used in taking motor actions; thus, the term “vision for action” used to describe the 
dorsal pathway processes (Goodale, 2014). However, that does not exclude the 
contribution of visual information that is processed by ventral visual system. Inputs 
from both systems have been shown to contribute to the motor responses as both 
systems are connected extensively (Goodale, 2014).    
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FOG PD patients have more deficits in visuospatial judgement, motion perception, 
and visual perception of the surrounding space than non-FOG patients and that might 
contribute to their freezing symptoms and walking performance (Almeida and Lebold 
2010). Another study showed that FOG patients underestimated the actual distances 
to a target during both static and dynamic conditions more than non-freezers patients 
and normal individuals (Martens, Ellard, & Almeida, 2014). It is unclear as to how 
much of this deficit was due to the loss of stereopsis since individuals can also use 
monocular depth clues and whether deficits in visual resolution hindered their ability 
to judge distances. 
It is not clear as to how much the reduction in the basic visual functions of visual 
resolution, contrast sensitivity and depth perception contribute to visuospatial and 
motion perception problems during walking among FOG PD patients. Impaired visual 
acuity was found to be associated with reduction of different gait parameters such as 
step length and gait velocity in older adults (Hallemans, et al., 2010; Shin, An, & 
Yoo, 2015; Spaulding et al., 1994). Impaired contrast sensitivity was also found to be 
associated with reduction of different gait parameters such as step width, step length, 
gait velocity and fear of falling (Moes & Lombardi, 2009; Swigler et al., 2012; Wang 
et al., 2012; Wood et al., 2009). Impairment in depth perception was found to be 
associated with difficulties in avoiding obstacles during gait in older adults (Menant, 
St George, Fitzpatrick, & Lord, 2010). It would be important to measure different 
visual functions among PD patients along with walking through gate assessments. 
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This would give more information as to whether the reduction in basic visual 
functions in PD patients can contribute to walking through gates difficulties.   
 
Several studies have shown that visual cues may facilitate or improve the movement 
and walking through gates in PD patients (Vitório et al., 2012). Visual cues such as 
stripes on the floor is one clue. The stripes enhanced the optic flow and the perception 
of these stripes was improved ability of persons with PD to walk through gates 
(Azulay et al., 1999). Because FOG PD patients had greater impairment of contrast 
sensitivity test particularly in low light levels, using high contrast visual cues in a 
well-lit environment may help them overcome their FOG symptoms (Davidsdottir, 
Cronin-Golomb, & Lee, 2005; Mestre, Blin, & Serratrice, 1992).     
The other objective of this thesis was to look at other ocular and perceptual functions 
in FOG and non-FOG PD patients. These include constriction and dilation pupil light 
reflex (PLR) and the visual information processing speed or the inspection time (IT). 
These measurements represent primarily the cholinergic and adrenergic pathways. 
Measuring PLR and IT can help us to determine whether PD patients also have a 
cholinergic deficit in the ANS or higher cortical centers and whether the FOG-PD are 
affected to a greater extent. 
Results from Study 3 (Chapter 6) showed that most of constriction parameters and 
some dilation parameters were affected in both patient groups compared with healthy 
controls. The deficits in constriction parameters in PD patients were believed mainly 
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due to deficits in sensory inputs from the retina or the optic nerve rather than motor 
responses. FOG PD patients had more constriction parameter deficits that are known 
to be mediated by the afferent (sensory) visual pathway such as constriction latency 
(LAT-C). This finding was consistent with the results found in Study 1, which 
showed a greater impairment of different visual functions in FOG PD patients. 
However, it is not that easy to separate the sensory causes from motor responses in 
some of constriction PLR deficits found in this study. The deficits in dilation latency 
and the amount of dilation that were present in both PD groups were likely due to an 
adrenergic system dysfunction. The larger pupils of the FOG PD group in the light 
could be due to a greater imbalance between parasympathetic/sympathetic autonomic 
nervous systems or a sensory deficit.  
Results from study 4 (Chapter 7) showed that FOG PD patients had a slower mean IT 
score than healthy controls. IT score on non-FOG PD patients fell in between the 
other two groups. These results support the Study 3 results that the cholinergic system 
affected in FOG patients more than non-FOG PD patients.  
Different visual parameters that were measured in this thesis were shown to be 
associated with the severity of the disease (UPDRS score), the duration of the disease, 
or with the cognitive status (MoCA score) among the non-FOG PD group but not 
with the FOG PD group. We are not certain why these associations were shown to be 
significant with some cases among non-FOG PD group but not with the FOG PD 
group. Probably FOG PD group was more variable in terms of the severity of the 
disease and cognitive status than non-FOG PD group even though the differences 
  176 
between groups were not statistically significant. The lack of associations between the 
cognitive status (MoCA score) and different visual parameters among FOG PD group 
could also be due to the fact that MoCA test is not considered as a comprehensive test 
for the cognitive impairments. Rather, it is considered as a quick screening test of 
mild cognitive impairments (Nasreddine et al., 2005).  
The results of different studies showed that the FOG PD patient group had larger 
deficits compared to the other two groups in tests that are believed to reflect the 
cholinergic system activities. This may suggest that FOG patients had a larger deficits 
in the central cholinergic system which could contribute to the FOG symptom and 
other motor disturbances. The contribution of cholinergic system to motor functions 
has been studied in PD rat models. It was found that the fall rates was more frequent 
in rats, that were injected with dual 192 IgG-saporin /6-hydroxydopamine (6-OHDA) 
than rats with either isolated cholinergic or isolated dopaminergic lesions(Kucinski et 
al., 2013). This drug partially destroys both cortical cholinergic and dopaminergic 
systems respectively. Kucinski et al. (2013) hypothesized that after dual cholinergic-
dopaminergic lesions, the attentional resources mediated by the cholinergic pathways 
can no longer compensate for the impairment of striatal control of movement in 
complex environment, as a result, falls occurs.     
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CONCLUSIONS: 
Results from Study 1 and Study 2 can be summarized as follows: 
1. Both PD patient groups have greater impairment in basic visual functions that 
are mediated by magno (dorsal) and parvo (ventral) visual functions compared 
with healthy controls. 
2. The impairment was greater in FOG PD patients than non-FOG PD patients 
especially with magno (dorsal) mediated visual functions.  
3. It was not possible to determine whether the reduction in 2-D visual resolution 
tests was due to dopamine deficits at the retinal or cortical level. However, the 
reduction in 3-D visual resolution tests in PD was likely caused by deficits at 
the cortical level. 
Results of study 3 and study 4 can be summarized as follows: 
1. Both PD patient groups had pupillary light reflex parameter abnormalities. 
It was difficult to determine whether the abnormalities were due to 
impaired sensory input or deficits in the parasympathetic motor input. 
Nevertheless, the FOG-PD group had larger differences for the parameters 
that were likely due to a sensory impairment, whereas parameters that 
were likely due to motor deficits were equally affected in both PD groups. 
There was also evidence that the pupillary sympathetic pathway was 
affected in PD. 
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2. The slower IT in FOG PD patients support the hypothesis that they may 
have a cholinergic system dysfunction in the higher cortical centers that 
process visual information.   
 
Finally, the results of this thesis show that FOG PD patients had more deficits in 
different visual and other perceptual functions than other two groups, and the non-
FOG PD patients had more visual deficits than healthy controls. These findings may 
suggest that the non-motor functions (i.e. sensory visual functions) can predict the 
occurrence of FOG symptoms better than the motor dysfunctions. This conclusion 
agrees with previous finding that the loss in contrast sensitivity can predict the FOG 
symptom better than the motor dysfunctions (Davidsdottir et al., 2005). Given these 
findings, PD patients are encouraged to check their eyes in routine basis and make 
sure their vision is fully corrected in order to avoid any movement difficulties 
especially in crowded and/or dim lighted environment.  
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Appendix A 
Table A1: Demographic Characteristics of FOG PD Patients 
ID Age Sex UPDRS- 
Score 
Duration MoCA 
Score 
Treatment List 
F001 63 M 25 20 28 Sinemet, Amantadine 
F002 81 M 29 4 21 Sinemet 
F003 81 M 21 2.5 24 Sinemet 
F004 69 M 16.5 20 25 Stalevo, Mirapex 
F005 76 M 39.5 4 19 Sinemet 
F006 72 M 18 12 29 Sinemet, Comtan, Mirapex 
F007 60 M 13.5 18 28 Amantadine 
F008 76 M 31.5 1 25 No Meds 
F009 73 M 14 3 28 Apo-levocarb, Azilect 
F010 74 F 21.5 8 26 Sinemet 
F011 59 F 32.5 1 28 No Meds 
F012 66 F 20 12 20 Sinemet, Seroquel 
F013 72 F 24 7 27 Sinemet/Apo-levocarb 
F014 77 M 18.5 14 25 Sinemet, Requip 
F015 78 M 28 6 26 Sinemet 
F016 75 M 10 13 25 Sinemet, Stalevo, Requip, Azilect 
F017 87 M 31.5 12 10 Sinemet 
F018 76 M 29 18 27 Sinemet, Amantadine 
F019 73 M 22 17 26 Sinemet 
F020 68 M 7 14 28 Sinemet, SinemetCR, Azilect 
F021 69 F 23 5 27 Sinemet, Requip 
F022 66 M 18 20 27 Sinemet 
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Table A2: Demographic Characteristics of non-FOG PD Patients 
ID Age Sex UPDRS- 
Score 
Duration MoCA 
Score 
Treatment List 
N001 59 F 22 14 28 Sinemet 
N002 84 M 22 2 25 Sinemet 
N003 58 M 13.5 14 24 Sinemet, Amantadine, Apo-trihexphenidyl 
N004 90 M 7.5 15 25 Sinemet 
N005 67 F 29 6 23 Sinemet, Mirapex 
N006 60 M 9 13 30 Sinemet, Stalevo, Requip, Mirtazipine 
N007 59 M 9 10 26 Sinemet, Stalevo 
N008 71 M 17.5 12 28 Sinemet, Mirtazipine 
N009 67 M 19.5 4 25 Apo-levocarb 
N010 77 M 13 2.5 23 Sinemet 
N011 71 M 18.5 1.5 25 Apo-levocarb 
N012 65 F 29.5 1 25 Sinemet 
N013 58 F 9.5 5 29 Sinemet, Azilect, Entacapone 
N014 65 M 19 3 25 Apo-levocarb 
N015 63 M 25.5 7 26 Sinemet 
N016 56 M 24 1 28 Apo-levocarb 
N017 54 M 53.5 10 22 Apo-levocarb, Trihexphenidyl 
N018 69 M 16 24 29 Sinemet, Amantadine 
N019 80 M 28 13 25 Prolopa 
N020 76 M 20.5 5 29 Sinemet 
N021 76 M 22.5 8 25 Apo-levocarb 
N022 71 F 26 6 24 Trihexphenidyl 
N023 74 M 20 3 25 Sinemet 
N024 58 M 11 1 27 Sinemet 
N025 60 F 13.5 21 23 Sinemet, Amantadine 
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Appendix B                                                                                                       
STUDY 1 RESULT TABLES 
 
Table B1: Means, Standard deviations, and standard error of the means for different 
visual acuity conditions for all groups  
 
Group 
Bright (Photopic) Condition Dim (Mesopic) Condition 
High Contrast Low Contrast High Contrast Low Contrast 
 
 
FOG 
(N=22) 
Mean 0.078 0.29 0.35 0.70 
Std. Deviation 0.059 0.108 0.13 0.159 
Std. Error of 
Mean 
0.012 0.023 0.028 0.034 
 
 
non-FOG 
(N=25) 
Mean 0.038 0.26 0.26 0.60 
Std. Deviation 0.085 0.12 0.11 0.159 
Std. Error of 
Mean 
0.017 0.024 0.022 0.031 
 
 
HC 
(N=25) 
Mean -0.024 0.17 0.176 0.45 
Std. Deviation 0.091 0.089 0.112 0.145 
Std. Error of 
Mean 
0.018 0.017 0.022 0.029 
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Table B2: Means, Standard deviations, and standard error of the means for different 
contrast sensitivity conditions for all groups  
 
Group 
Contrast Sensitivity 
Bright (Photopic) 
Condition 
Dim (Mesopic) 
Condition 
 
 
FOG 
(N=22) 
Mean 1.588 0.831 
Std. Deviation 0.110 0.309 
Std. Error of 
Mean 
0.023 0.066 
 
 
non-FOG 
(N=25) 
Mean 1.704 1.170 
Std. Deviation 0.136 0.178 
Std. Error of 
Mean 
0.027 0.035 
 
 
HC 
(N=25) 
Mean 1.812 1.326 
Std. Deviation 0.129 .0172 
Std. Error of 
Mean 
0.025 0.034 
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Table B3: Means, Standard deviations, and standard error of the means for different Vernier 
acuity conditions for all groups  
 
Group 
Bright (Photopic) Condition Dim (Mesopic) Condition 
Horizontal Vertical Horizontal Vertical 
 
 
FOG 
(N=22) 
Mean 42.32 43.65 111.85 110.26 
Std. Deviation 28.30 28.67 33.28 35.32 
Std. Error of 
Mean 
6.03 6.11 7.09 7.53 
 
 
non-FOG 
(N=25) 
Mean 23.66 24.36 85.32 92.79 
Std. Deviation 14.49 13.68 39.53 35.71 
Std. Error of 
Mean 
2.89 2.73 7.90 7.14 
 
 
HC 
(N=25) 
Mean 17.37 18.99 43.56 50.36 
Std. Deviation 10.95 10.38 34.09 34.93 
Std. Error of 
Mean 
2.191 2.076 6.81 6.98 
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Appendix C 
STUDY 2 RESULT TABLES 
 
Table C1: Medians, the minimums, the maximums, and the ranges of the local stereoacuity 
tests for all groups 
 
Group 
Circles Test Line Test 
Crossed Uncrossed Crossed Uncrossed 
 
 
FOG 
(N=22) 
Median 80 100 60 60 
Minimum 40 40 10 10 
Maximum 140 200 120 180 
Range 100 160 110 170 
 
 
non-FOG 
(N=25) 
Median 50 50 20 20 
Minimum 40 40 10 10 
Maximum 140 140 120 120 
Range 100 100 110 110 
 
 
HC 
(N=25) 
Median 40 40 10 10 
Minimum 40 40 10 10 
Maximum 100 80 60 60 
Range 60 40 50 50 
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Table C2: Frequencies of participants who attained different stereothreshold criteria on 
local tests 
Groups Criteria 
Circles Test Line Test 
Crossed Uncrossed Crossed Uncrossed 
FOG 
(N=22) 
 
Minimum 
 
1                  
(4.5 %) 
1              
(4.5 %) 
2             
(9 %) 
2              
(9 %) 
≤ 60”  
9              
(40.9 %) 
9             
(40.9 %) 
21                       
(95.45 %) 
19                       
(86.36 %) 
No 
Maximum 
0 0 0 
0 
non-FOG 
(N=25) 
 
Minimum 
 
10                  
(40 %) 
10             
(40 %) 
9             
(36 %) 
8             
(32 %) 
≤ 60”  
19                  
(76 %) 
15                  
(60 %) 
22                  
(88 %) 
20                  
(80 %) 
No 
Maximum 
0 0 0 
0 
HC 
(N=25) 
 
Minimum 
 
23                  
(92 %) 
21             
(84 %) 
22             
(88 %) 
21              
(84 %) 
≤ 60”  
24                  
(96 %) 
24              
(96 %) 
25            
(100 %) 
25              
(100 %) 
No 
Maximum 
0 0 0 
0 
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Table C3: Means and standard error of the means of the times needed to perceive local 
stereoacuity tests for all groups 
 
Group 
Circles Test Line Test 
Crossed Uncrossed Crossed Uncrossed 
 
FOG 
(N=22) 
Mean 46.3 42.2 50.1 48.3 
SEM 4.5 3.3 4.5 4.4 
 
non-FOG 
(N=25) 
Mean 38.2 37.2 39.1 40.1 
SEM 3.1 2.9 3.6 3.6 
 
HC 
(N=25) 
Mean 29.8 26.92 21.4 20.4 
SEM 3.7 2.4 2.5 2.3 
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Table C4: Medians, the minimums, the maximums, and the ranges of the global stereoacuity 
tests for all groups 
 
Group 
Steps Test Randot 3 Test TNO Test 
Crossed Uncrossed Crossed Uncrossed Crossed Uncrossed 
 
 
FOG 
(N=22) 
Median 720 720 320 320 720 960 
Minimum 60 60 25 25 60 120 
Maximum 720 720 320 320 960 960 
Range 660 660 295 295 900 840 
 
 
non-FOG 
(N=25) 
Median 180 180 160 160 240 240 
Minimum 30 30 12.50 12.50 30 30 
Maximum 720 720 320 320 960 960 
Range 690 690 307.50 307.50 930 930 
 
 
HC 
(N=25) 
Median 60 60 40 40 60 120 
Minimum 30 30 12.50 12.50 30 30 
Maximum 720 720 63 100 960 960 
Range 690 690 50.50 87.50 930 930 
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Table C5: Frequencies of participants who attained different stereothreshold criteria on 
global tests 
Groups Criteria 
Steps Test Randot 3 Test TNO Test 
Crossed Uncrossed Crossed Crossed Crossed Uncrossed 
FOG 
(N=22) 
 
Minimum 
 
0 0 0 
0 0 0 
≤ 60”  
1               
(4.5 %) 
1            
(4.5 %) 
4                       
(18.18 %) 
4                       
(18.18 %) 
1            
(4.5 %) 
0 
No 
Maximum 
14               
(63.63 %) 
14            
(63.63 %) 
17                       
(77.27 %) 
17                       
(77.27 %) 
11            
(50 %) 
12            
(54.5 %) 
non-FOG 
(N=25) 
 
Minimum 
 
1              
(4 %) 
1           
(4%) 
1                       
(4 %) 
1                      
(4 %) 
0 0 
≤ 60”  
4               
(16 %) 
3            
(12 %) 
9                       
(36 %) 
7                       
(28 %) 
7           
(28 %) 
7            
(28 %) 
No 
Maximum 
8               
(32 %) 
8            
(32 %) 
10                       
(40 %) 
10                       
(40 %) 
3           
(12 %) 
2            (8 
%) 
HC 
(N=25) 
 
Minimum 
 
9               
(36 %) 
7            
(28 %) 
2                       
(8 %) 
2                       
(8 %) 
0             0             
≤ 60”  
20              
(80 %) 
19          
(76 %) 
25                       
(100 %) 
22                       
(88 %) 
16            
(64 %) 
12            
(48 %) 
No 
Maximum 
1               
(4 %) 
1               
(4 %) 
0 
0 1               
(4 %) 
1               
(4 %) 
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Table C6: Means and standard error of the means of the times needed to perceive global 
stereoacuity tests for all groups 
 
Group 
Steps Test Randot 3 Test TNO Test Butterfly 
Test 
Crossed Uncrossed Crossed Uncrossed Crossed Uncrossed 
 
FOG 
(N=22) 
Mean 72.1 72.3 82.9 80.7 76.3 73.7 54.5 
SEM 5.6 5.6 3.5 4. 3.7 4.6 5.1 
 
non-FOG 
(N=25) 
Mean 68 68 73 73 68 68.6 33.3 
SEM 5.1 4.9 4.3 4.4 4.2 4.8 2.7 
 
HC 
(N=25) 
Mean 39.2 39.8 56.9 52.9 62.2 63.1 16.9 
SEM 4.1 4.3 4.1 4.6 3.9 3.9 3.1 
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Table C7: Means, SDs, Medians, and SEMs for different fixation disparity parameters 
for all groups  
 
Group 
Horizontal Fixation Disparity Parameters 
Fixation Disparity      
(Y-Intercept) 
Associated Phoria 
(X-Intercept) 
Slope 
 
 
FOG 
(N=22) 
Mean -0.4091 -1.0455 -0.1068 
Std. Deviation 1.333 2.645 0.420 
Median 0 0 0 
Std. Error of 
Mean 
0.284 0.563 0.089 
 
 
non-FOG 
(N=25) 
Mean -0.60 -0.84 -0.083 
Std. Deviation 1 1.99 0.353 
Median 0 0 -0.1600 
Std. Error of 
Mean 
0.20 0.398 0.070 
 
 
HC 
(N=25) 
Mean -0.68 -1.20 -0.030 
Std. Deviation 0.90 1.870 0.229 
Median 0 0 0 
Std. Error of 
Mean 
0.180 0.374 0.045 
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Table C8: Frequencies of participants who had different fixation disparity curve type 
Groups Type 1 
 
Type 2 
 
Type 3 
 
Type 4 
FOG 
(N=22) 
13                  
(59 %) 
1                  
(4.5 %) 
3              
(13.63 %) 
5             
(22.72 %) 
non-FOG 
(N=25) 
17                  
(68 %) 
 
0 
4             
(16 %) 
4             
(16 %) 
HC 
(N=25) 
 20                  
(80 %) 
1                  
(4 %) 
4             
(16 %) 
0 
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Appendix D 
STUDY 3 RESULT TABLE 
 
Table D1: Associations between different PLR and visual resolution tests. 
 
PLR 
Parameters 
FOG non-FOG HC 
Low 
Contrast 
VA 
Photopic 
H. 
Vernier 
Mesopic 
 
V. 
Vernier 
Mesopic 
Low 
Contrast 
VA 
Photopic 
H. 
Vernier 
Mesopic 
 
V. 
Vernier 
Mesopic 
 
Low 
Contrast 
VA 
Photopic 
H. 
Vernier 
Mesopic 
 
V. 
Vernier 
Mesopic 
 Init-Con -.290 -.003 -.026 .112 -.111 -.141 -.042 .150 .089 
 End-Con -.404 .079 .085 .027 -.057 -.119 .012 .199 .127 
Amount of 
Constriction 
.220 -.169 -.230 .252 -.173 -.105 -.171 -.038 -.049 
 Con % .331 -.181 -.218 .149 -.177 -.058 -.209 -.245 -.175 
LAT-C -.033 -.248 -.218 -.109 .210 .034 .378 .231 .226 
 ACV .083 .174 .204 .268 -.235 -.119 -.304 -.124 -.104 
 MCV .177 .087 .019 .234 -.265 -.136 -.237 -.129 -.104 
 re-ADV -.026 .272 .251 .051 .087 .152 -.263 -.127 -.046 
T75 %  .303 .158 .328 .258 .071 .087 -.097 .095 -.072 
Init-Dia -.200 -.053 -.035 .047 .034 -.005 .284 .073 -.008 
 End-Dia -.187 -.023 .005 .049 -.007 .002 .126 .090 .007 
Amount of 
Dilation 
-.068 .092 .143 -.037 -.083 .054 -.243 .098 .036 
Dia % .072 .116 .155 -.073 -.070 .087 -.525 .016 -.018 
LAT-D .298 .041 .146 -.175 .020 -.078 .249 -.031 .027 
ADV .110 .227 .195 -.042 -.179 .057 -.216 .066 .017 
 None of correlations were significant at 0.05 level
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
